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ABSTRACT 
Fascioliasis is a zoonotic parasitic disease caused by Fasciola hepatica and F. gigantica. Emergence of 
human fascioliasis prompted a worldwide control initiative including a pilot study in several countries. 
Given the necessity to characterize the fasciolid populations involved, the overall aim of the present 
research is, first, the phenotypic characterization of faciolid adults and eggs implicated in human 
endemic areas, where this initiative has been implemented, through a computer image analysis 
system (CIAS) applied on the basis of standardized measurements. Second, new immunological 
techniques and their potential use as immunological diagnostic tests in those areas are evaluated. 
The specific results have been grouped into five parts. A) Characterization of eggs of both F. hepatica
and F. gigantica for their differential diagnosis. The study revealed that eggs shed by humans show 
morphological traits different from eggs shed by animals. In humans, F. hepatica eggs are bigger and 
F. gigantica eggs are smaller than reported to date from livestock, and their measurements overlap 
when compared. B) Study of the correlation between egg-shedding and uterus development in F.
hepatica human and animal isolates. Uterus area (UA) development of adult F. hepatica obtained at 
different days post infection (dpi) in a Wistar rat model with isolates obtained from cattle, sheep, 
pigs and humans from the endemic human fascioliasis zone of the Northern Bolivian Altiplano was 
analysed and compared with the number of eggs shed per gram of faeces as obtained through the 
Kato–Katz technique. This work shows a positive correlation between liver fluke UA and egg 
production. C) Study of F. hepatica phenotypic characterization in Andean human endemic areas. The 
results showed that two phenotypic patterns could be distinguished in F. hepatica adult size: the 
valley pattern (Cajamarca and Mantaro, Peru) and the altiplanic pattern (northern Altiplano, Bolivia). 
Furthermore, the Andean valley population and European standard populations presented phenotypic 
homogeneity. The Altiplano population showed a large size range with a pronouncedly lower 
minimum size, indicating that uterus gravidity is reached at a smaller size than in valley populations. 
D) Study of the DRG Fasciola hepatica IgG ELISA test as a serological diagnostic tool of human
fascioliasis in different epidemiological situations. The study shows that sensitivity and specificity of 
the DRG assay were 95.3% (95% confidence intervals, 82,9–99,2%) and 95,7% (95% confidence 
intervals, 92,3–97,5%), respectively. No correlation between egg output and the optical density (OD) 
values of the test was observed.  E) Field evaluation of the MM3 coproantigen detection test for 
fascioliasis diagnosis and surveillance in human hyperendemic areas of Andean countries. As part of 
the above-mentioned control initiative, two hyperendemic areas were chosen: Huacullani, Northern 
Altiplano, Bolivia, representing the Altiplanic transmission pattern with high prevalences and 
intensities; the Cajamarca valley, Peru, representing the valley pattern with high prevalences but low 
intensities. It can be concluded that the coproantigen-detection test allows for high sensitivity and 
specificity, fast mass screening, detection in the chronic phase, early detection of treatment failure or 
reinfection in post-treated subjects, and is convenient in surveillance programmes. However, this 
technique falls short when evaluating the fluke burden on its own. 
KEY WORDS: F. hepatica, F. gigantica, adult, uterus, egg, number per gram of faeces, biometry, 
growth model, principal component analysis, experimental population, natural population, Wistar, 
human, sheep, cattle, pig, Bolivian Altiplano, Cajamarca valley, Mantaro valley, Bolivia, Peru, 
Georgia, Egypt, Vietnam, worldwide control initiative, DRG Fasciola hepatica test, MM3 coproantigen. 
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1.1. FASCIOLIASIS WORLDWIDE 
Fascioliasis is an important human and animal disease caused by the 
trematode species Fasciola hepatica and F. gigantica, depending on the causal 
agent it is a parasitic disease of different epidemiological, pathological and control 
characteristics. F. hepatica has a cosmopolitan distribution, mainly in temperate
zones, while F. gigantica is found in tropical regions of Africa and Asia. However, the 
two fasciolid species overlap in large regions (MAS-COMA & BARGUES, 1997). 
Fascioliasis in livestock has always been recognized as a veterinary problem on a 
worldwide scale, but in humans the disease was only considered of secondary 
importance until the end of the 1980´s owing to the relative small number of 
human reports. Only about 2000 human cases were reported in the 25 years 
previous to 1990 (CHEN & MOTT, 1990). This scenario changed dramatically after 
the initiative launched by the World Health Organization at the beginning of the 
1990´s. At present, estimates for all continents reach 17 million people to be 
infected, and this may even be an underestimate when the total lack of data 
concerning numerous Asian and African countries is considered (MAS-COMA, 2005). 
At present, fascioliasis is emerging or re-emerging in numerous regions of 
Latin America, Africa, Europe and Asia, both in humans and animals (MAS-COMA et 
al., 2009a), a phenomenon which could partly be related to climate change (MAS-
COMA et al., 2008, 2009b). Major human health problems are encountered in 
Andean countries (Bolivia, Peru, Chile and Ecuador), the Caribbean (Cuba), 
northern Africa (Egypt), south western Europe (Portugal, France and Spain) and the 
Caspian area (Iran and neighbouring countries) (MAS-COMA, 2005). Emergence, 
long-term pathogenicity (VALERO et al, 2003, 2006a, 2008) and immunological 
interactions (BRADY et al., 1999; GIRONES et al., 2007) prompted WHO to include 
this disease among the so-called neglected tropical diseases (NTDs), which are 
chronic, debilitating, poverty-promoting and among the most common causes of 
morbidity in developing countries. Their control and elimination is now recognized 
as a priority to achieve the United Nations Millennium Development Goals and 
targets for sustainable poverty reduction (HOTEZ et al., 2007, 2008).  
In the Americas, among Andean countries, the highest human fascioliasis 
prevalence and intensities are encountered in the northern Altiplano of both Bolivia 
(ESTEBAN et al., 1997; MAS-COMA et al., 1999a) and Peru (ESTEBAN et al., 2002), 
Tesis doctoral: Ignacio Pérez Crespo 
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as well as in the Cajamarca valley (Peru) (ORTIZ et al., 2000; HILLYER et al., 
2001; ESPINOZA et al., 2007; GONZALEZ et al., 2011), and in the Mantaro valley 
(Peru), (STORK et al., 1973; MARCOS et al., 2004) where F. hepatica is the only
fasciolid species present (VALERO et al., 1999, 2001) and children and females 
appear to be the most affected subjects (MAS-COMA, 2005; MAS-COMA et al., 
2005, 2009a). Within the human fascioliasis high altitude transmission pattern 
related to F. hepatica transmitted by Lymnaeid vectors of the Galba/Fossaria group 
in Andean countries, two different sub-patterns have been distinguished according 
to physiographic and seasonal characteristics (MAS-COMA, 2005; MAS-COMA et al., 
2009a): 
a) the altiplanic pattern, with endemicity distributed throughout an area of
homogeneous altitude and transmission throughout the whole year caused
by high evapotranspiration rates leading lymnaeid vectors to concentrate in
permanent water bodies, e.g. the northern Bolivian Altiplano (MAS-COMA
et al., 1999a; FUENTES et al., 1999)
b) the valley pattern, with endemicity distributed throughout an area of
heterogeneous altitude and seasonal transmission related to climate, e.g.
the Cajamarca valley in Peru (CLAXTON et al., 1997, 1999; GONZALEZ et
al., 2011).
In developed countries, patients are diagnosed in hospitals or other health 
centres usually during the acute phase or at the beginning of the chronic phase. On 
the contrary, infected subjects detected in surveys in human endemic areas of 
developing countries are mainly in the advanced stage of chronicity, when not 
already re-infected due to the high contamination risk, as the liver fluke is able to 
survive up to 13.5 years in human beings (MAS-COMA et al., 2005). The public 
health impact of this scenario has reached an importance never expected before, 
owing to the above-mentioned (i) great pathogenicity of long-term liver fluke 
infection proven experimentally (VALERO et al., 2003, 2006a, 2008) and (ii) the 
immune-modulation of fasciolids in the acute phase (BRADY et al., 1999) and their 
immune suppression effect in chronic and advanced chronic phases (GIRONES et 
al., 2007), which is in the background of co-infections with other parasitic and 
infectious diseases (MAS-COMA et al., 2005). In recent years, the availability of a 
very effective drug against fascioliasis, namely triclabendazole (SAVIOLI et al., 
1999), prompted WHO to launch a worldwide initiative against human fascioliasis 
(WHO, 2007, 2008). This initiative implements control activities against human 
fascioliasis in endemic areas presenting different epidemiological situations and 
Introduction 
19 
transmission patterns (MAS-COMA, 2005; MAS-COMA et al., 2009a). Bolivia and 
Peru are two of the countries selected for priority intervention due to the high 
public health problem caused by this disease. Different pilot schemes were 
designed to assess the best control strategies according to the different 
epidemiological situations and transmission patterns. The Northern Bolivian 
Altiplano was chosen as an example of the altiplanic pattern, while the Cajamarca 
valley was chosen as an example of the valley pattern. 
In addition to this, WHO decided in October 2006 to launch a worldwide 
initiative against this disease (WHO, 2007) based on the success of obtaining a 
donation of Egaten®, the only highly efficient drug presently available for human 
treatments (WHO, 2008). After an initial pilot scheme in Vietnam, Egypt, Peru and 
Bolivia, this initiative is currently being extended to many other countries. 
Therefore, the capacity to correctly diagnose human fascioliasis becomes crucial. 
Unfortunately, there are some unavoidable difficulties in human fascioliasis 
diagnosis in human endemic areas of developing countries. Thus, indirect tests, 
either serological or using coproantigens, are useless for intensity estimation, are 
generally expensive and require a minimum of laboratory infrastructure. 
Furthermore, indirect tests have so far never proved to be able to differentiate 
between infection by F. hepatica and F. gigantica, an important aspect considering 
the higher pathogenicity of the latter due to its larger fluke size but also because of 
their different epidemiology, transmission and control characteristics. Molecular 
tests have shown to be useful for differential diagnosis (MARCILLA et al., 2002), but 
are often unaffordable, too. Therefore, direct coprological analysis for the detection 
and identification of fasciolid eggs continues to be the most appropriate diagnostic 
strategy for both detection of infection and estimation of intensity, not only for 
those human endemic rural areas but also for the implementation of the WHO 
treatment drive. This conclusion is reached even in spite of the recognized lower 
sensitivity of egg detection in faecal samples and its uselessness for the diagnosis 
of patients in the acute phase (HILLYER, 1999), as well as the lack of an accurate 
relationship between egg counts per gram of faeces and the fluke burden (VALERO 
et al., 2006b). Moreover, in areas of Africa and Asia where the two fasciolid species 
overlap, fluke egg size was believed to be the only method allowing the differential 
diagnosis between F. hepatica and F. gigantica. The use of serological tests or the 
lack of a calibrated microscope for measurements with an ocular micrometer 
explains why subjects diagnosed from areas where both species co-exist are 
currently referred to as infected by Fasciola sp. (MAS-COMA et al., 2005). In such a 
situation it is surprising that an analysis of the size of eggs shed by humans has 
never been carried out, so that in fact an extrapolation of the size of the fluke eggs 
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shed by livestock species has always been used for human diagnosis. In fascioliasis, 
the usual diagnosis during the biliary stage of infection is based on the classification 
of eggs found in stools, duodenal contents or bile. However, large variations were 
first observed in the size of F. hepatica eggs in livestock from different geographical 
locations (TINAR, 1984). Furthermore, it has been experimentally shown that the 
final host species (sheep, cattle, pig and donkey) decisively influences the size of 
the F. hepatica eggs even within the same endemic area (northern Bolivian 
Altiplano) (VALERO et al., 2001a). The problem has even been further aggravated 
by the confirmation of the existence of morphologically intermediate forms between 
the two fasciolid species and genetic hybrids of both in overlapping areas, endemic 
for animals (ITAGAKI et al., 2005; SEMYENOVA et al., 2006) and humans in Africa 
(PERIAGO et al., 2008) and Asia (ASHRAFI et al., 2006; LE et al., 2008). The 
existence of these intermediate forms has been molecularly verified to be not only 
common but even the rule in these overlapping areas (BARGUES et al., in prep.) 
and poses a question mark on whether egg characteristics are suitable as a tool for 
the differential diagnosis of fascioliasis caused by either species. A concrete 
example of this problem has been recently emphasized in the diagnosis of 
fascioliasis in humans (INOUE et al., 2007). 
As aforementioned, an alternative to coprological egg detection is the use of 
immunodiagnostic tests based on the detection of anti-Fasciola antibodies and/or 
coproantigens released by the parasite. Nevertheless, surveys on human fascioliasis 
have usually been made through various coprological techniques verifying the 
presence of eggs in stools (VALERO et al., 2009a) and antibody detection tests to 
confirm the diagnosis of human fascioliasis (HILLYER, 1999). Among these 
techniques, classical coprological egg detection methods are the most frequently 
used (CHEN & MOTT, 1990; MAS-COMA et al., 1999b). However, the use of 
coproantigen detection was applied to diagnose F. hepatica infection in patients 
only in Cuba (ESPINO et al., 1998; MILLAN et al., 2000). The enzyme-linked 
immunosorbent assay (ELISA) methods developed for determination of Fasciola 
coproantigens in stool samples from animals and humans provide an alternative to 
coprological examination (ESPINO & FINLAY, 1994; ABDEL-RAHMAN et al., 1998). 
One of these methods is the MM3 capture ELISA (MM3-COPRO) test for fascioliasis 
diagnosis detection of fecal excretory-secretory antigens (ESAs) by using the 
monoclonal antibody (mAb), whose usefulness for detection of F. hepatica and F. 
gigantica coproantigens in experimental and natural Fasciola infections of sheep 
and cattle has already been demonstrated (MEZO et al., 2004; VALERO et al., 
2009b). This test proved to be highly sensitive (confirmed by necropsy) and specific 
(no cross reaction was observed with antigens from other helminths), and allowed 
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for the detection of Fasciola infections 1–5 weeks before patency in cattle. 
Furthermore, other researchers recently tested a commercial version of the test, 
and its appropriateness for the detection of F. hepatica infections in cattle was 
confirmed under field conditions (CHARLIER et al., 2008). The suitability of the 
MM3-COPRO method for detection of Fasciola coproantigens in both fresh and 
preserved stools from hospital patients has been demonstrated (UBEIRA et al., 
2009), but its application for detection of F. hepatica infections in humans under 
field conditions has not been proved. 
Counting with an efficient coproantigen test for human fascioliasis diagnosis 
could represent a valuable tool to facilitate population screening and post-treatment 
surveillance to be implemented within control campaigns, above all in communities 
were people do not accept to furnish stool samples due to ethnic/religious aspects. 
1.2. OBJECTIVES 
The overall aim of the present research is the phenotypic characterization of 
faciolids adults and eggs from human endemic areas. Moreover, new techniques 
and their potential use as immunological diagnostic tests in those areas are 
evaluated. 
To reach the first target, the following specific objectives are addressed: 
• characterization of eggs of both F. hepatica and F. gigantica for their
differential diagnosis;
• to analyse the possible relationship between the liver fluke uterus area and
egg-shedding;
• to phenotypically characterise F. hepatica in Andean human endemic areas.
To reach the latter target: 
• to validate the DRG F. hepatica IgG ELISA test as a serological 
diagnostic test in human fascioliasis;
• to validate MM3-COPRO ELISA test as new coprological human 
fascioliasis test.

MATERIAL Y METODOS 
MATERIAL AND METHODS 

2. MATERIAL Y METODOS
2.1. MATERIAL PARASITOLOGICO PARA EL ESTUDIO MORFOMETRICO 
2.1.1. RECOLECCION HUEVOS DE FASCIOLA 
La fijación ejerce una influencia decisiva sobre el tamaño y la forma de los 
huevos de helmintos. Por este motivo, en el presente estudio, los huevos utilizados 
no estaban fijados si no que estaban suspendidos en agua y guardados en 
oscuridad a 4 ºC hasta su utilización. Tras su obtención, los huevos se midieron 
dentro de la siguiente quincena. 
2.1.1.1. HUEVOS PROCEDENTES DE HUMANOS 
Se analizaron un total de 1049 huevos procedentes de humanos. El material 
de Bolivia, Perú y Egipto se obtuvo de individuos de una escuela, el material de 
Georgia procedió de individuos dentro de un estudio de población total y el material 
de Vietnam se obtuvo de pacientes adultos del Hospital Quy Nhon. Se analizó el 
siguiente material: 
 154 huevos procedente de 5 niños (6-12 años de edad) de Huacullani (en
el Altiplano norte de Bolivia)
 167 huevos procedente de 4 niños (7-14 años de edad) de Santa Rosa de
Chaquil (en el Valle de Cajamarca, Perú)
 53 huevos procedente de 3 individuos (10-40 años de edad) de Akhali
Terjola e Itkhvisi (en la región de Kutaisi, Georgia)
 608 huevos procedente de 13 niños (8-11 años de edad) de Abis, Ola
Garbea, Hosh Essa y El Waquad (en el Delta del Nilo, Egipto)
 67 huevos procedente de 2 adultos (17, 27 años de edad) de Quy Nhon 
(Vietnam)
Los individuos fueron escogidos al azar y participaron en el estudio con su 
consentimiento. A todos los individuos se les proporcionó un envase de plástico 
limpio de boca ancha, numerado y con tapa a presión, de 30 mL de capacidad, el 
cual debería ser devuelto en el menor tiempo posible con sus heces. Las muestras 
se recolectaron de todos los individuos que dieron su consentimiento, anotándose 
los datos personales en el envase de entrega. Todas las muestras de heces se 
transportaron al laboratorio en las siguientes 5 horas. De cada muestra se realizó 
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una lámina de Kato-Katz (helm-Test®, AK test, AK Industria e Comèrcio Ltda, Belo 
Horizonte, Brasil). De las muestras que dieron positivo se recuperaron los huevos 
del trematodo mediante filtrado. 
2.1.1.2. HUEVOS PROCEDENTES DEL GANADO 
Los datos del estudio corresponden a huevos de fasciólidos de animales 
domésticos de las mismas áreas, o alrededores, de procedencia de las muestras 
humanas. Para la comparación de los huevos de muestras humanas del Altiplano 
norte de Bolivia y del valle de Cajamarca de Perú se utilizaron datos de huevos de 
F. hepatica procedentes de los reservorios más comunes del área hiperendémica 
humana del Altiplano norte de Bolivia (104 huevos de ovino, 168 de ganado bovino, 
186 de porcino y 161 de asno) (VALERO et al., 2001a). Se incluyó un total de 117 
huevos de F. hepatica procedentes de 3 bovinos de la región de Kutaisi, Georgia. 
De la región del Delta del Nilo, se analizaron 35 huevos de F. hepatica y 73 de F. 
gigantica obtenidos de tres y cuatro individuos de bovino respectivamente. Se 
analizaron un total de 101 huevos de F. gigantica de tres bovinos del área de Qhy 
Nhon, Vietnam. Para la comparación con F. gigantica, se usaron datos de una 
población conocida estándar, concretamente 142 huevos de bovinos del área Bobo 
Dioulasso, Burkina Faso, donde F. hepatica está ausente y Radix natalensis es el 
único molusco vector presente (PERIAGO et al., 2006). 
2.1.1.3. CRITERIO PARA LA CLASIFICACION ESPECIFICA DE HUEVOS 
PROCEDENTES DE HUMANOS Y ANIMALES 
En Bolivia y Perú, F. hepatica es la única especie presente del género 
Fasciola infectando tanto humanos como ganado en el Altiplano norte de Bolivia 
(MAS-COMA et al., 1999a) y en el Valle de Cajamarca (ESPINOZA et al., 2007). 
En Georgia, Egipto y Vietnam, sin embargo, se tomaron precauciones 
especiales ya que la distribución de ambas especies de fasciólidos se solapa en cada 
una de las respectivas áreas endémicas de donde proceden las muestras de huevos 
estudiadas. Los adultos fasciólidos tienden a cruzarse, a pesar de ser hermafroditas 
(HURTREZ-BOUSSES et al., 2004). Así, el problema en estas áreas de solapamiento 
es que los adultos de ambas especies de fasciólidos se hibridan y encontramos 
vermes adultos que muestran características morfológicas de formas intermedias 
(ASHRAFI et al., 2006a; PERIAGO et al., 2008; LE et al., 2008). Los huevos en 
estas áreas endémicas pueden diferir fenotípicamente de los huevos típicos de las 
especies estándar. Por tanto, la única forma para asegurar la clasificación específica 
de los huevos es la obtención de los huevos directamente del adulto y después 
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procesar este adulto para su clasificación específica. Desafortunadamente, esto sólo 
es posible para las muestras de animales y no para las muestras humanas. Por lo 
tanto, los adultos fasciólidos se obtuvieron de los hígados del ganado bovino en 
mataderos próximos a las áreas humanas estudiadas. Los adultos se clasificaron 
como F. hepatica o F. gigantica siguiendo el criterio de PERIAGO et al. (2006, 
2008). Para evitar coger huevos inmaduros del útero, los cuales pueden diferir 
fenotípicamente de los huevos maduros, se obtuvieron directamente a partir de la 
parte final del útero de adultos grávidos. Cabe recordar que los huevos en la parte 
final del útero están completamente formados, maduros y viables. Para la obtención 
de huevos maduros se aplicó al Trematodo adulto una ligera presión en la zona del 
acetábulo y así se forzó a los huevos maduros a salir por el poro genital. Otro 
procedimiento para obtener huevos maduros es rasgar el parénquima en la parte 
superior del acetábulo con dos agujas enmangadas. Hay que tener en cuenta que 
en las especies de Fasciola el útero no sólo se considera un órgano en donde 
maduran los huevos sino que también actúa como un órgano de almacenaje 
(VALERO et al., 2001b). La ausencia de diferencia en tamaño, madurez y viabilidad 
entre los huevos de la parte final del útero y los encontrados en la bilis y las heces 
fue verificada en diferentes individuos animales. Obtener los huevos de esta forma 
resulta fácil ya que los adultos fasciólidos maduros son muy grandes, además la 
mayor parte de su útero es post-acetabular pero termina pre-acetabularmente. Los 
huevos obtenidos por esta técnica son del mismo tamaño y forma que los 
encontrados en la bilis y las heces. Los resultados muestran que en Georgia sólo 
está presente F. hepatica, en Egipto están presentes ambas especies de fasciólidos 
mientras que en los animales analizados en Vietnam solo habían presente formas 
de F. gigantica. 
2.1.2. RECOLECCION DE ADULTOS DE FASCIOLA 
2.1.2.1. OVINOS INFECTADOS NATURALMENTE 
Después del sacrificio de los individuos ovinos (Ovis aries) se analizaron los 
hígados. Los fasciólidos presentan en el hospedador definitivo una migración desde 
el parénquima hepático hasta su ubicación final en el canal biliar. VALERO et al., 
(2006b) a través de un modelo logístico caracterizó el crecimiento corporal de los 
adultos fasciólidos en dos fases: a) la parte “exponencial” del crecimiento logístico 
correspondiente al desarrollo corporal durante la migración en la cavidad abdominal 
y en el parénquima hepático; b) su desarrollo y maduración sexual en el sistema de 
conductos biliares hasta el inicio de la producción de huevos. A partir de este 
momento, el desarrollo del adulto fasciólido sigue la parte “saturada” del modelo 
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logístico de crecimiento, es decir, la entrada en el conducto biliar induce la 
maduración y la producción de huevos. En este sentido, sólo se analizaron los 
adultos de F. hepatica que se encontraron dentro de los canales biliares. En el 
estudio morfológico de la presente Tesis doctoral únicamente se han incluido 
fasciólidos con huevos en el útero (n=542). Las muestras analizadas incluían la 
mayor variabilidad de vermes posible (diferentes estados de maduración, tamaño 
corporal y gravidez uterina). Los vermes adultos fueron fijados en solución de Bouin 
entre porta y cubre pero sin ejercer presión para evitar la distorsión. Los 
especímenes fueron teñidos con Carmín Borácico de Grenacher, diferenciados, 
deshidratados y montados en bálsamo de Canadá. 
Todos los ovinos analizados eran adultos originarios de zonas cercanas al 
matadero donde se obtuvo el material. Pasaremos a detallar ahora el material 
analizado especificando zona geográfica, número de parásitos adultos analizados, 
número de hospedadores y matadero de procedencia: 
a) Material procedente del valle de Cajamarca (Perú): 130 vermes adultos de
F. hepatica procedentes de 8 ovinos de la raza Merino (2, 2, 12, 15, 18,
21, 28 y 32 adultos por ovino, respectivamente), del matadero de Rodicio
(altitud aproximada de 2663 m sobre el nivel del mar)
b) Material procedente del valle del Mantaro (Perú): 47 vermes adultos de F.
hepatica procedentes de 5 ovinos autóctonos de la raza Junin (3, 4, 8, 10 y
21, vermes por ovino, respectivamente), de los mataderos de Huayucachi,
Pachacayo y Huancayo (altitud aproximada de 3271 m sobre el nivel del
mar)
c) Material procedente del Altiplano norte (Bolivia): 201 vermes adultos de F.
hepatica procedentes de 12 ovejas de la raza Merino (6, 8, 9, 12, 15, 18,
19, 22, 22, 26 y 30, vermes adultos por ovino, respectivamente), del 
matadero de Batallas (altitud aproximada de 4000 m sobre el nivel del 
mar) 
d) Material procedente de la costa Mediterránea (España): 37 vermes adultos 
de F. hepatica procedentes de 5 ovejas de la raza Merino (2, 7, 8, 10 y 10, 
vermes adultos por ovino, respectivamente), del matadero de Massamagrell 
(a una altitud cercana al nivel del mar)
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2.1.2.2. OVINOS INFECTADOS EXPERIMENTALMENTE 
Las metacercarias de F. hepatica se obtuvieron experimentalmente, tal y 
como describe MAS-COMA et al. (2001). Tanto el aislado de F. hepatica como su 
caracol hospedador intermediario son originarios de Bialowieza, Polonia y de la 
Albufera de Valencia, España, respectivamente. Los procesos de recolección como 
transporte, mantenimiento y cría de los caracoles Lymnaeidos, embrionación de 
huevos del parásito, infección de los caracoles y obtención de las metacercarias 
experimentales fueron llevados a cabo por el equipo de la Prof. Dra. M. D. Bargues. 
El grupo experimental incluyo 4 ovejas de entre 4 y 5 semanas de edad (raza 
autóctona Guirra). Los animales se criaron y mantuvieron en la granja de ovinos 
experimental de la Universidad Politécnica de Valencia (al nivel del mar). Los 
animales fueron infectados per os con 200 metacercarias de F. hepatica/ovino. La 
comida y el agua se proporcionaron ad libitum. Las experiencias fueron llevadas a 
cabo con el correspondiente permiso para la investigación de Comité de Ética 
Animal para la Investigación de la Universidad Politécnica de Valencia. La necropsia 
se llevó a cabo a las 40 semanas post-infección. Se recuperaron un total de 127 
vermes adultos de F. hepatica (20, 28, 34 y 45 vermes por oveja). 
2.1.2.3. RATAS WISTAR INFECTADAS EXPERIMENTALMENTE 
Sólo se utilizaron especímenes F. hepatica y Galba truncatula procedentes 
del Altiplano norte de Bolivia. Los caracoles emisores de las cercarias que 
posteriormente dieron origen a las metacercarias, son cepas mantenidas en el 
laboratorio (en cámaras climáticas Heraeus-Vöstsch HPS 1500 y HPS 500; 
condiciones experimentales: 20 ºC de temperatura, fotoperiodo de 12/12 h 
luz/oscuridad; humedad relativa 90%). Estos caracoles fueron a su vez infectados 
monomiracidialmente con huevos de F. hepatica que se encontraron en heces de 
ovinos, bovinos, porcinos y humanos infectados naturalmente (MAS-COMA et al., 
2001). Se obtuvieron cuatro aislados de metacercarias (aislado bovino, aislado 
ovino, aislado porcino y aislado humano). Las metacercarias se almacenaron en 
agua mineral a 4 ºC en oscuridad. Se infestaron un total de 73 ratas Wistar macho 
(Iffa Credo, Barcelona, España) con una edad de entre 4-5 semanas, utilizándose la 
técnica de infección oral mediante una jeringa orogástrica. Las ratas fueron alojadas 
en jaulas aisladas (Iffa Credo, Barcelona, España), en un recinto estéril libre de 
patógenos, con calefacción controlada y con un ciclo de 12/12 h de luz/oscuridad 
(condiciones en cumplimiento del acuerdo Europeo de Estrasburgo, 18 de Marzo 
1986). La comida y el agua fueron provistas ad libitum. Las ratas Wistar se 
dividieron en cuatro grupos de acuerdo a cada tipo de aislado: bovino (12 
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ratas), ovino (24), porcino (19) y humano (18), y se infectaron con una dosis de 20 
metacercarias por rata. La infección se confirmó mediante la disección del animal y 
por la detección de huevos en heces. La disección se llevó a cabo a distintos días 
post-infección (dpi) (entre 40 y 300 dpi) con el fin de obtener vermes en diferentes 
estados de madurez, tamaño corporal y gravidez del útero. El parásito se localizó 
en el conducto biliar a partir de los 40 dpi. La detección de huevos emitidos en 
heces se llevó a cabo mediante la técnica de Kato-Katz (Helm-Test®, AK test, AK 
Industria e Comercio Ltda, Belo Horizonte, Brasil). La intensidad de la infección se 
caracterizó por el número de adultos que se encontraron en el hígado. Sólo se 
utilizó el material parasitario procedente de infecciones leves (≤4 adultos 
fasciólidos/rata) para evitar el posible efecto de la carga parasitaria en la 
producción de huevos (VALERO et al., 2006b). Igualmente, para prevenir el posible 
efecto de la patología presente en el hospedador en la producción de huevos 
(VALERO et al., 2000, 2006a) sólo se utilizó material procedente de ratas sin signos 
de litiasis. 
Las 73 ratas fueron sacrificadas en tiempos de infección diferentes entre 40 
y 300 dpi (ver Tabla 3.6). Se obtuvieron los siguientes adultos de fasciólido por 
aislado: 
a) Aislado bovino: 14 adultos (50 dpi:1 en una rata, 1 en otra rata; 75dpi:
1,1; 100 dpi: 1,1; 150 dpi: 3,1; 200 dpi: 1,1; 225 dpi: 1,1; media:
1,2±0,6, rango: 1-3)
b) Aislado ovino: 51 adultos (40 dpi:1,1; 75dpi: 3,3,2,3; 100 dpi: 3,2,3,1;
150 dpi: 2,1,1,1; 225 dpi: 2,2,1; 300 dpi: 3,3,3,4,2,2,2; media: 2,1±0,9,
rango: 1-4)
c) Aislado porcino: 22 adultos (40 dpi:1,1; 50 dpi: 1,1; 75dpi: 1,1; 100 dpi:
1,1; 150 dpi: 1,1; 175 dpi: 1,1,1; 200 dpi: 2,1; 225 dpi: 2,1; 261 dpi: 2,1;
media: 1,2±0,4, rango: 1-2)
d) Aislado humano: 29 adultos (50 dpi:1,2; 75dpi: 1,2; 100 dpi: 1,2; 150 dpi:
1,2; 175 dpi: 2,2,2,2,3; 225 dpi: 1,2; 300 dpi: 1,1,1; media: 1,6±0,6,
rango: 1-3)
Los especímenes adultos de F. hepatica se fijaron en solución de Bouin entre 
portaobjetos y cubreobjetos, teñidos con Carmín Borácico de Grenacher y 
montados en Bálsamo de Canadá (Panreac, Barcelona, España). 
2.1.2.4. ESTUDIO DE SEGUMIENTO DE EMISION DE HUEVOS 
Se recogieron muestras fecales frescas a las 9:00 a.m. todos los días de las 
73 ratas, y se almacenaron en placas Petri cerradas para evitar la desecación de las 
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muestras antes de su examen. La detección de huevos se llevó a cabo mediante la 
lectura de una lámina de Kato-Katz por día y por rata, calculándose los huevos por 
gramo de heces (epg). Los análisis se llevaron a cabo diariamente a partir de 30 dpi 
hasta los 300 dpi en el caso de los aislados ovinos y de humanos, hasta el 225 dpi 
en el aislado bovino y hasta 261 dpi en el aislado porcino. Se asumió que no se 
produjo la desparasitación de las ratas hospedadoras, ya que el número de adultos 
de F. hepatica/rata no varió a lo largo del experimento en los distintos grupos de 
edad analizados. Esta premisa está apoyada por el hecho de que el número de 
huevos detectados en heces no disminuye de forma brusca en ninguna de las ratas 
analizadas. La producción de huevos por verme se calculó dividiendo los huevos por 
gramo de heces por el número de adultos recuperados en el conducto biliar. Se 
obtuvo la media de producción de huevos emitidos por gramo de heces por adulto y 
día entre los 10 días anteriores hasta el día correspondiente a la obtención de los 
datos del área uterina (UA). Este día corresponde al día de la necropsia del animal 
(40, 50, 75, 100, 150, 175, 200, 225, 261 y 300 dpi). 
2.2. MATERIAL PARASITOLOGICO PARA EL ESTUDIO INMUNOLOGICO 
2.2.1. MUESTRAS HUMANAS 
El suero se obtuvo de la seroteca de la Unidad de Parasitología de la 
Facultad de Farmacia, Universidad de Valencia, España, WHO Collaborating Centre 
on Fascioliasis and Its Snail Vectors. Se analizó sueros obtenidos entre los años 
2004-2008. Se realizaron alícuotas y se almacenaron a -80 ºC hasta su uso. Los 
sueros humanos utilizados se clasificaron en tres grupos: 
a) 54 sueros humanos de individuos con fascioliasis procedentes de tres áreas 
geográficas con situaciones epidemiológicas diferentes. La positividad a la 
infección fue verificada a través tanto de la técnica ELISA CL1 como por la 
presencia de huevos en heces (técnica de Kato-Katz)
b) 168 sueros de individuos con otras enfermedades parasitas/fúngicas 
distintas a la fascioliasis (para evaluar potenciales reacciones cruzadas) 
obtenidos de casos confirmados clínicamente, serológicamente y a veces 
parasitológicamente
c) 89 sueros parasitológicamente negativos procedentes de colecciones de 
sueros almacenados en el Centro Nacional de Microbiología (ISCIII, Madrid, 
España) y el Servicio de Microbiología del Hospital Universitario y Politécnico 
“La Fe” (Valencia, España)
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2.2.2. PROCEDIMIENTOS Y ANALISIS DE MUESTRAS FECALES 
Los estudios coprológicos se realizaron en la localidad de Huacullani, la cual 
pertenece al municipio de Tiwanku, tercera sección de la provincia de Ingavi del 
Departamento de La Paz, Bolivia. Esta localidad se encuentra a 85 km de la capital, 
La Paz, en el extremo occidental del denominad corredor Tambillo-Aygachi en el 
Altiplano Norte de Bolivia (MAS-COMA et al., 1999a). Según el censo de 2005 por 
parte del Instituto Nacional de Estadística Boliviano, Huacullani tiene un total de 
2525 habitantes. La recolección de muestra se realizó en las escuelas de la 
localidad obteniéndose un total de 437 muestras procedentes de niños. Estudios 
anteriores en dicha localidad mostró altas prevalencias en niños del 38,2% en el 
año 1992, 31,2% en 1993, y 34,8% en 1996, y en el total de la comunidad (niños 
más adultos) del 18,4% en 1996 y 11,8% en 1997 (ESTEBAN et al., 1999). 
También se recolectaron muestras en el Departamento de Cajamarca, Perú, 
el cual ocupa un área de alrededor de 35.400 km2 en la parte Norte Andina de Perú 
y está habitada por 1.416.000 personas. Este departamento comprende 13 
provincias y en el caso de la provincia de Cajamarca incluye 12 distritos 
(GONZALEZ et al., 2011). Un total de 362 muestras fecales fueron recolectadas de 
niños procedentes de las siguientes escuelas: Escuela de Varones del Distrito 
(Distrito de Jesús), Santa Rosa de Chaquil (distrito de La Encañada), y Andrés 
Avelino Caceres (distrito de Baños del Inca). Estudios previos mostraron 
prevalencias muy altas en esta área endémica, con una media del 24,4% con una 
prevalencia máxima del 47,7% en Santa Rosa de Chaquil, la mayor prevalencia 
local detectada en Perú (GONZALEZ et al., 2011). 
En Huacullani, se obtuvieron muestras fecales de 437 niños seleccionados al 
azar (220 varones y 217 mujeres) de entre 5 a 16 años de edad (media ± SD = 8,8 
± 2,3). A cada participante en el estudio se le dio un bote de plástico, limpio y de 
boca ancha. A todos los participantes se les pidió que llenaran el bote con sus 
propias heces y lo devolvieran inmediatamente. Se recogió una muestra por sujeto 
y se anotaron los datos personales (nombre, sexo y edad) en el bote. Las muestras 
fueron transportadas al laboratorio de parasitología en la Facultad de Farmacia, 
Universidad Mayor de San Andrés (UMSA), La Paz, entre 1 y 3 horas después de la 
recolección. Una de las alícuotas se utilizó para llevar a cabo el test MM3-COPRO 
ELISA y otra fue preservada a 4 ºC para realizar las láminas de Kato-Katz. Las 
láminas de Kato-Katz se realizaron en la Facultad de Medicina, UMSA, y fueron 
analizados inicialmente en menos de 1 h desde su preparación para evitar la sobre 
clarificación de algunos huevos de helmintos. 
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En Cajamarca, las muestras fecales se obtuvieron al azar de 362 niños (264 
varones y 98 mujeres) de entre 7 y 15 años de edad (media ± SD = 9,9 ± 2,2) por 
medio de procedimientos similares. Las muestras fueron transportadas a la ciudad 
de Cajamarca entre 1 y 3 horas después de la recolección y almacenada a 4º C 
hasta su posterior envió al Laboratorio de Parasitología en el Instituto de Medicina 
Tropical Alexander von Humboldt, Lima, donde se llevó a cabo el análisis 
coproparasitológico. Se realizaron tanto las láminas de Kato-Katz como el ELISA a 
dos alícuotas de la muestra, mientras que una tercera alícuota fue preservada en 
una solución al 10% de formalina (1:3) para la detección de huevos mediante la 
técnica de sedimentación rápida (LUMBRERAS et al., 1962). 
2.3. TECNICAS PARASITOLOGICAS 
Las técnicas utilizadas en la presente Tesis se incluyen en cuatro grandes 
bloques: 
 Técnicas mastozoológicas: van a proporcionar información sobre el
tratamiento de los hospedadores definitivos utilizados para poder
recuperar los diferentes estadios (adultos y huevos) de los digénidos.
 Técnicas helmintológicas: se utilizan para la preparación y estudio de los
digénidos adultos, para su posterior estudio morfométrico y
morfoanatómico.
 Técnicas inmunológicas: se utilizan para el estudio de la respuesta inmune
que los adultos digénidos producen en el hospedador definitivo.
 Métodos matemáticos: los cuales, finalmente, se aplicaran al resultado de
los estudios de los materiales parasitológicos antes nombrados.
2.3.1. TECNICAS MASTOZOOLOGICAS 
2.3.1.1. ESTUDIO DEL HIGADO Y CANALES BILIARES 
Dado que en F. hepatica el microhábitat de parasitación específico del adulto 
es el hígado, se realizó un minucioso estudio de este órgano. Después de la 
apertura ventral del animal, al visualizar el hígado in situ se observa si existen 
lesiones en el parénquima hepático y si los canales biliares están engrosados, lo 
que nos indicara la presencia de adultos en su interior. El hígado se extrae cortando 
el canal biliar principal a la altura de su unión con el intestino y se pesa. Asimismo 
se efectúan las medidas morfométricas del canal biliar y se fotografía las lesiones 
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macroscópicas si las hubiera. El parénquima hepático se examina a la lupa 
binocular raspando con un bisturí, especialmente donde se observan lesiones, 
pudiéndose encontrar en ellos individuos jóvenes de F. hepatica que aún no han 
completado su migración hasta el canal biliar principal (fase de invasión). Los 
canales biliares aumentan mucho su diámetro en la fase de estado, siendo fácil 
detectar si van a existir adultos de F. hepatica en ellos. Al abrir el canal biliar con 
unas tijeras, los digénidos adultos salen vivos, procediéndose a su recolección y 
fijación. Posteriormente se efectúa un enjuagado con agua tanto de la cavidad 
abdominal, como de los distintos órganos para tener la seguridad de la total 
recogida de los parásitos (PANOVA, 2002). 
2.3.2. TECNICAS HELMINTOLOGICAS 
2.3.2.1. TECNICAS MACROSCOPICAS GENERALES 
Estas técnicas incluyen los procesos realizados desde la recogida de los 
vermes hasta su estudio en el microscopio, es decir, la fijación de los Trematodos, 
su conservación, coloración, diferenciación, deshidratación y montaje. 
2.3.2.1.1. FIJACION 
Para que la visualización de la anatomía interna del Trematodo sea óptima, 
el verme se debe fijar in vivo y sometido a una ligera presión. El proceso de fijación 
fue el siguiente: 
En ejemplares pequeños: se coloca el Trematodo vivo con un pincel sobre un 
portaobjetos en una gota de agua. Se añade una gota de líquido de Bouin en la 
cara inferior de un cubreobjetos y se deja caer sobre el Trematodo, cuidando que 
éste no se encuentre ladeado, en cuyo caso se enderezará con ayuda de una aguja 
enmangada. El verme debe permanecer entre porta y cubreobjetos unos 20 
minutos. Luego se levanta y se traslada el Trematodo con un pincel a una placa 
Petri con fijador de Bouin, en el que permanecerá unos 30 minutos (MARCOS, 
1993). 
En ejemplares grandes: los Trematodos fueron fijados con Bouin entre dos 
placas Petri. Se introduce líquido de Bouin en una de las placas y con un pincel se 
coloca el verme vivo sobre dicha placa. Se deja caer la otra placa Petri sobre el 
Trematodo por su cara inferior, procurando que quede lo más plano posible, pero 
sin presionar demasiado. El Trematodo debe quedar unos 30 minutos entre las dos 
placas y luego, con uno o dos pinceles, se pasan a otra placa Petri con líquido de 
Bouin unos 40 minutos (MARCOS, 1993). 
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En ambos casos, transcurrido el tiempo establecido, se llevan a alcohol de 
70º, cambiando este diariamente hasta que el verme pierda la coloración amarilla 
dada por el fijador; en nuestro caso oscila entre 30 a 90 días dependido del tamaño 
del Trematodo. 
El líquido de Bouin se considera uno de los mejores fijadores topográficos. 
Su composición por cada 100 ml es la siguiente: 
 Solución acuosa de ácido pícrico  75 ml 
 Formol (solución comercial al 40%)  25 ml 
 Ácido acético  5 ml 
Se prepara de la siguiente manera: en un matraz, se pone un litro de agua y 
se calienta hasta que esté templada. Se coloca el matraz sobre un agitador y se le 
va añadiendo poco a poco ácido pícrico hasta conseguir una solución saturada del 
mismo, es decir, hasta que el ácido pícrico no se disuelva en el agua. 
Una vez conseguido se deja reposar 24 horas (solución madre). Para utilizar 
el fijador se añade a pequeñas fracciones de la mezcla la cantidad correspondiente 
de ácido acético (5 partes de ácido acético por cada 100 partes de solución) 
(PANOVA, 2002). 
El líquido de Bouin fija de forma homogénea y penetra rápidamente. La 
retracción en el momento de la fijación es más débil que con otras buenas mezclas 
fijadoras (BARGUES, 1986). 
2.3.2.1.2. CONSERVACION 
La conservación se realiza en viales con alcohol de 70º, en el cual los 
Digénidos pueden permanecer hasta el momento de su tinción (PANOVA, 2002). 
2.3.2.1.3. COLORACION 
Las tinciones utilizadas dan lugar a preparaciones permanentes, 
imprescindibles en el estudio llevado a cabo. El colorante utilizado ha sido el Carmín 
Borácico de Grenacher, cuya fórmula es la siguiente: 
 Solución acuosa de bórax al 4% (8 gramos de bórax en 200 cc de agua
destilada)
 Carmín (casa Merck)
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El protocolo de preparación del carmín Borácico de Grenacher es el 
siguiente: en un matraz redondo se pone la solución acuosa anterior y se le añaden 
5 gramos de carmín. Se calienta en un recipiente de reflujo, en el cual tenemos un 
cazo con tierra y el matraz esférico, con un refrigerador por el que entra y sale 
agua. Se deja hervir suavemente durante 30 minutos y se le añaden 200 cc de 
alcohol de 70º. Se deja reposar 24 horas y se filtra (PANOVA, 2002). 
Los Digénidos obtenidos deben permanecer en el colorante un tiempo 
determinado que depende de su grosor y su capacidad de tomar el colorante. Los 
adultos de F. hepatica y F. gigantica deben teñirse de forma suficiente pero no 
excesiva para facilitar su posterior diferenciación. Si los ejemplares se tiñen en 
exceso deben estar más tiempo en el líquido diferenciador, lo que puede alterar el 
inicial de la tinción e incluso los tejidos del verme. En líneas generales diremos que 
los adultos de F. hepatica de mayor grosor y los adultos de F. gigantica se han 
teñido durante 24 horas en la mezcla de carmín Borácico de Grenacher. La tinción 
óptima se controla periódicamente bajo la lupa binocular. 
2.3.2.1.4. DIFERENCIACION 
Una vez que el Trematodo ha sido teñido efectuamos la diferenciación en 
alcohol clorhídrico. Con un pincel bien seco extraemos los vermes del colorante y 
los colocamos, de uno en uno, en una placa Petri añadiendo, gota a gota, ácido 
clorhídrico comercial (35%). El trematodo va alcanzando una tonalidad rosada con 
luz superior de la lupa, debiéndose observar con la inferior todas las estructuras del 
parásito por transparencia. La duración de esta operación depende del tamaño y 
grosor del Trematodo (PANOVA, 2002). 
2.3.2.1.5. DESHIDRATACION 
Tras la diferenciación colocamos una serie de placas Petri con distintos 
alcoholes en los que, con ayuda de un pincel, iremos pasando sucesivamente los 
parásitos. En la primera placa, con etanol de 70º, el digénido debe estar 10 
minutos. Después lo llevamos a otra placa con alcohol de 96º, 15 minutos. De ésta 
pasa a alcohol de 100º 15 minutos más, otros 15 minutos en alcohol butílico y 
finalmente 15 minutos en xilol, terminando con este paso la cadena de 
deshidratación. 
2.3.2.1.6. MONTAJE 
El montaje se realiza con un portaobjetos, un cubreobjetos y bálsamo de 
Canadá, resina comercial que solidifica rápidamente y proporciona preparaciones de 
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larga vida. Sin embargo, para poderla emplear es necesaria una previa 
deshidratación del material, ya que no es soluble en agua. 
Para realizar el montaje se coloca sobre el portaobjetos una gota de bálsamo 
de Canadá y sobre ella el Trematodo en posición ventral, es decir, con la ventosa o 
acetábulo ventral de cara al cubreobjetos. Con un pincel mojado en xilol 
eliminamos las posibles burbujas que se hayan podido formar en el bálsamo antes 
de colocar el cubreobjetos sobre él. 
Si una vez montado, el parásito no presenta suficiente bálsamo, o si éste se 
retrae, se puede añadir más pincelando con xilol los bordes entre porta y cubre, 
añadiendo una gota de bálsamo de Canadá. que entra en la preparación por 
capilaridad (MARCOS, 1993). 
Por último, se introducen las preparaciones en la estufa a 20º C de 
temperatura de 4 a 24 horas hasta que estén secas. Si el bálsamo se retrae por el 
calor, se repite la operación anteriormente descrita de pincelado con xilol y bálsamo 
por capilaridad (PANOVA, 2002). 
2.3.2.2. TECNICAS COPROLOGICAS 
La técnica de Kato-Katz es utilizada para la búsqueda, hallazgo y recuento 
de los huevos de helmintos en heces, además resulta ser una técnica muy útil y 
práctica para conseguir un diagnóstico rápido de las parasitosis producidas por 
Digénidos, Cestodos y Nematodos. Para la realización de la técnica se siguió las 
recomendaciones de la OMS (ASH et al., 1994) usando el kit Helm-Test, AK test, 
AK industria e Comércio Ltda, Belo Horizonte, Brasil. Para realizar este examen se 
precisa de: una placa de plástico con un orificio central que admite un volumen de 
heces de 41,7 mg (o sea 1/24 g), un tamiz de nailon con una apertura de malla de 
entre 200 y 300 μm, una espátula o cuchara de una casa comercial, un 
portaobjetos y un papel de celofán empapado en un líquido colorante. El líquido 
colorante del papel de celofán se compone de: solución al 50% en agua destilada 
de solución glicerina/verde malaquita (preparación de la solución de glicerina/verde 
malaquita: 100 ml de agua destilada + 10 ml de glicerina + 1 ml de solución de 
verde malaquita al 3%). En esta solución se introducen el papel celofán en tiras y 
en 24 horas podrán ser utilizadas ya que estarán bien impregnadas de la misma. 
Para la realización de la técnica procederemos como sigue (ORDOÑEZ, 2010): 
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1. Depositamos una muestra de heces en un trozo de papel satinado, con el
propósito de que el papel no absorba la humedad de las heces (por 
ejemplo, la hoja de una revista). 
2. Colocamos la malla sobre las heces y presionamos suavemente. De esta
forma dejamos en el filtro o malla las partículas grandes que puedan 
impedir una óptima visualización microscópica de los huevos de Fasciola 
sp. 
3. Con la ayuda de una espátula se toma el filtrado y se deposita en un
molde situado en un portaobjetos etiquetado con los datos del hospedador 
definitivo utilizado. 
4. A continuación se enrasa la muestra con ayuda de la espátula hasta
colmar el orificio. Posteriormente retiramos la placa con precaución y 
tenemos un flan de 41,7 mg de heces. 
5. Por último, se coloca sobre la muestra un papel de celofán previamente
recortado y embebido en el líquido colorante. Se da la vuelta al porta-
objetos y se presiona suavemente sobre un papel absorbente para recoger 
el líquido sobrante. Conviene esperar al menos 30 minutos para realizar la 
primera observación al microscopio, aunque se recomienda una espera de 
24 horas para optimizar la visualización de los huevos. Por su alto 
contenido en glicerina, es posible el mantener estas preparaciones durante 
varios meses sin deterioro. Posteriormente, se realiza la observación 
microscópica de la preparación, realizando un barrido completo y anotando 
el número total de huevos de F. hepatica que aparecen en la misma. Ya 
que la cantidad de heces analizadas es de 1/24 g y como el dato que a 
nosotros nos interesa es el de huevos por gramo de heces (hgh), lo único 
que tenemos que hacer es multiplicar el resultado por 24. 
En el caso del seguimiento de la cinética de emisión de huevos de F. 
hepatica en el modelo murino, se utilizó exclusivamente la técnica de Kato-Katz. En 
el caso de la validación de la técnica  MM3-COPRO ELISA en muestras humanas se 
utilizó tanto la sedimentación rápida como la técnica de Kato-Katz. Estas técnicas 
coprológicas clásicas para la detección de huevos se utilizaron como pruebas 
estándares para el diagnóstico cualitativo (sedimentación rápida y Kato-Katz) y 
cuantitativo (Kato-Katz). Para la técnica de Kato-Katz los huevos fueron detectados 
en muestras frescas después del análisis de tres láminas de Kato-Katz por muestra, 
dependiendo de la concentración de huevos de F. hepatica. La cantidad media de
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huevos de las tres láminas se calculó como huevos por gramo de heces (epg). La 
inspección parasitológica fue realizada mediante microscopia por un parasitólogo 
entrenado. La intensidad de la infección, medida como huevos por gramo de heces 
(epg), se utilizó como indicador de la carga de F. hepatica en humanos infectados. 
2.3.3. ESTUDIO MORFOMETRICO CIAS 
Para la obtención de imágenes y para el cálculo de las diferentes medidas 
morfométricas con un analizador de imágenes, tanto unidimensionales como 
bidimensionales y para la obtención de imágenes se han utilizado los siguientes 
programas: 
 Image-Pro® Plus, versión 5.1 para Windows (Media Cybernetics Inc., Silver
Spring, USA): con dicho programa comercializado se han creado macros
para el cálculo de las dimensiones en imágenes digitalizadas mediante
cámara digital Nikon Coolpix 5400 y Leica V-LUX 1 (para medidas de
adultos) y mediante un microscopio Nikon modelo SE equipado con un
revolver de 4 objetivos (4x, 10x, 40x, 100x y 2 oculares de 10x),
conectado con videocámara de color 3CCD (Sony DXC-930P) (para
medidas de ventosas y faringes).
 Microsoft Excel: programa comercializado para análisis y cálculos de datos.
Los datos obtenidos a través de Image-Pro® Plus se exportaban a los
archivos de dicho programa para poder operar después con ellos.
La estandarización de la metodología para la realización de las medidas es 
fundamental en cualquier estudio morfométrico (VALERO & MAS-COMA, 1985; 
VALERO, 1986; VALERO et al., 1987; VALERO et al., 1996, 2005; PERIAGO et al., 
2006, 2008). Los trabajos de VALERO et al. (1996, 2005) y PERIAGO et al. (2006, 
2008) proponen la metodología Computer Image Analysis System (CIAS). para el 
estudio morfométrico de los adultos de F. hepatica y F. gigantica. Se han realizado 
mediciones de adultos de fasciólidos en material fijado y montado in toto en 
preparaciones permanentes. La medida del útero de los fasciólidos adultos se 
realizó de acuerdo al método propuesto por VALERO et al. (2001b), calculando el 
área delimitada por el perímetro exterior de la imagen uterina. Las medidas del 
área uterina de los adultos fasciólidos (UA) vienen expresadas en mm2. 
Los parámetros morfométricas analizados en el huevo de Fasciola son los 
siguientes: 
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Características biométricas lineales: EL = Longitud del huevo; EW = anchura 
del huevo; EP = perímetro del huevo; ER = circularidad del huevo (ER=EP2/4πEW). 
Superficies: EA = área del huevo. 
Relaciones: EL/EW = relación entre longitud del huevo y anchura del huevo. 
Los parámetros morfométricas analizados en el adulto son los siguientes 
(ver Fig. 2.1.): 
Características biométricas lineares: BL= longitud corporal; BW= anchura 
corporal; BWOv= anchura corporal a nivel del ovario; BP= perímetro corporal; BR= 
circularidad corporal (BR=BP2/4πBW); CL= longitud del cono; CW= anchura de 
cono; OSMax= diámetro máximo de la ventosa oral; OSmin= diámetro mínimo de 
la ventosa oral; VSMax= diámetro máximo de la ventosa ventral; VSmin= diámetro 
mínimo de la ventosa ventral; A-VS= distancia entre el extremo anterior del cuerpo 
y la ventosa ventral; OS-VS= distancia entre la ventosa oral y ventosa ventral; VS-
Vit= distancia entre la ventosa ventral hasta el final de las glándulas vitelógenas; 
Vit-P= distancia entre las glándulas vitelógenas hasta la parte posterior corporal; 
VS-P= distancia entre la ventosa ventral y la parte posterior corporal; PhL= 
longitud de la faringe; PhW: anchura de la faringe; TL= longitud testicular; TW= 
anchura testicular; TP= perímetro testicular; TR= circularidad testicular 
(TR=TP2/4πTW). 
Superficies: BA= superficie corporal; OSA= superficie de la ventosa oral; 
VSA= superficie de la ventosa ventral; PhA= superficie de la faringe; TA= superficie 
testicular. 
Relaciones: BL/BW= relación entre longitud corporal y anchura corporal; 
BWOv/CW= relación entre la anchura corporal a nivel de ovario y anchura de cono; 
BL/VS-P= relación entre la longitud corporal y la distancia entre la ventosa ventral 
y el final corporal; OS/VS= relación entre área de la ventosa oral y área de la 
ventosa ventral. 
La medida de la circularidad se utilizó para cuantificar su forma. Esta medida 
sirve para conocer como de circular es un objeto. Un objeto circular tendrá una 
circularidad de 1.0, cuanto más irregular es el objeto más grande son los valores 
(PERIAGO et al., 2008).  
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Figura 2.1. Medidas estandarizadas en adulto de: A) F. hepatica y B) F. gigantica. (PERIAGO et al., 
2006). 
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2.3.4. METODOS INMUNOLOGICOS 
2.3.4.1. ELISA 
2.3.4.1.1. ELISA DE CATEPSINA L1 
La catepsina L1 (CL1) fue obtenida del Laboratorio de Parasitología 
Molecular, Escuela de Biotecnología, Facultad de Salud y Ciencia, Dublin City 
University, Dublin, Irlanda. La aplicación del ELISA de catepsina CL1 fue llevado a 
cabo y descrito previamente (O´NEILL et al., 1999). Se incubaron “overnight” 100 
µl de antígeno CL1 (5 µg/mL) a 37 ºC en placas de microtitulación (Nuclon, 
Kamstrup, Roskilde, Denmark). Los pocillos se bloquearon con una solución de 
albumina de suero bovino al 2%/ 0,1% de Tween 20 en un tampón salino fosfatado 
durante 30 minutos a 37º C , posteriormente se añadió el suero humano (dilución 
1:100) en los pocillos por duplicado. Los anticuerpos humanos específicos se 
detectaron usando IgG4 biotin-conjugada anti-humano (dilución 1:2000), fosfatasa 
alcalina avidin-conjugada y el sustrato 2, 2-azino-bis (ácido 3-etilbenzotiazolina-6-
sulfonico) (todos los productos procedentes de Sigma Chemical Co., Poole, Dorset, 
UK). Después de 20 minutos las placas se leyeron a una absorbancia de 405 nm en 
un lector de placas de ELISA (Bio-Rad, Modelo 680, Hércules, CA, USA). El “cut-off” 
se estableció en 3,09 y la desviación estándar de la media del suero control, el cual 
fue 0,098. 
2.3.4.1.2. ELISA DRG 
Todos los kits comerciales usados en el presente capitulo fueron enviados 
por DRG Instruments GmbH, Alemania. El test está basado en la detección de 
antígenos de excreción/secreción de F. hepatica que contienen predominantemente 
proteasas de cisteína del verme (SALIMI-BEJESTANI et al., 2005). Todos los pasos 
se llevaron de acuerdo al protocolo facilitado por el fabricante. El suero humano, los 
controles positivos y negativos así como el control del “cut-off” (CO) (dilución 
1:100) se añadieron por triplicado en los pocillos. Las placas se leyeron en un lector 
de ELISA a una absorbancia de 450 nm (Bio-Rad, Modelo 680, Hércules, CA, USA). 
El test se consideró valido cuando se cumplieron las siguientes condiciones, el 
substrato blanco tuvo una absorbancia por debajo de 0,100, el control negativo por 
debajo de 0,200, el control CO entre 0,250 y 0,750 y el control positivo superior a 
0,600. Los resultados están expresados como la media de la densidad óptica (OD) 
obtenida en las muestras por triplicado, expresadas como un porcentaje del CO 
usando la siguiente formula: 
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Porcentaje positivo (PP)= (Media OD de la muestra/ Media OD del Control+)*100. 
Un suero era considerado positivo cuando el valor de la media de su 
absorbancia era superior al 10% del CO. 
Los resultados mostrados en unidades DRG (DU) se calcularon de acuerdo a 
la siguiente formula: 
DU= (valor medio de la absorbancia de la muestra*10)/CO. 
Los resultados eran considerados negativos cuando DU<9, y positivos 
cuando DU>11. 
Para evitar cualquier prejuicio, todos los sueros fueron procesados sin el 
conocimiento de su clasificación en los tres grupos anteriormente mencionados 
(positivos para fascioliasis, otras parasitosis o sueros negativos). 
2.3.4.1.3. ELISA MM3-COPROANTIGENO 
Los kits de MM3-COPRO ELISA fueron proporcionados por el Dr. F.M. Ubeira 
de la Universidad de Santiago de Compostela (España), fueron preparados y 
testados como ha sido descrito anteriormente (MEZO et al., 2004, VALERO et al., 
2009b; UBEIRA et al., 2009). Existe una versión comercial del MM3-COPRO ELISA 
llamada BIO K 201, Bio-X Diagnostics, La Jemelle, Belgium. En resumen, se 
incubaron placas de microtitulación de poliestireno de tiras 1 x 8 F (Greiner Bio-One 
GmbH, Frickenhausen, Alemania) durante toda la noche con 100 μL/pocillo de una 
solución que contenía 10 μg/mL de un anticuerpo de conejo policlonal IgG anti-
Fasciola en una solución tampón salina fosfato (PBS) (pocillos de filas impares), o 
con 100 μL/pocillo de una solución que contenía 10 μg/mL de anticuerpos 
policlonales IgG procedentes de conejos no inmunizados (pocillos de filas pares). 
Los sitios sin revestir se bloquearon con caseinato sódico al 1,5% en PBS durante 1 
hora a temperatura ambiente. Cada sobrenadante fecal (100 μL) se añadió por 
cuadruplicado (2 pocillos de filas impares más 2 pocillos de filas pares), y se incubo 
durante toda la noche a 4º C. Después de lavar 6 veces con PBS al 0,2% Tween-20 
(PBS-T), se añadió a cada pocillo 100 μL de una solución que contenía 0,3 μg de 
anticuerpos biotinados con MM3 en PBS-T más 1% albumina bovina de suero (PBS-
T-BSA) y se incubo durante 1 h a 37º C. Después de lavar, tal y como hemos 
comentado anteriormente, la unión con el anticuerpo MM3 se detectó mediante 
incubación, primero con neutravidin conjugada con peroxidasa (Pierce, Rockford, 
Illinois; dilución 1:2000 en PBS-T-BSA) durante 1 h a 37º C , y después con el 
substrato (tampón H2O2 y o-fenilendiamina, OPD, Sigma-Aldrich, Madrid, España). 
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Después de una incubación de 20 minutos a temperatura ambiente, la reacción se 
paró mediante la adición de H2SO4 3N. Finalmente, la DO se midió a 492 nm. El 
valor de la DO se calculó como DO1-DO2, donde DO1 es la media de los pocillos de 
filas impares (recubiertas con anticuerpos policlonales anti-Fasciola), y DO2 es la 
media de los pocillos de filas pares (recubiertos con anticuerpos policlonales 
inespecificos). El valor de DO para cada muestra se calculó restando la DO de los 
pocillos pares a la DO de los pocillos impares. El valor de corte usado fue 0,097 
(UBEIRA et al., 2009). 
2.3.5. ANALISIS MATEMATICO 
2.3.5.1. TRAYECTORIAS ONTOGENICAS 
Las nubes de dispersión de puntos obtenidas de las medidas morfométricas 
frente a la edad (t) ofrecen trayectorias ontogenéticas empíricas para los adultos de 
F. hepatica (VALERO et al., 2006b). En el presente estudio, la trayectoria 
ontogénica describe el cambio del UA como una función respecto al tiempo en días. 
Las trayectorias ontogénicas son el resultado de ecuaciones diferenciales que 
expresan las leyes de crecimiento de variables morfológicas (ALBERCH et al., 1979; 
DE RENZI, 1988). Un análisis preliminar de los resultados mostro que el modelo 
“amortiguado” ofrece la mejor representación de los datos. Para las trayectorias 
ontogénicas del UA, se ha verificado dos modelos “amortiguados”: el modelo 
saturado (a) (y=ym[1-z0(-kt)]) y el modelo logístico (b) (y=ym/[1+z0(-kt)]), donde ym
es el valor máximo alcanzado por el UA, y z0 y k son constantes o parámetros de 
las trayectorias; z0 está relacionada con el valor inicial del área uterina (y), es decir 
y0 cuando t=0, y exhibe una expresión diferente en cada caso. El parámetro k es 
una tasa de crecimiento en ambos casos. Para ajustar los modelos se utilizó el 
paquete estadístico McCurve Fit. El procedimiento consiste en seleccionar la función 
que minimiza la suma de los mínimos cuadrados residuales (sse), es decir (yi-ÿi)2, 
con los datos brutos de yi y sus estimaciones ÿi. El ajuste de las funciones de 
curvas no lineales se testó usando r2 y sse. El software GRAPHPAD PRISM 5.0 se 
utilizó para representar las trayectorias ontogénicas. Se han considerado resultados 
estadísticamente significativos cuando P<0,05. Se utilizó el software SPSS Statistics 
versión 19 para el cálculo del test chi-cuadrado, del test de Fisher y de la 
correlación de Pearson. Se han considerado resultados estadísticamente 
significativos cuando P<0,05. 
2.3.5.2. ANALISIS DE COMPONENTES PRINCIPALES (ACP) 
El análisis de los componentes principales (ACP), permite explorar la 
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variación individual y reconocer eventualmente los agrupamientos particulares 
sobre un “mapa factorial”, que generalmente se trata de un “plot” de los dos 
primeros componentes principales (ROHLF & MARCUS, 1993; KLINGERBERG, 1996; 
DUJARDIN et al., 2002; DUJARDIN & LE PONT, 2004). Este análisis no toma en 
cuenta la pertenencia de cada individuo a grupos distintos. Es un análisis ciego y 
frecuentemente puede detectar estos grupos a partir de los valores individuales 
(DUJARDIN et al.,2002). En resumen, la función del análisis en componentes 
principales es doble. Por una parte, permite reconocer una estructuración en 
particular de los individuos, correspondiente o no a su clasificación inicial, así que 
también puede ser utilizado como instrumento de clasificación. Por otra parte, el 
análisis en componentes principales presenta el interés adicional de proporcionar 
una “variable de tamaño”, en general el primer componente principal (CPI), 
variable que será utilizada después para eliminar el “efecto tamaño” de las 
poblaciones en comparación (DUJARDIN et al., 2002). Así, el análisis en 
componentes principales brinda una variable de tamaño (CPI), que es la 
combinación lineal que representa la varianza máxima. Además, geométricamente 
CPI se corresponde con la dirección del eje más largo a través de la nube de 
puntos. Las subsiguientes variables (CPII, CPIII, etc…), matemáticamente 
independientes, alcanzan la varianza máxima, siendo un eje ortogonal al resto de 
los componentes (KLINGERBERG, 1996). Además esta clase de análisis permite 
separar la influencia del tamaño de la influencia de la forma sobre la estructuración 
observada (DUJARDIN et al., 2002). 
En esta tesis hemos utilizado un análisis discriminante canónico en ausencia 
de tamaño, en la matriz de covarianza de logaritmos transformados. Esta técnica 
consiste en la regresión de cada carácter por separado dentro del grupo del primer 
componente principal (CP1), que es una estimación multivariada del tamaño 
(BOOKSTEIN, 1989; DOS REIS et al., 1990). El análisis se llevó a cabo usando el 
software BAC v.2 (DUJARDIN, 2002). El método estadístico usado para las medidas 
tanto de los huevos como para los adultos de F. hepatica es muy similar a la 
utilizada por PERIAGO et al., (2008) en especies adultos de F. hepatica y F. 
gigantica de la misma zona geográfica. 
Para realizar de manera óptima estos dos objetivos del análisis en 
componentes principales, los datos iniciales deben transformarse en logaritmos en 
base 10. Esta transformación presenta numerosas ventajas estadísticas 
(normalización de las distribuciones, igualación de las varianzas, etc...) y permite 
comparar las diferencias relativas más que las absolutas (DUJARDIN et al.,2002). 
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2.3.5.3. ANALISIS DISCRIMINANTE CANONICO 
Se realizó un estudio de inclusión por pasos usando la λ de Wilk´s (SPSS 
versión 12.0 y versión 15.0) de las poblaciones de fasciólidos por un análisis 
discriminante de medias usando el origen del área geográfica y la especie 
hospedadora como criterio de agrupación. Las variables canónicas se presentan 
como combinaciones lineales de las variables originales y se expresan por una 
función discriminante. 
2.3.5.4. ANALISIS ESTADISTICO DE COMPARACION DE MEDIAS 
La comparación de las medias sè lleva.on a cabo usando los siguientes test: 
a) ANOVA de una vía, b) ANOVA de tres vías, c) test post hoc Bonferroni y d) test t 
de student (SPSS v 19.0). El efecto del tamaño de la muestra se controla por el 
POWER (NORUSIS, 1994). Los valores se consideraron significativamente 
estadísticos cuando P < 0,05. 
2.3.5.5. CORRELACIONES 
Para el calculó de la correlación entre dos variables se utilizó la correlación 
de Pearson. Se han considerado resultados estadísticamente significativos cuando 
P<0,05. 
2.3.5.6. CALCULO DE LA SENSIBILIDAD, ESPECIFICIDAD, VALOR PREDICTIVO 
POSITIVO (PPV) Y VALOR PREDICTIVO NEGATIVO (NPV) 
En los test inmunológicos, se ha calculado los valores de sensibilidad y 
especificidad (FLETCHER & FLETCHER 2005) con un intervalo de confianza del 95% 
(95% CI; EPIINFO). El valor predictivo positivo (PPV) se calculó usando la siguiente 
formula: 
PPV= (sensibilidad*prevalencia) / (sensibilidad*prevalencia) + ((1-
especificidad)*(1-prevalencia)). 
El valor predictivo negativo (NPV) se calculó usando la siguiente formula: 
NPV= (especificidad*(1-prevalencia)) / (((1-sensibilidad)*prevalencia) + 
((especificidad)*(1-prevalencia))). 
El test del t-Student se calculó usando el software del SPSS v 19.0. 
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3. FENOTIPAJE DE FASCIOLIDOS
3.1. LAS CACTERISTICAS MORFOLOGICAS DE LOS HUEVOS DE LOS 
FASCIOLIDOS COMO HERRAMIENTAS EN EL DIAGNOSTICO DE LA FASCIOLIASIS 
HUMANA Y ANIMAL CAUSADA POR F. HEPATICA Y F. GIGANTICA 
El objetivo del presente apartado es validar la identificación de F. hepatica y 
F. gigantica basándose en el tamaño y forma de los huevos emitidos por humanos y 
animales infectados, caracterizando sus rasgos morfométricos mediante un 
analizador de imágenes. Se ha analizado la influencia tanto del lugar de 
procedencia de la muestra (Sur América, Europa, África y Asia) como de la especie 
hospedadora (humano y diferentes especies de animales domésticos). 
Para ilustrar la situación dentro de un área local endémica, hemos 
comparado las medidas de los huevos del parásito emitidos por humanos con 
huevos emitidos por el ganado procedente de la misma área geográfica. Este 
mismo esquema de trabajo lo hemos efectuado en distintas áreas geográficas 
consideradas importantes áreas endémicas de fascioliasis humana. En el nuevo 
mundo, hemos utilizado material  del Altiplano Norte de Bolivia (MAS-COMA et al., 
1999a) y el valle de Cajamarca, Perú (ESPINOZA et al., 2007), áreas caracterizadas 
por sus altas prevalencias e intensidades en humanos causada únicamente por F. 
hepatica. 
En Europa, hemos utilizado material de la región de Kutaisi en Georgia, área 
donde está ampliamente distribuida F. hepatica, pero en donde sólo se ha 
detectado esporádicamente F. gigantica hace varias décadas (GIGITASHVILI, 1969) 
y en donde la fascioliasis humana está emergiendo actualmente (ZENAISHVILI et 
al., 2004). 
En África, el material procede de la región del Delta del Nilo de Egipto, en 
donde ambas especies, F. hepatica y F. gigantica  co-existen y  además los 
humanos presentan altas prevalencias e intensidades (ESTEBAN et al., 2003; 
CURTALE et al., 2007). 
En Asia, el análisis se llevó a cabo en Vietnam, donde la enfermedad ha 
aparecido en humanos en los últimos años a lo largo de todo el país (DE et al., 
2003; LE et al., 2008). 
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Para la realización del presente apartado se utilizó el material que viene 
detallado en el punto 2.1.1. del capítulo de Material y Métodos (ver tabla 3.1, tabla 
3.2 y tabla 3.3), incluyendo un aislado de Bolivia, uno de Perú, dos de Georgia, tres 
de Egipto y dos de Vietnam. Cuatro aislados de animales descritos previamente
(VALERO et al., 2001a) fueron incluidos para su comparación. 
Las medidas morfométricas analizadas y la técnica de medición a través del 
analizador de imágenes utilizada en los huevos de Fasciólidos estudiadas vienen 
detallados en el punto 2.3.3. del capítulo de Material y Métodos (ver tabla 3.1, tabla
3.2 y tabla 3.3). Para la comparación de medias se ha utilizado el test t de student
y un test post-hoc (Bonferroni) (véase apartado 2.3.5.4.). 
Se ha utilizado un análisis de los componentes principales (véase apartado 
2.3.5.2. del capítulo de Material y Métodos) incluyendo sólo cinco de las medidas 
realizadas (LH, AH, PH, ArH, LH/AH). Asimismo, se ha realizado un análisis 
discriminante canónico (véase apartado 2.3.5.3. del capítulo de Material y Métodos). 
Tabla 3.1- Comparación de datos morfométricos de huevos de Fasciola procedentes de humanos y animales 
domésticos de regiones Andinas Sudamericanas: Altiplano Norte (Bolivia), valle de Cajamarca (Perú). Todos los valores 
se muestran como rango con la media ± la desviación estándar entre paréntesis. n= tamaño de la muestra. 
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Tabla 3.2- Comparación de datos morfométricos de huevos de Fasciola procedentes de humanos y bovinos de 
regiones europeas: región de Kutaisi (Georgia). Todos los valores se muestran como rango con la media ± la 
desviación estándar entre paréntesis. n= tamaño de la muestra. 
Tabla 3.3- Comparación de datos morfométricos de huevos de Fasciola procedentes de humanos y bovinos de regiones 
de Asia y África: Delta del Nilo (Egipto), Quy Nhon (Vietnam) y Burkina Faso. Todos los valores se muestran como 
rango con la media ± la desviación estándar entre paréntesis. n= tamaño de la muestra. 
 Las diferencias significativas encontradas cuando comparamos cada medida 
del huevo de las muestras humanas con los distintos hospedadores animales de la 
misma área se realizaron  mediante un test post hoc (Bonferroni) en Bolivia (*) y 
Egipto (v) y mediante el estudio de t de student en Georgia (£) y Vietnam (œ) 
(p<0,05) tal y como se muestra en tabla 3.1, tabla 3.2 y tabla 3.3. Los datos 
procedentes de individuos de F. gigantica “estándar” procedentes de Burkina Faso 
se incluyeron en la comparación. 
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3.1.2. RESULTADOS 
En las muestras de los huevos de las especies de Fasciola emitidas por 
humanos, el extremo opuesto al opérculo de la cubierta del huevo es normalmente 
irregular o arrugado (más o menos pronunciado) (Fig. 3.1). Aunque a veces, esta 
irregularidad está localizada lateralmente. El análisis morfológico de los huevos 
muestra que esta irregularidad en la superficie de la cubierta es muy común en 
Bolivia (99 casos con una protuberancia de 154 huevos: 64,3%) igual que en Perú 
(121 casos de 167: 72,5%). Esta irregularidad es menos frecuente en las muestras 
humanas de Egipto (30,1%). Además, es muy infrecuente en las muestras humanas 
de Georgia (solo fue detectado un huevo de 53: 1,9%) y Vietnam (solo en 8 huevos 
de 67: 11,9%). 
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Figura 3.1- Variabilidad de la forma y tamaño de huevos emitidos por adultos fasciolidos en muestras de humanos: 
(A–G) F. hepatica del Altiplano Norte de Bolivia; (H–P) F. hepatica del valle de Cajamarca, Perú; (Q–S) F. hepatica de 
la región de Kutaisi, Georgia; (T–V) huevos de fasciolidos (principalmente fenotipos de F. hepatica) de la región del 
Delta del Nilo, Egipto; (W–Y) F. gigantica del área de Quy Nhon, Vietnam. Nótese la presencia de irregularidades 
laterales en la superficie de la cubierta de los huevos en I, J y R, presencia de las mismas irregularidades de la cubierta 
en el extremo opuesto al opérculo en C, E–G, N–P y X, y su ausencia en M e Y. Escalas: A–D, H–L, Q–X= 150µm; E–G, 
M–P, Y = 50µm (VALERO et al., 2009). 
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3.1.2.1. ESTUDIO DE LA INFLUENCIA DE LA LOCALIZACION GEOGRAFICA 
El tamaño de los huevos de F. hepatica obtenidos tanto de muestras 
animales como humanas se muestran en la tabla 3.1, tabla 3.2 y tabla 3.3. El 
estudio de la influencia de la localización geográfica en el tamaño de los huevos 
fasciólidos emitidos por humanos fue llevado a cabo mediante el análisis del CP1 y 
un análisis discriminante canónico. Un estudio similar fue llevado a cabo también en 
los huevos obtenidos en infecciones de bovinos: 
A. Huevos emitidos por humanos: Las variables de los huevos de fasciolidos 
procedentes de muestras humanas de Bolivia, Perú, Georgia, Egipto y 
Vietnam se correlacionan significativamente en CP1, el cual contribuyo en 
un 78% a la variación total. El mapa factorial resultante (Fig. 3.2) ilustra 
claramente las diferencias globales en las poblaciones analizadas. Se 
pueden diferenciar dos zonas: una zona formada por Bolivia, Perú, Georgia 
y Egipto, mientras que la otra zona está formada sólo por Vietnam y se 
solapa con la zona de las muestras bolivianas y peruanas. Los resultados 
muestran que los datos de Georgia y Egipto se incluyen en el tamaño 
global de F. hepatica. Las funciones canónicas discriminantes tienen 
valores de λ de Wilks estadísticamente significantes (P < 0,001). Las 
funciones y1 e y2 incluyen 99,4% de la varianza acumulada y son las 
siguientes: 
y1 = 0,908LH + 0,696AH – 5,366PH + 3,668AH + 1,693 LH/AH 
y2 = 0,825LH + 1,225AH – 0,401PH – 2,139AH + 0,684 LH/AH 
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Figura 3.2- Mapa factorial correspondiente a huevos de Fasciola emitidos por humanos procedentes de 
Altiplano Norte de Bolivia, Perú, Georgia, Egipto y Vietnam. Las muestras son proyectadas sobre el primer 
(CPI, 74%) y el segundo (CPII, 19%) componente principal. Cada grupo está representado por su perímetro. 
Las funciones lineares discriminantes (ejes 1, y1 y 2, y2) diferencian 
claramente los huevos de F. hepatica procedentes de Bolivia y Perú de los 
huevos de F. gigantica procedentes de Vietnam. Los resultados de acuerdo 
a la clasificación de predicción de grupos obtenidos con estas funciones 
discriminantes se incluyen en la tabla 3.4. Los especímenes procedentes de 
Georgia se solapan con algunos especímenes procedentes de Bolivia, Perú, 
Egipto y Vietnam. Aun así, los especímenes procedentes de Egipto forman 
un grupo diferente a los formados por los especímenes estándar de F. 
hepatica y F. gigantica y sólo se solapan con algunos especímenes de 
Vietnam. La media de los datos obtenidos en las muestras humanas 
muestra valores muy similares en todas las medidas de los huevos 
procedentes de Bolivia, Perú, Georgia y Egipto. 
En resumen, el rango de la longitud y anchura de los huevos de F. 
hepatica de los humanos en zonas Andinas de altitud, donde solo F. 
hepatica está presente, es de 100,6-161,0/65,9-104,5 µm, valores que 
están muy cerca de los valores obtenidos en las muestras humanas 
procedentes de Georgia (104,5-162,0/72,1-96,6 µm) y Egipto (106,5-
171,5/63,9-95,4 µm), donde F. hepatica y F. gigantica co-existen. Las 
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muestras humanas procedentes de Vietnam tienen los valores más altos, 
150,9-182,2/85,1-106,2 µm, solapándose con los obtenidos en las otras 
muestras humanas analizadas. 
Tabla 3.4- Resultados de la clasificación de predicción de grupos. 
B. Huevos procedentes de bovino: Las variables de los huevos de fasciolidos 
procedentes de bovino de Bolivia, Georgia, Egipto y Vietnam se 
correlacionan significativamente en CP1, el cual contribuye el 94% a la 
variación total. El mapa factorial resultante (Fig. 3.3) ilustra claramente las 
diferencias globales del tamaño en las poblaciones analizadas. Este mapa 
factorial muestra que, aunque el tamaño de los huevos de F. hepatica y F. 
gigantica procedente de bovino no se solapa cuando se comparan 
poblaciones alopátricas de zonas geográficas distantes, como por ejemplo 
Bolivia y Vietnam, el tamaño de los huevos de F. hepatica y F. gigantica se 
solapan cuando se comparan poblaciones simpátricas, como por ejemplo 
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en Egipto. Las funciones canónicas discriminantes tienen valores 
significativos de λ de Wilks (P<0,001). Las funciones y1 e y2, incluyen el 
97,7% de la variación acumulada y son las siguientes: 
y1 = 1,082LH + 2,228AH – 0,103PH – 1,645AH + 2,299LH/AH 
y2 = - 3,469LH – 0,053AH – 0,300PH + 2,911AH + 3,089LH/AH 
Figura 3.3- Mapa factorial correspondiente a huevos de Fasciola procedentes de ganado bovino 
infectado naturalmente de Bolivia, Georgia, Egipto y Vietnam. Las muestras se proyectan sobre el primer 
(PC1, 94%) y el segundo (PC2, 5%) componente principal. Cada grupo es representado por su 
perímetro. 
Las funciones lineares discriminantes (ejes 1, y1 y 2, y2) claramente 
diferencian los huevos de F. hepatica de Bolivia de los huevos de F. 
gigantica procedente de Vietnam. Los resultados de la clasificación de 
acuerdo a la predicción de grupos obtenidos con esta función discriminante 
se incluyen en la tabla 3.5. Los especímenes de Georgia se solapan con 
algunos especímenes de Bolivia y Egipto. Aun así, los especímenes de F. 
gigantica procedente de Egipto forman un grupo diferente pero se solapan 
con algunos especímenes de F. hepatica procedentes de Bolivia, Georgia y 
Egipto y algunos especímenes de F. gigantica procedentes de Vietnam. 
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Tabla 3.5- Resultados de la clasificación de predicción de grupos. 
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3.1.2.2. ESTUDIO DE LA INFLUENCIA DE LA ESPECIE HOSPEDADORA 
El estudio de la influencia de la especie hospedadora sobre el tamaño del 
huevo se llevó a cabo mediante un análisis de CP1 en dos áreas geográficas, Bolivia 
y Vietnam. Las variables morfométricas de los huevos de F. hepatica del Altiplano 
Norte de Bolivia procedente de humanos y animales domésticos (ovino, bovino, 
porcino y asno) se correlacionaron significativamente en CP1, el cual contribuyo el 
86% a la variación total. El mapa factorial resultante (Fig.3.4) ilustra claramente 
las diferencias globales de tamaño en la población humana analizada frente a las 
especies hospedadoras animales domésticas, incluyendo un mayor tamaño en los 
huevos procedentes de humanos. Las funciones canónicas discriminantes tienen 
valores significativos de λ de Wilks (P<0,001). Las funciones y1 e y2, incluyen 
95,0% de la varianza acumulada y son las siguientes: 
y1 = 0,074LH + 1,930AH – 1,349PH – 1,224AH + 1,518LH/AH 
y2 = -3,915LH + 3,853AH + 0,867PH – 1,563AH + 5,366LH/AH 
Figura 3.4- Mapa factorial correspondiente a huevos de Fasciola procedentes de humanos y ganado (bovino, 
ovino, porcino y asno) de la misma zona endémica en el Altiplano Norte de Bolivia. Las muestras se proyectan 
sobre el primer (CP1, 86%) y el segundo (CP2, 11%) componente principal. Cada grupo está representado por su 
perímetro. 
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Las funciones lineares discriminantes (ejes 1, y1 y 2 y2) diferencian 
claramente la población de huevos de F. hepatica procedente de humanos y la 
población de huevos de F. hepatica de otras especies hospedadoras. Los resultados 
de la clasificación de acuerdo a la predicción de grupos obtenido con estas 
funciones discriminantes se muestran en la tabla 3.6. Los especímenes procedentes 
de humanos forman un grupo diferente pero se solapan con algunos especímenes 
procedentes de ovino, bovino, porcino o asno. El análisis de la media de las 
medidas absolutas de los huevos obtenidos del Altiplano Norte de Bolivia muestra 
que los valores de los huevos de F. hepatica de las muestras humanas son mayores 
que la media de los valores de huevos procedentes de las especies hospedadoras. 
Las diferencias significativas obtenidas cuando se comparan cada par de datos de 
medidas de los huevos procedentes tanto de muestras de humanos como de 
animales usando el test Bonferroni se muestran en la tabla 3.1, tabla 3.2 y tabla 
3.3. Los resultados confirman que el tamaño de los huevos de F. hepatica en las 
muestras humanas poseen su propia identidad morfológica. 
Las medidas de los huevos de F. gigantica procedente de muestras humanas 
y bovino están correlacionadas significativamente con el CP1, que contribuye al 
74% de la variación total. El mapa factorial resultante (Fig. 3.5) ilustra claramente 
las diferencias globales de tamaño en la población humana analizada, incluyendo un 
menor tamaño global de los huevos de F. gigantica de humanos que los huevos 
procedentes de bovino. 
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Tabla 3.6- Resultados de la clasificación de predicción de grupos. 
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Figura 3.5- Mapa factorial correspondiente a huevos de Fasciola procedentes de humanos y bovinos de la misma 
zona endémica en Vietnam. Las muestras se proyectan sobre el primer (PC1, 70%) y el segundo (PC2, 13%) 
componente principal. Cada grupo está representado por su perímetro. 
Las funciones discriminantes canónicas tienen valores de λ de Wilks estadísticamente 
significativa (P<0,001). Los resultados de la clasificación de acuerdo a la predicción de 
grupos, obtenidos con estas funciones discriminantes se muestran en la tabla 3.7. Las 
diferencias significativas obtenidas cuando se comparan los pares de puntos de cada media 
de los huevos procedentes de muestras humanas y animales usando un test t student se 
muestran en la tabla 3.1, tabla 3.2 y tabla 3.3. Los resultados confirman que el tamaño de 
los huevos de F. gigantica en las muestras humanas posee su propia identidad, y estos 
huevos de F. gigantica procedentes de muestras humanas tienen valores medios más 
pequeños que los valores medios de los huevos procedentes del bovino. 
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Tabla 3.7- Resultados de la clasificación de predicción de grupos. 
3.1.3. DISCUSION 
Hasta el final de 1990, la fascioliasis humana fue considerada como una 
enfermedad adquirida raramente en zonas endémicas animales. Así, la mayoría de 
los estudios publicados se limitaban solo a casos individuales o citas de grupos 
familiares. En estas situaciones, los huevos encontrados eran escasos y se 
presentaban en intervalos irregulares. Siendo a veces necesaria la repetición del 
examen coproparasitológico de las muestras para detectar los huevos (ARJONA et 
al., 1995). No obstante en la actualidad se han descrito zonas hiperendémicas 
humanas, en las que se han detectado intensidades y prevalencias de parasitación 
pronunciadamente altas, especialmente en los niños (MAS-COMA et al., 2005). 
Desafortunadamente, los análisis realizados en estas áreas, sólo incluían estudios 
epidemiológicos humanos a gran escala, y hasta el presente estudio, no se había 
efectuado un análisis exhaustivo de la morfometría de los huevos de fasciolidos 
procedentes de parasitaciones humanas. Los huevos de las especies de Fasciola son 
operculados, largos, amarillentos parduzcos, ovalados y no embrionados en el 
momento de la puesta, y su anchura y longitud están dentro de un rango 
especifico, que es uno de los criterios utilizados para el diagnóstico de la fascioliasis 
humana. 
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Clásicamente, se ha considerado que en el extremo opuesto al opérculo, la 
superficie de los huevos de Fasciola es a menudo rugosa y esta zona irregular no se 
observa en los huevos de Fasciolopsis (ASH & ORIHEL, 1997). Cabe destacar que 
nuestro estudio muestra que la frecuencia de esta característica en F. hepatica es 
población dependiente, y por tanto no es un criterio patognomónico en el 
diagnóstico. No obstante, no podemos analizar ni establecer si la irregularidad en la 
superficie del huevo en el extremo opuesto al opérculo y/o lateral observada en 
este estudio está relacionada con el origen geográfico o es debida a las 
anormalidades de la producción de huevos por el tratamiento antiparasitario 
administrado a los humanos (como por ejemplo, el uso habitual de Albendazol en 
campañas de tratamiento de los países Andinos).  
Tradicionalmente, la Fascioliasis se ha considerado un problema veterinario 
en todo el mundo, y por lo tanto el rango de tamaño de los huevos que podemos 
encontrar en la literatura aplicado al diagnóstico humano en realidad se ha obtenido 
a través del análisis de muestras parasitas procedentes de hospedadores animales 
domésticos: F. hepatica 130-148/63-90 µm (BORAY, 1982), 130-145/70-90 µm 
(WHO, 1991) o 130-150/63-90 µm (MAS-COMA & BARGUES, 1997), y F. gigantica 
150-196/90-100 µm (BORAY, 1982; MAS-COMA & BARGUES, 1997). Por lo tanto, 
tradicionalmente los extremos que permitían la diferenciación de ambas especies, 
se consideraba que eran 150 µm de longitud y 90 µm de anchura, donde los 
valores menores representaban a individuos de F. hepatica y los mayores a F. 
gigantica. 
Nuestro estudio revela que los humanos, en comparación con otras especies 
hospedadoras, tienen una influencia decisiva en el tamaño de los huevos de F. 
hepatica y F. gigantica, mostrando una gran variación con el rango de tamaño 
mencionado anteriormente. Así, en humanos el tamaño de los huevos de F. 
hepatica es mayor y el tamaño de los huevos de F. gigantica es más pequeño que 
el tamaño clásicamente indicado en la literatura. Aun así, estas variables de 
tamaño intraespecíficas se solapan cuando ambas especies se comparan. Esta 
variabilidad en el tamaño de los huevos de Fasciola también es similar al tamaño de 
los huevos de otras especies de Trematodos que pueden infectar al hombre y que 
presentan una morfología similar, como por ejemplo las especies de los géneros 
Fasciolopsis, Gastrodiscoides (MAS-COMA et al., 2005) y Echinostoma (WHO, 1991) 
y pueden provocar una confusión en la clasificación de huevos cuando esta es 
llevada a cabo por personal sin experiencia, si no se considera ningún otro criterio 
diagnostico (ver, por ejemplo, BELISARIO et al., 2007). 
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El solapamiento de la distribución geográfica de F. hepatica y F. gigantica 
también ha provocado una gran controversia en la identificación taxonómica de las 
especies de Fasciola encontradas en países del Sud-Este Asiático, en donde algunos 
ejemplares se parecen a F. hepatica, mientras que otros son similares a F. gigantica 
y también hay presentes formas morfológicamente intermedias. Cabe añadir 
también la existencia de un fenómeno anormal de gametogénesis, partenogénesis 
diploide, triploide y mixoploide, y procesos de hibridación entre genotipos 
diferentes (MAS-COMA & BARGUES, 1997). Hoy en día, el camino más fácil para 
confirmar genéticamente que un espécimen recolectado en la naturaleza es un 
híbrido es detectando una introgresión (DOWLING & SECOR, 1997; MAS-COMA & 
BARGUES, 2009). En el caso de Fasciola, ha sido confirmada la existencia de 
formas hibridas cuando se mostró que los fasciólidos procedentes de animales en 
Japón presentaban secuencias de DNA casi idénticas a una de las especies de 
fasciolidos y secuencias mitocondriales de DNA casi idénticas a las obtenidas en la 
otra especie (ITAGAKI & TSUTSUMI, 1998; ITAGAKI et al., 1998). Por otra parte, 
en áreas asiáticas simpátricas de ambas especies de Fasciola se ha detectado un 
gran solapamiento en las medidas de los huevos emitidos (WATANABE, 1962; 
SAHBA et al., 1972; KIMURA et al., 1984; SRIMUZIPO et al., 2000). En Vietnam, 
los vermes adultos encontrados en animales y pacientes humanos se dividían en 
dos categorías morfológicas, una típica de F. gigantica y otra muy similar a F. 
hepatica (LE et al., 2008). LE et al. (2008) público datos que informaban que la 
hibridación ocurría en las poblaciones de Fasciola en Vietnam y éstas poblaciones 
parásitas estaban implicadas en la infección humana. Los huevos analizados en este 
capítulo muestran que el tamaño de los huevos emitidos por humanos en Vietnam 
sólo se corresponde con la morfología de los emitidos por F. gigantica. 
F. gigantica es el principal fasciólido presente en África. Los valores 
morfométricos de los huevos de fasciólidos procedentes de bovinos europeos y 
africanos fueron analizados por PERIAGO et al. (2006) usando CIAS. Los resultados 
mostraron que el rango de las medidas de los huevos analizados se solapa con 
poblaciones alopátricas de F. hepatica y F. gigantica (LH: 107,3-152,7 µm en F. 
hepatica procedente de España, 100,2-155,6 µm en F. hepatica procedente de la 
isla francesa de Córcega, y 129,6-204,5 µm en F. gigantica de Burkina Faso; AH: 
52,4-89,1 µm en F. hepatica procedente de España, 55,0-87,7 en F. hepatica 
procedente de Córcega, y 61,6-112,5 µm en F. gigantica de Burkina Faso). En 
Egipto, tanto F. hepatica como F. gigantica están presentes, pero normalmente se 
utiliza la terminología de Fasciola sp. para la fascioliasis humana en el Delta del Nilo 
(ESTEBAN et al., 2003; CURTALE et al., 2007). En Egipto, en áreas endémicas 
humanas, se ha descrito en bovino formas fenotípicas de vermes adultos 
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intermedias de F. hepatica/F. gigantica, siendo la morfología de F. hepatica más 
frecuente que la morfología típica de F. gigantica (PERIAGO et al., 2008). Estos 
datos concuerdan con los obtenidos en nuestro estudio, en donde el tamaño de los 
huevos emitidos por humanos corresponden morfológicamente con F. hepatica. 
Cabe resumir que las medidas de los huevos de F. hepatica y F. gigantica 
que pueden obtenerse a partir de un microscopio como son LH, AH y LH/AH, tanto 
de origen animal como humano, en parte se solapan en áreas donde ambas 
especies de fasciólidos coexisten, como es el caso de Egipto, por lo que se debe 
tener precaución cuando se utiliza el tamaño de los huevos como único criterio de 
diagnóstico diferencial (tabla 3.1, tabla 3.2 y tabla 3.3). Se alcanza una conclusión 
similar cuando se comparan otras medidas obtenidas mediante el CIAS como son 
PH, CH y ArH (tabla 3.1, tabla 3.2 y tabla 3.3). En este sentido, nuestros hallazgos 
deberían ayudar a los clínicos de estas áreas ya que el uso del rango de tamaño 
clásico de los huevos de Fasciola puede conducir a un diagnóstico erróneo. 
Las medidas de los huevos de fasciólidos emitidos en las muestras de un 
paciente japonés (INOUE et al., 2007) constituye un buen ejemplo para ilustrar el 
problema expuesto.  En este paciente, los adultos fasciólidos fueron obtenidos vivos 
mediante endoscopia y mostraron características morfométricas similares al patrón 
F. hepatica. Las secuencias de DNA ribosomales ITS-2 e ITS-1 (fragmentos 
completos de 327 y 351 pb y secuencias espaciadoras de 364 y 432 pb, 
respectivamente) obtenidas de una mezcla de huevos procedentes de las heces del 
paciente coincidían con esta especie de fasciólido. La secuencia mitocondrial COI 
obtenida (desafortunadamente sólo se pudo obtener un fragmento corto de 493-pb 
y no la secuencia genética completa de 1533-pb) era también cercana a F. 
hepatica. Aunque todas estas características indicaban que se trataba de F. 
hepatica, el tamaño de los huevos 153-175/75-95 µm (media 164,7/83,7 µm) 
(INOUE et al., 2007) no se ajustaba a las características de tamaño tradicionales de 
F. hepatica (130-150/63-90 µm), sin embargo sí que se ajusta a las de F. gigantica 
(150-196/90-100 µm) (MAS-COMA & BARGUES, 1997). Cuando se comparan con 
los datos de huevos obtenidos de muestras humanas en el presente estudio, el 
tamaño los huevos procedentes de Japón se ajusta bien con el tamaño de los 
huevos de F. hepatica observados en zonas donde ambas especies de fasciolidos se 
solapan, excepto por la longitud del huevo (175 µm), la cual sobrepasa ligeramente 
la detectada en humanos en Egipto (171,5 µm). La media de la anchura de huevo 
de los fasciólidos procedentes de Japón (83,7 µm) es muy parecida a la obtenida en 
los huevos de F. hepatica procedentes de Perú (80,2 µm) o Georgia (82,1 µm). 
Además, la anchura mínima de los huevos procedentes de Japón (75 µm) es mucho 
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menor que la anchura mínima obtenida en los adultos de F. gigantica procedentes 
de Vietnam (85,1 µm). Esta comparación sugiere que los fasciólidos Japoneses se 
originaron probablemente a partir de una introgresión en el linaje a largo plazo y 
que dicha introgresión no fue detectada en el corto fragmento de la secuencia COI 
obtenida en el artículo. Hay que tener en cuenta que la introgresión puede suponer 
sólo la substitución de una parte del genoma mitocondrial, y no necesariamente de 
todos los genes del mtDNA, por lo que en un área de solapamiento de ambas 
especies, se puede esperar una acumulación de muchas formas hibridas de 
introgresión genéticamente diferentes como resultado de un cruzamiento (MAS-
COMA & BARGUES, 2009). 
3.2. CORRELACION ENTRE LA EMISION DE HUEVOS Y EL DESARROLLO UTERINO 
EN AISLADOS HUMANOS Y ANIMALES DE F. HEPATICA 
El objetivo del presente apartado es estudiar en el modelo murino Wistar, 
bajo unas condiciones de dosis infectivas estandarizadas, la relación entre el 
crecimiento uterino vs la emisión de huevos en adultos de F. hepatica obtenidos 
experimentalmente a partir de aislados procedentes de áreas hiperendémicas 
humanas como es el caso del Altiplano Norte de Bolivia. Hemos realizado un 
seguimiento a largo plazo de más de 300 días post-infección, incluyendo así el 
estado de cronicidad avanzada. Este es el primer estudio que relaciona el tamaño 
del útero y el número de huevos por gramo de heces (epg) emitidos, cuantificados 
mediante la técnica de Kato-Katz, la herramienta más común en el diagnóstico para 
infecciones por helmintos en humanos. En este apartado se ha estudiado la 
evolución del área uterina de F. hepatica vs el tiempo y se ha analizado la influencia 
de diferentes factores, como son el tipo de aislado y el estado de cronicidad 
avanzado, sobre el desarrollo uterino. 
3.2.1. MATERIAL Y METODOS 
Para la realización del presente apartado se utilizó el material que viene 
detallado en el punto 2.1.2.3. y 2.1.2.4. del capítulo de Material y Métodos. 
En la tabla 3.8 se especifica la evolución del área uterina y epg de los 
distintos aislados a lo largo de toda la infección. 
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Para la realización del presente apartado se utilizó técnica de Kato-Katz 
detallada en el punto 2.3.2.2 del capítulo de Material y Métodos. Las medidas 
morfométricas y la técnica de medición utilizada en los úteros de Fasciola, vienen 
detallados en el punto 2.3.3 del capítulo de Material y Métodos. Por último, en el 
punto 2.3.5.1 del citado capítulo se detalla el método matemático que se utilizó en 
el cálculo de las trayectorias ontogenéticas. Para evaluar el posible efecto del origen 
del aislado de las metacercarias experimentales, se ha utilizado un ANOVA de tres 
vías, con cada valor individual de UA en cada grupo de edad. 
3.2.2. RESULTADOS 
3.2.2.1. SEGUIMIENTO DE LOS HUEVOS Y EL AREA UTERINA (40-300 dpi) 
En la Fig. 3.6 se representa la evolución de la media epg/adulto/día obtenido 
para cada aislado frente al tiempo. Los resultados del recuento de huevos en heces 
muestran que existe una fuerte oscilación de un día para otro en todos los aislados. 
Se ha realizado el análisis de la correlación (ANOVA) de la media de UA vs la media 
de ln (epg), incluyendo: (a) la media de epg emitidos entre los 10 días antes de la 
obtención del valor correspondiente de UA; (b) la media de epg emitidos entre los 
25 días antes de la obtención del valor correspondiente de UA. La correlación 
obtenida en el ANOVA sólo fue estadísticamente significativa cuando se correlacionó 
UA frente a la media de los últimos 10 días del ln (epg) (bovino: F=10.223, 
P<0,033, power: 42%; ovino: 11.215, 0,020, 99%; porcino: 11.215, 0,020, 
52,2%; y humano: 7.444, 0,041, 25,5%). La evolución de la UA de acuerdo con los 
dpi en las ratas inoculadas con los cuatro aislados y la evolución de la emisión de 
huevos en heces 10 días antes de la obtención del correspondiente valor de UA 
obtenido se muestran en la tabla 3.8 y Fig. 3.7, respectivamente. 
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Figura 3.7- Evolución del área del útero de fasciolidos (UA) y huevos por gramo de heces (epg)/adulto a lo 
largo de la infección en los cuatro aislados de F. hepatica analizados: (A) aislado humano (□); (B) aislado
bovino (X); (C) aislado porcino (Δ) y (D) aislado ovino (+). Cada símbolo representa la media por cada día 
analizado. UA: cada símbolo representa la media de UA de cada grupo de fasciolidos a diferentes días. Epg: 
cada símbolo representa la media de epg emitidos entre 10 días antes y el día cuando se obtuvo el dato de UA; 
--- = UA; __ = epg/adulto. 
3.2.2.2. CRECIMIENTO DEL AREA UTERINA 
El modelo de regresión múltiple muestra que UA es dependiente de los dpi 
(P<0,001) y del tipo de aislado (P<0,001). El análisis general de todos los parásitos 
correspondientes a los 225-300 dpi muestra una elevada dispersión del UA, que por 
lo general tiende a disminuir hasta los 225 dpi. Es interesante apuntar que se 
observó la completa ausencia de huevos en el útero en algunos adultos parásitos a 
los 300 dpi (8%), lo cual corresponde con el cese de emisión de huevos en la fase 
crónica avanzada. Por ello, se analizó el desarrollo medio de UA en adultos 
fasciólidos de cada aislado exclusivamente entre los 40 hasta 225 dpi. El UA sigue 
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un modelo de crecimiento asintótico hasta los 225 dpi y después disminuye. Se han 
estudiado las trayectorias ontogénicas de las medidas de UA en adultos fasciólidos. 
Los resultados obtenidos están reflejados en la Fig. 3.8. 
Figura 3.8- Trayectoria ontogénica del área del útero (UA) (en mm2) en función del tiempo (días) con el 
modelo de crecimiento saturado y=ym[(1-zo(-kt)] en adultos obtenidos de ratas Wistar infectadas 
experimentalmente con los cuatro aislados de F. hepatica analizados: (A) aislado humano (□); (B) aislado
bovino (X); (C) aislado porcino (Δ) y (D) aislado ovino (+). Cada símbolo representa la media de UA en el 
día correspondiente. 
3.2.3. DISCUSION 
En ensayos experimentales, la determinación de los epg emitidos por 
helmintos se realiza de forma aproximada. Así, la eficacia del tratamiento 
antihelmíntico experimental se determina por la disminución del recuento de 
huevos en heces (McCONVILLE et al., 2009). Además de reducir la carga de 
helmintos adultos, algunas vacunas pueden inducir una reducción en la producción 
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de huevos de los parásitos (HILLYER, 2005; PIEDRAFITA et al., 2010). Las técnicas 
microscópicas comúnmente empleadas en el diagnóstico cuantitativo de huevos de 
helmintos son muy específicas pero sin embargo son poco sensibles. Las cantidades 
de epg en materia fecal normalmente son muy variables. Además, la técnica de 
recuento de epg aplicada es de particular importancia (EBRAHIM et al., 1997). La 
técnica de Kato-Katz se emplea rutinariamente para el diagnóstico y la 
cuantificación de la carga parasitaria (KATZ et al., 1972) en la mayoría de las 
helmintiasis humanas. Tanto la simplicidad del test como su fácil realización en 
condiciones de trabajo de campo han asegurado su aplicación universal. Sin 
embargo, la sensibilidad de un único examen puede ser muy baja debido a diversos 
factores como pueden ser: (a) pequeña cantidad de muestra analizada; (b) 
variación en la distribución de los huevos en una sola muestra de heces; (c) 
diferentes cargas parasitarias; (d) las fluctuaciones diarias en un individuo debido a 
la producción y consistencia fecal; (e) las fluctuaciones diarias de un individuo 
debido a los patrones de ovoposición del parasito (HALL, 1982; DE VLAS et al., 
1992; ENGELS et al., 1997; UTZINGER et al., 2001). Además, la consistencia de la 
materia fecal también depende de la carga parasitaria y hay que tener en cuenta 
que las infecciones parasitarias con cargas tanto moderadas como altas pueden 
causar diarrea (TEESDALE et al., 1985; FELDMEIER & POGGENSEE, 1993). También 
se debe tener en cuenta las cantidades de fibra o grasa presentes en la dieta del 
hospedador. Todos estos factores limitan la validez de la aplicación de las técnicas 
cuantitativas cuando se calculan los epg, lo cual provoca cierta imprecisión 
poniendo en peligro los ensayos experimentales (EBRAHIM et al., 1997; UTZINGER 
et al., 2001). Por consiguiente, a una sola cuantificación de epg no da la suficiente 
confianza, por lo que se requiere de numerosas muestras para la detección de 
diferencias entre grupos de hospedadores o parásitos. En este sentido, dado que el 
recuento de huevos emitidos en materia fecal es esencial, los estudios aplicados 
podrían beneficiarse de una mayor precisión si se dispusiera de un marcador poco 
variable. 
En los últimos años se ha producido un dramático resurgimiento de la 
fascioliasis. Este fenómeno ha sido atribuido, entre otros factores, al cambio 
climático (MAS-COMA et al., 2009b). Además, se conoce desde hace unos años la 
resistencia de F. hepatica a los fasciolicidas comerciales disponibles, como es el 
caso del Triclabendazol (Fasinex) y el Nitroxynil (Trodax) (OVEREND & BOWEN, 
1995; FAIRWETHER & BORAY, 1999; GAASENBEEK et al., 2001). Por ello, en la 
actualidad, se ha incrementado el número de estudios encaminados a encontrar 
nuevos posibles fármacos o vacunas eficaces. En estos estudios, la eficacia del 
fármaco o la de la vacuna normalmente se determina usando como biomarcador el 
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descenso de la producción de huevos. Sin embargo, tal y como hemos comentado, 
la emisión de huevos de F. hepatica en heces está normalmente sujeto a 
oscilaciones, tanto en el caso de animales así como en el hombre (VALERO et al., 
2002; EL-MORSHEDY et al., 2002). Para evitar estas inexactitudes, algunos autores 
han cuantificado el estado de desarrollo de órganos sexuales (testículos, glándulas 
vitelógenas, ovario y útero) de acuerdo con un sistema de puntuación (HANNA et 
al., 2006; McCONVILLE et al., 2009). 
En este estudio se muestra que existe una relación entre el UA del adulto 
fasciólido y la producción de huevos, lo cual coincide con los resultados obtenidos 
en otras helmintiasis. En el caso de Nematodos de animales, se ha descrito una 
correlación positiva entre el tamaño del verme y la producción de huevos 
(SKORPING et al., 1991; STEAR et al., 1997; STEAR & BISHOP, 1999; RICHARDS & 
LEWIS, 2001; IRVINE et al., 2001; DEZFULI et al., 2002; UGLAND et al., 2004). 
Una correlación positiva similar también existe en el caso de infecciones humanas 
por Ascaris lumbricoides (SINNIAH & SUBRAMANIAM, 1991; WALKER et al., 2009), 
detectándose una relación entre la producción de huevos y peso, longitud y 
diámetro del verme (SINNIAH & SUBRAMANIAM, 1991). Cabe remarcar que antes 
de que el adulto hembra de A. lumbricoides alcance su crecimiento corporal 
máximo, existe un descenso en la producción de huevos, tal y como ocurre con F. 
hepatica. Los adultos fasciólidos siguen un proceso de desarrollo establecido en su 
hospedador definitivo (VALERO et al., 2001a, 2006b; PERIAGO et al., 2008). En el 
caso de F. hepatica, la longitud del útero en sus diferentes estadios de desarrollo se 
correlaciona con el tamaño corporal (NEUHAUS, 1978). En poblaciones de bovino, 
ovino y porcino infectadas en la naturaleza del Altiplano Norte de Bolivia, el UA vs 
el área corporal sigue un modelo de crecimiento asintótico (VALERO et al., 2001b). 
En el estudio experimental de PANOVA (2002) se demostró que el desarrollo del UA 
de F. hepatica con respecto el tiempo se ajusta a un modelo saturado, mientras que 
el crecimiento corporal sigue un modelo logístico caracterizado por dos fases 
(VALERO et al., 1998): la parte “exponencial” del crecimiento logístico corresponde 
al desarrollo corporal durante la migración intraorgánica a través de la cavidad 
abdominal y el parénquima hepático, así como el desarrollo y la maduración sexual 
en los conductos biliares hasta el inicio de la producción de huevos. Desde este 
momento en adelante, el desarrollo corporal sigue un crecimiento logístico 
“saturado” con una persistencia considerable del crecimiento corporal después de la 
maduración sexual. La ovoposición es el punto de inflexión del crecimiento logístico 
el cual marca el final del periodo “exponencial” y el principio del periodo “saturado”. 
Es decir, el comienzo de la emisión de huevos al medio externo constituye el factor 
biológico que marca el punto de inflexión (VALERO et al., 2006b). PANOVA (2002) 
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muestra que el UA presenta un modelo saturado frente al tiempo y que el área 
corporal y el UA de F. hepatica siguen un modelo de crecimiento sincronizado 
después de comenzar la emisión de huevos. Estudios previos efectuados por otros 
autores demuestran la existencia de una variabilidad inherente en distintos aislados 
de F. hepatica y la relación entre esas diferencias y la fecundidad del parasito 
(WALKER et al., 2006). Estos autores comparan la producción de huevos in vitro de 
dos aislados distintos, llamados Oberon y Fairhurst, y muestran que el segundo 
producía cuatro veces más huevos. Nuestro estudio también detecta diferencias en 
la producción de huevos entre los aislados analizados. 
3.3. CARACTERIZACION FENOTIPICA DE F. HEPATICA EN AREAS ANDINAS 
HUMANAS ENDEMICAS: ANALISIS DEL PATRON VALLE VERSUS PATRON 
ALTIPLANICO DE FASCIOLIDOS PROCEDENTES DE OVINOS 
El objetivo del presente apartado es la caracterización fenotípica de 
poblaciones de F. hepatica de áreas andinas hiperendémicas humanas de alta 
altitud. Dichas poblaciones se han comparado con poblaciones estándar europeas 
de baja altitud. La caracterización fenotípica es un paso más en la caracterización 
de la fascioliasis en áreas hiperendémicas humanas andinas, proporcionando 
información que permitirá aplicar las medidas apropiadas para el control de la 
enfermedad en los distintos países Sudamericanos. Aunque la infectividad de las 
metacercarias no parece diferir en los distintos aislados de ganado (VALERO & 
MAS-COMA, 2000), la especie de hospedador definitivo afecta de manera esencial 
al fenotipo tanto del adulto fasciólido como de los huevos emitidos en las heces, 
debido principalmente a la diferencia en el tamaño del microhábitat, el canal biliar 
(VALERO et al., 2001a, b, 2002,2009). 
3.3.1. MATERIAL Y METODOS 
Para la realización del presente apartado se utilizó material de adultos 
grávidos de F. hepatica obtenidos de ovino, una especie hospedadora típica de este 
parásito. Como poblaciones andinas de altitud se utilizó material procedente del 
Altiplano norte de Bolivia (4000 m de altitud) y de los valles peruanos de Mantaro 
(3271 m de altitud) y Cajamarca (2663 m de altitud). Como material estándar 
europeo de baja altitud se utilizó parásitos procedentes de infecciones naturales de 
F. hepatica de Valencia (España) y adultos experimentales procedentes de un 
aislado de Polonia (ambas poblaciones de zonas geográficas próximas al nivel del 
mar). Este material que viene detallado en el punto 2.1.2.1. y 2.1.2.2. del capítulo 
de Material y Métodos. Todas las medidas estandarizadas realizadas a los adultos 
de F. hepatica fueron acordes a los métodos propuestos por VALERO et al. (2005) y 
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PERIAGO et al. (2006, 2008) (ver Fig. 2.1) y están descritas detalladamente en el 
punto 2.3.3.1. del capítulo de Material y Métodos. Los datos morfométricos del 
adulto se estudiaron mediante un análisis de los componentes principales, detallado 
en el punto 2.3.5.2. del capítulo de Material y Métodos. 
3.3.2. RESULTADOS 
Los valores morfométricos de los adultos de F. hepatica procedente de zonas 
de alta altitud del valle de Cajamarca, valle del Mantaro y del Altiplano Norte de 
Bolivia, así como adultos estándar europeos de F. hepatica de zonas situadas a 
nivel de mar se indican en la tabla 3.9 (características biométricas lineares), tabla 
3.10 (superficies) y tabla 3.11 (relaciones entre medidas). Estos resultados son la 
primera descripción fenotípica de los adultos de F. hepatica procedentes de Perú. El 
análisis de la circularidad corporal (BR) de las poblaciones de F. hepatica muestra 
un solapamiento general entre ellas, a pesar de su diferente área geográfica de 
origen. El tamaño de los adultos fasciólidos se analizó mediante un análisis 
multivariante. La Fig. 3.9 muestra el mapa factorial de los dos primeros 
componentes principales (CP). Cabe recordar que el primer componente principal 
(CP1) se interpreta como una medida del tamaño total. El análisis de la proyección 
en el CP1 de las 5 poblaciones de F. hepatica estudiadas indica que las poblaciones 
procedentes de los valles de Cajamarca y Mantaro (Perú), así como las poblaciones 
estándar de España y la población experimental, presentan un tamaño corporal 
máximo y mínimo similar. Por otra parte, la población procedente del Altiplano 
Norte de Bolivia comparte el mismo valor máximo con las poblaciones 
anteriormente mencionadas pero presenta un tamaño mínimo más bajo (Fig. 3.9). 
Estos resultados indican que los fasciólidos procedentes de Perú y Europa (tanto los 
de infecciones naturales como experimentales) poseen un tamaño mínimo común 
en el cual los adultos parásitos son grávidos, mientras que, este tamaño mínimo es 
más bajo en los adultos fasciólidos procedentes de Bolivia. 
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Tabla 3.9- Comparación de los resultados morfométricos relativo a las características biométricas lineares (valores máximos 
y mínimos, media y desviación estándar) de adultos de F. hepatica procedentes de ovinos infectados de forma natural en 
zonas de alta altitud del valle de Cajamarca, valle del Mantaro y el Altiplano Norte de Bolvia, y adultos de F. hepatica 
procedentes de ovinos infectados tanto de forma natural como experimental de zonas europeas de baja altitud (n = número 
de adultos). 
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Tabla 3.10- Comparación de los resultados morfométricos relativo a las superficies (valores máximos y mínimos, 
media y desviación estándar) de adultos de F. hepatica procedentes de ovinos infectados de forma natural en zonas de 
alta altitud del valle de Cajamarca, valle del Mantaro y el Altiplano Norte de Bolivia, y adultos de F. hepatica 
procedentes de ovinos infectados tanto de forma natural como experimental de zonas europeas de baja altitud (n = 
número de adultos). 
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Tabla 3.11- Comparación de los resultados morfométricos relativo a las relaciones entre medidas (valores máximos y 
mínimos, media y desviación estándar) de adultos de F. hepatica procedentes de ovinos infectados de forma natural en 
zonas de alta altitud del valle de Cajamarca, valle del Mantaro y el Altiplano Norte de Bolivia, y adultos de F. hepatica 
procedentes de ovinos infectados tanto de forma natural como experimental de zonas europeas de baja altitud (n = 
número de adultos). 
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Figura 3.9- Mapa factorial correspondiente a especímenes de F. hepatica procedentes de ovejas infectadas de 
forma natural de los valles de Cajamarca y Mantaro (Perú), Altiplano Norte (Bolivia), Valencia (España) y ovinos 
infectados experimentalmente (F. hepatica = aislado procedente de Polonia). Los resultados se proyectan sobre el 
primer (CP1, 59%) y el segundo (CP2, 17%) componente principal. Cada grupo está representado por su 
perímetro. 
No existe una relación consistente entre el patrón de variación “size-free” y la 
diferencia altitudinal entre poblaciones (Fig. 3.10). No existe tampoco una 
correlación significativa entre las distancias de Mahalanobis y las distancias 
geográficas (datos no mostrados), así como tampoco se detectó una correlación 
significativa entre la media del CP1 de los adultos fasciólidos y la carga parasitaria 
(datos no mostrados). 
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Figura 3.10- Grafica de las distancias de Mahalanobis procedentes de las variables libre de alometrías (eje vertical) 
frente a las diferencias altitudinales (eje horizontal en m). La predicción de la regresión linear viene representada por 
la línea recta. a= ovejas infectadas naturalmente procedentes de  Valencia (España) – ovejas infectadas 
experimentalmente (aislado procedente de Polonia); b= ovejas infectadas naturalmente procedentes del valle de 
Cajamarca – valle del Mantaro (Perú); c= ovejas infectadas naturalmente procedentes del valle del Mantaro (Perú) – 
Altiplano Norte (Bolivia); d= ovejas infectadas naturalmente procedentes del valle de Cajamarca (Perú) – Altiplano 
Norte (Bolivia); e= ovejas infectadas naturalmente procedentes del valle de Cajamarca (Perú) – Valencia (España); 
f= ovejas infectadas naturalmente procedentes del valle de Cajamarca (Perú) - ovejas infectadas experimentalmente 
(aislado procedente de Polonia); g= ovejas infectadas naturalmente procedentes del valle del Mantaro (Perú) – 
Valencia (España); h= ovejas infectadas naturalmente procedentes del valle del Mantaro (Perú) - ovejas infectadas 
experimentalmente (aislado procedente de Polonia); i= ovejas infectadas naturalmente procedentes del Altiplano 
Norte (Bolivia) - ovejas infectadas experimentalmente (aislado procedente de Polonia); j= ovejas infectadas 
naturalmente procedentes del Altiplano Norte (Bolivia) – Valencia (España). 
3.3.3. DISCUSION 
La variación morfológica cuantitativa informa tanto de la variación genética como 
de las influencias externas (DUJARDIN et al., 2009). En el caso de los 
endoparásitos, es necesario distinguir entre macrohábitat (características 
medioambientales externas relativas a la geografía) y microhábitat (órgano 
parasitado en el interior del hospedador). Las áreas geográficas analizadas en este 
estudio incluyen ambientes de zonas de alta y baja altitud. Vale la pena mencionar 
que el entorno en zonas de alta altitud, hay menos oxígeno y la densidad del aire 
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es menor, la temperatura y la humedad son bajas y hay un incremento de la 
radiación. Estos factores medioambientales pueden ejercer una influencia decisiva 
sobre los mamíferos y por lo tanto los animales que nacen y viven en zonas de alta 
altitud pueden mostrar características morfológicas y fisiológicas diferentes en 
comparación con aquellas características que muestran los mamíferos que habitan 
en zonas de baja altitud (JACKSON et al., 1987; FRISANCHO & FRISANCHO, 1992). 
Los resultados del presente estudio muestran que aparentemente no hay 
relación entre la forma del fasciólido adulto con respecto a la diferencia altitudinal o 
geográfica entre muestras de dos zonas geográficas diferentes. Los resultados 
obtenidos en el análisis de los componentes principales muestran que las 
poblaciones procedentes de los valles Andinos y las poblaciones tanto naturales 
como experimentales de F. hepatica de zonas europeas de baja altitud presentan 
una homogeneidad fenotípica. Los resultados muestran que el tamaño corporal 
mínimo para alcanzar la gravidez es similar en el material procedente tanto de los 
valles peruanos como en las zonas de baja altitud europeas. Por otra parte, la 
población procedente del Altiplano presenta un tamaño corporal mínimo más bajo 
para alcanzar la madurez en los adultos. Esto significa que las poblaciones de 
adultos de F. hepatica procedente del Altiplano alcanzan antes la madurez del útero 
en su crecimiento en el interior del hígado (Fig. 3.9). 
Cabe mencionar que el tamaño del útero y el tamaño corporal son 
proporcionales (VALERO et al., 2001b), por lo que se podría concluir que los adultos 
procedentes de los valles de Mantaro y Cajamarca presentan un tamaño de útero 
mayor al que presentan los adultos fasciólidos procedentes de poblaciones 
Altiplánicas. 
En otros organismos como los insectos, la “forma libre de alometría” 
requiere cambios externos importantes para producir modificaciones significativas. 
Por ejemplo, DUJARDIN & LE PONT (2004) detectaron en Flebotómidos que la 
variación libre de alometría estaba estrechamente relacionada con diferencias 
altitudinales, indicando su posible relación con la temperatura y/o la vegetación. 
Estos resultados son contrarios a los obtenidos en nuestro estudio, en donde la 
forma libre de alometría aparece como un rasgo más estable que el tamaño en 
especies de fasciólidos en diferentes condiciones de altitud y latitud. 
Muchos mamíferos pueden actuar como hospedadores definitivos para F. 
hepatica aunque hay una variación considerable en la susceptibilidad y patología de 
acuerdo a las distintas especies (MAS-COMA et al., 2009a). Usando un modelo 
alométrico, VALERO et al., (2001a) indica que la especie hospedadora definitiva 
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(ovino, bovino, porcino) ejerce una influencia decisiva en el tamaño de los adultos 
de F. hepatica, aunque esta influencia desaparece en un modelo experimental 
murino infectado con diferentes aislados. Además, se ha demostrado la existencia 
de ciertos rasgos morfológicos (diferencias alométricas entre BW vs. BL y BL vs. 
VS-P) que caracterizan a los adultos de F. hepatica en diferentes hospedadores 
definitivos (VALERO et al., 2001a). 
La carga parasitaria es otro de los factores medioambientales que afectan a 
la variación del tamaño en los fasciolidos. El “crowding effect” se refleja en los 
adultos de F. hepatica como una reducción de los valores máximos morfométricos 
(ym) de las trayectorias ontogénicas del área corporal, BP, BL y BW debido a una 
reducción de la tasa de crecimiento (VALERO et al., 2006b). Así, en roedores, el 
tamaño del verme es dependiente del nivel de infección, disminuyendo el tamaño 
cuando la carga parasitaria aumenta. Este fenómeno no está presente en 
infecciones ligeras en ovino, es decir con cargas parasitarias menores o iguales a 
45 adultos/oveja. 
En el caso de poblaciones de F. hepatica naturales, se ha detectado ligeras 
diferencias en modelos alométricos (BL, BW, P vs. BA o BL) entre los adultos de F. 
hepatica procedentes de ovinos infectados tanto en áreas de alta altitud bolivianas 
como áreas de baja altitud españolas (VALERO et al., 1999). Sin embargo, 
comparando las mismas especies hospedadoras, las poblaciones de F. hepatica 
procedentes de ovinos y bovinos del Altiplano Norte de Bolivia presentan, con la 
misma área corporal, una menor área uterina que la de las poblaciones de F. 
hepatica europeas (VALERO et al., 2001b). 
El ciclo biológico de F. hepatica tiene lugar alternativamente entre un 
ecosistema acuáticos y otro terrestre. Los huevos del parásito los emite un 
hospedador definitivo terrestre. Sin embargo, el huevo se desarrolla en agua dulce 
y el desarrollo de la fase larvaria ocurre luego en caracoles Lymnaeidos acuáticos y 
anfibios (MAS-COMA, 2005). La emisión de los huevos de F. hepatica con las heces 
normalmente está sujeta a oscilaciones a lo largo del tiempo tanto en animales 
como en humanos. Un ejemplo de la adaptación de la cronobiología de la emisión 
de huevo a la estacionalidad podemos encontrarlo en el trabajo de VALERO et al. 
(2002). Así, la rata negra naturalmente parasitada con fasciólidos en la isla 
Mediterránea de Córcega muestra una emisión continua de huevos, con valores 
mínimos en verano, cuando el desarrollo del huevo es más difícil (en los meses de 
verano en el área Mediterránea, la evapotranspiración es mayor que las 
precipitaciones), mientras que es en los meses de primavera y otoño se alcanza los 
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picos máximos de emisión, cuando existe un nivel aceptable de precipitaciones y 
suficiente humedad ambiental (VALERO et al., 2002). Las poblaciones de G. 
truncatula europeas son mayoritariamente anfibias (EUZEBY, 1971). Por el 
contrario, los especímenes de G. truncatula altiplánicos, son más acuáticos y sólo 
en raras ocasiones pueden encontrarse en el barro, fuera del agua. Suelen habitar 
principalmente en cuerpos de agua permanentes y nunca en cuerpos de agua 
temporales originados en la temporada de lluvia (Octubre-Marzo). Los cuerpos de 
agua originados por las precipitaciones no permanecen el tiempo suficiente para 
permitir la colonización por Lymnaeidos e incluso, en años muy lluviosos, los 
periodos de sequía son demasiado largos como para permitir la supervivencia de 
Lymnaeidos enterrados y en letargo. Esto está relacionado con las elevadas tasas 
de evapotranspiración propias de la alta altitud, así como con que las temporadas 
de sequía coincidan con las temperaturas mínimas del año (Abril-Septiembre). De 
esta forma, los Lymnaeidos dispersos en pastos inundados irregularmente, lo cual 
constituye el foco de transmisión más importante en Europa Central, no se 
encuentra casi nunca en el Altiplano. De la misma forma, la relación entre la 
fascioliasis y los periodos de lluvia, reconocida tanto en animales como en humanos 
en el hemisferio norte (CHEN & MOTT, 1990), no puede aplicarse al Altiplano Norte 
de Bolivia. En el Altiplano, la presencia a lo largo de todo el año de poblaciones de 
Lymnaeidos en los focos de transmisión, permite la transmisión del parásito 
durante todas las estaciones. En el caso del Altiplano Norte de Bolivia, las 
diferencias entre las medias de temperatura entre las estaciones es muy baja, solo 
de 5,0-6,5º C. Las mayores diferencias en la temperatura ocurren a lo largo del 
mismo día, desde 10,3 hasta 13,0º C (en las costas del lago Titicaca), y de 13,4 
hasta 22,4º C (lejos del Lago). Además, la ausencia de árboles y arbustos implica la 
inexistencia de sombra y que por lo tanto hay una intensa incidencia de la radiación 
solar, lo cual incrementa la temperatura de los cuerpos de agua al mediodía (el 
rango de temperatura a lo largo del día en los cuerpos de agua poblados por los 
Lymnaeidos oscila entre 3,0-10,0º C por la noche y entre 15,0-28.9º C durante el 
día) (MAS-COMA et al., 1999a; FUENTES et al., 1999). 
Estudios realizados en el Altiplano Norte de Bolivia muestran que en el ciclo 
biológico del parásito no existe una fase en la cual no parezca estar modificada de 
tal manera que la transmisión se reduzca. No obstante, hay ciertos aspectos que 
parecen favorecer la transmisión, como es un periodo de emisión cercariana largo y 
una gran producción cercariana. Estos dos aspectos parecen estar relacionados con 
la mayor supervivencia de los caracoles Lymnaeidos infectados. Cuando se compara 
con áreas de baja altitud, estas diferencias pueden ser interpretadas como 
estrategias de adaptación a las condiciones extremas en las que se encuentran las 
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poblaciones de áreas de alta altitud (MAS-COMA et al., 2001). Nuestros resultados 
indican que las poblaciones de adultos de fasciólidos tanto de Perú como Europa 
(naturales y experimentales) presentan un tamaño mínimo común para alcanzar la 
madurez, mientras que este valor de tamaño mínimo es más bajo en las 
poblaciones procedentes de las zonas altiplánicas de Bolivia. Esta diferencia se 
puede atribuir a una variabilidad intraespecifica o puede estar relacionada con la 
influencia que ejerce la alta altitud. La divergencia detectada entre la población 
altiplánica y el resto de poblaciones analizadas es difícil de entender, además es 
difícil prever ventajas evolutivas. Se sabe que se requiere oxígeno para la 
producción de huevos en F. hepatica (MANSOUR, 1958; BJORKMAN & THORSELL, 
1963; McGONIGLE & DALTON, 1995) (el paso de gran altitud a alta altitud 
normalmente se realiza a partir de los 3200 m). La hipoxia existente a gran altitud 
puede ser el origen de la menor producción de huevos en los adultos fasciólidos. 
Por otra parte, el útero en los Digénidos adultos tradicionalmente no se ha 
considerado un órgano de almacenaje si no que principalmente se ha considerado 
como un órgano adaptado para dar tiempo al desarrollo de los huevos (en los 
fasciolidos, los huevos se emiten sin embrionar y el miracidio solo comienza su 
desarrollo una vez llega a agua dulce). En el apartado 3.2. del presente capítulo, 
hemos demostrado la existencia de una relación directa entre el tamaño del útero y 
el número de huevos por gramo de heces emitido. En los patrones de transmisión 
de los valles y de zonas de baja altitud de Europa, la capacidad de almacenaje del 
útero es mucho más necesaria, debido a la transmisión estacional que se da en 
estas zonas, con una emisión continua de huevos pero con oscilaciones, con valores 
mínimos en aquellas estaciones desfavorables, y picos de máximos de emisión en 
las estaciones favorables. Como se ha mencionado antes, en el Altiplano Norte de 
Bolivia, las condiciones climáticas, las características del agua dulce y la ecología de 
los Lymnaeidos permiten que la transmisión de la fascioliasis tenga lugar a lo largo 
de todo el año (FUENTES et al., 1999; MAS-COMA et al., 1999a), la emisión de 
huevos es continua y la menor capacidad de almacenaje del útero puede estar 
relacionada con esta transmisión continua, así como con la disponibilidad todo el 
año de poblaciones del molusco hospedador. 
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4. ASSESSING THE VALIDITY OF NEW INMUNOLOGICAL TESTS IN THE
DIAGNOSIS OF HUMAN FASCIOLIASIS 
4.1. DRG F. HEPATICA IgG ELISA TEST AS A SEROLOGICAL DIAGNOSIS OF 
HUMAN FASCIOLIASIS IN DIFFERENT EPIDEMIOLOGICAL SITUATIONS 
The present section evaluates a qualitative microtiter strip-based enzyme-
linked immunosorbent assay (ELISA) for the detection of IgG class antibodies 
against F. hepatica in human serum, a solid phase enzyme immunoassay based on 
the sandwich principle, known as ‘DRG Fasciola hepatica IgG (human) ELISA’, in 
the following situations: (i) a hyperendemic F. hepatica area where humans usually 
shed large amounts of parasite eggs in faeces, (ii) an epidemic F. hepatica area 
where humans usually shed small amounts of parasite eggs and (iii) an overlap 
area of both Fasciola species where human shedding of parasite eggs in faeces is 
usually scarce or non-existent. 
4.1.1. MATERIAL AND METHODS 
The serum used in the next study is detailed in section 2.2.1. in the  
Materials & Methods section. The gender and age characteristics of patients used in 
the study are detailed on table 4.1. 
Fascioliasis positivity of the samples used had been verified through egg 
detection (Kato–Katz technique) (see 2.3.2.2. in Materials & Methods) or the ELISA 
Cathepsin L1 (CL1) (see 2.3.4.1.1.) protease test. ELISA CL1 is used here as the 
serological gold standard method in samples from areas where humans usually 
shed small amounts of parasite eggs or where parasite eggs in faeces are usually 
scarce or non-existent. ELISA CL1 was previously successfully employed for the 
diagnosis of human fascioliasis in the Northern Bolivian Altiplano (O’NEILL et al., 
1998) and in Iran (ROKNI et al., 2002), showing it to be highly specific (100%) and 
sensitive (100%). 
In the following study we assessed the validity of the DRG Kit (commercial 
ELISA kit). DRG Instruments GmbH, Germany, provided all commercial kits used in 
this study. The protocol used is detailed in 2.3.4.1.2. 
The diagnostic sensitivity and specificity values were calculated (Fletcher & 
Fletcher 2005) with its 95% confidence interval (95% CI; EPIINFO). The positive 
predictive value (PPV) and negative predictive value (PNV) were calculated using 
formulae detailed in section 2.3.5.6. 
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Student’s t-test was calculated using SPSS statistics version 19 software. 
*Amoebiasis 12; leishmaniasis 3; malaria 12; toxoplasmosis 10; schistosomiasis 15; hydatidosis 15;
hymenolepiasis 1; taeniasis ⁄ cysticercosis 15; trichinellosis 15; strongyloidiasis 18; ascariasis 1; 
toxocariasis 8; anisakiasis 25; loasis 2; gnathostomiasis 10; trichuriasis and ascariasis coinfection 1; 
malaria, trichuriasis and ascariasis coinfection 2; Entamoeba coli, trichuriasis, ascariasis and ancylostomiasis 
coinfection 1; trichuriasis, ancylostomiasis and enterobiasis coinfection 1; histoplasmosis 1. 
Table 4.1- Gender and age characteristics of individuals whose serum samples were used in the validation. 
4.1.2. RESULTS 
The mean of DRG units (DU) values (see 2.3.4.1.2.) for all serum groups is 
shown in Figure 4.1 A, B. DU values were significantly higher in the proven 
fascioliasis group than in the groups of parasitic diseases other than fascioliasis and 
the healthy controls, respectively (P < 0,001). 
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Figure 4.1- Mean DRG Units (DU) obtained with the DRG F. hepatica IgG ELISA test in fascioliasis patients from 
different epidemiological situations. (A) Endemic F. hepatica area where humans usually shed small amounts of 
parasite eggs; (B) an overlap area of both Fasciola species where human shedding of parasite eggs in faeces is usually 
scarce or non-existent. Data points are the mean optical density (OD) obtained from triplicate samples expressed as a 
percentage of the cut-off (CO), using the following formula: Percent positive (PP) = ((Mean OD of test sample)/ Mean 
OD of C+)*100. A serum is considered positive when its absorbance value is above 10% of CO. The results in DRG 
Units (DU) were calculated according to the following formula: DU= (sample (mean) absorbance value * 10)/ CO. The 
results were negative if DU <9, and positive if DU > 11 (black line). 
The numbers of true positive and false negative test results in fascioliasis 
cases of humans with and without detection of eggs in their faecal samples are 
provided in table 4.2 and table 4.3. 
Table 4.2- Diagnostic characteristics of the F. hepatica IgG ELISA test applied to sera from patients with helminthiases 
other than fascioliasis and negative sera from healthy subjects. 
Tesis doctoral: Ignacio Pérez Crespo 
92 
* Gold standard determined according to the Kato–Katz technique.
¥ Gold standard determined according to the ELISA CL1 test. 
Table 4.3- Diagnostic characteristics of the F. hepatica IgG ELISA test applied to fascioliasis patients sera from 
different disease endemic areas. 
In the samples from a hyperendemic F. hepatica area egg detection in 
faeces through the Kato-Katz technique was used as reference standard, and the 
sensitivity of the F. hepatica IgG ELISA test was 100% (67,9–100%). No correlation 
between egg output - a measure of infection intensity - and the OD450 values of 
the F. hepatica IgG ELISA test was observed in this study area (Fig. 4.2). 
In the samples from an epidemic F. hepatica area CL1 ELISA was used as 
reference standard. Sensitivity was 91,7% (95% confidence intervals, 71,5–
98,5%), detecting 2 false negative cases of which one was egg positive in faeces, 
while the other was not. 
CL1 ELISA was used as reference standard in the samples from an overlap 
area of both Fasciola species. Sensitivity was 100% (95,9–100%). Populations of 
the two latter endemic areas were grouped as result of the ELISA CL1 and the F. 
hepatica IgG ELISA test evaluation as follows: fascioliasis positive cases by CL1 
(Fas+) ⁄ seropositive by F. hepatica IgG ELISA test (test+) and fascioliasis positive 
cases by CL1 (Fas+) ⁄ seronegative by F. hepatica IgG ELISA test (test-) (Fig. 4.1 
A, B). Statistical differences between the results for sensitivity values from the two 
latter situations were not found, and true positive cases (41) and false negative 
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cases (2) for these two areas together were used for the calculation of sensitivity, 
presenting a value of 95,3% (82,9–99,2%). 
Figure 4.2- DRG F. hepatica IgG ELISA test and intensity of F. hepatica infection. Data points represent the mean 
absorbance at 450 nm from copropositive patients from a hyperendemic F. hepatica area where humans usually 
shed a great deal of parasite eggs in faeces. epg = egg count per gram of faeces. 
Specificity was calculated from the results in table 4.2 and table 4.3 
providing the numbers of false negative and true positive test results in infected 
sera other than fascioliasis and negative cases. These results can be grouped as 
follows: infected positive cases other than fascioliasis (infected+) ⁄ seropositive by 
F. hepatica IgG ELISA test (test+) and infected positive cases other than fascioliasis 
(infected+) ⁄ seronegative by F. hepatica IgG ELISA test (test-) (Figure 4.3 A). 
Table 4.2 also shows the total number of sera without fascioliasis, and these values 
were used to calculate specificity, presenting a value of 95,7% (92,3–97,5%). Ten 
serum samples from a heterologous infection cross-reacted with the kit, mainly 
originating from patients with helminthiases, namely schistosomiasis (4 samples), 
hydatidosis (2 samples), taeniasis ⁄ cysticercosis (1 sample), trichinosis (1 sample), 
strongyloidiasis (1 sample), and histoplasmosis (1 sample) (Figure 4.3 B). 
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Figure 4.3- Mean DRG Units (DU) obtained with the DRG F. hepatica IgG ELISA test in (A) patients with parasitoses 
other than fascioliasis (B) and negative control sera. Data points represent the mean absorbance at 450 nm obtained 
from three replicates of each serum tested. Data points are the mean optical density (OD) obtained from triplicate 
samples expressed as a percentage of the cut-off (CO), using the following formula: Percent positive (PP) = ((Mean OD 
of test sample)/ Mean OD of C+)*100. A serum is considered positive when its absorbance value is above 10% of CO. 
The results in DRG Units (DU) were calculated according to the following formula: DU= (sample (mean) absorbance 
value * 10)/ CO. The results were negative if DU < 9, and positive if DU > 11 (black line). 
Theoretical PPVs and NPVs vs fascioliasis prevalence are represented in 
Figure 4.4, showing the expected PPVs and NPVs depending on whether the test 
was used in low, medium or high prevalence scenarios. 
















Figure 4.4- Theoretical PPVs and NPV values vs fascioliasis prevalence, showing the expected PPVs and 
NPV values if the test were used in low (below 1%), medium (between 1% and 10%) or high (above 
10%) prevalence scenarios (expressed in vertical lines). 
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4.1.3. DISCUSSION 
Coprological analysis, based on the identification of eggs found in stools, 
duodenal contents or bile analysis is still commonly employed to diagnose human 
fascioliasis (VALERO et al., 2009a), despite the overwhelming consensus that this 
method is not wholly reliable (HILLYER 1999) for several reasons. Eggs are not 
detected until the latent period of infection when much of the liver damage has 
already occurred, and similarly patients may not shed eggs in faeces in ectopic 
cases known in both infections by F. hepatica and F. gigantica (LE et al., 2007). 
Additionally, eggs are released sporadically from the bile ducts and hence stool 
samples of infected patients may not necessarily contain eggs (MAS-COMA et al., 
1999b). 
However, coprological methods of egg detection are still usually considered 
the gold standard, although unfortunately they are not applicable in endemic areas 
where: 
i. Humans do not shed eggs in faeces
ii. The shedding is often very low and difficult to detect
iii. In cases of communities that do not supply stool samples due to ethnic /
cultural customs.
Hence, it is essential to have serological techniques also available when 
diagnosing the disease. Therefore, in this study, besides Kato–Katz, another 
serological test, the ELISA CL1 test, was also used as gold standard. 
Serodiagnosis of fascioliasis in human and animal species has been 
successfully carried out employing several antigenic fractions of Fasciola (MEZO et 
al., 2003; SANCHEZ-ANDRADE et al., 2008; DEMERDASH et al., 2011), purified 
antigens (O´NEILL et al., 1998; ROKNI et al., 2002), and recombinant antigens 
(O´NEILL et al., 1999; CARNEVALE et al., 2001). Cathepsins L are the most 
frequently used target antigens for detecting anti-Fasciola antibodies (CARNEVALE 
et al., 2001; ROKNI et al., 2002; MEZO et al., 2004, 2007, 2010; INTAPAN et al., 
2005; WONGKHAM et al., 2005; VALERO et al., 2009b; MUIÑO et al., 2011), as 
circulating antibodies to these molecules remain at high levels for long periods 
(VALERO et al., 2009b). 
The commercial DRG test was evaluated in cattle, obtaining a sensitivity and 
specificity of 98% (96–100%) and 96% (93–98%) respectively at a cut-off value of 
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15% positivity (SALIMI-BEJESTANI et al., 2005). The sensitivity and specificity 
values of the DRG test here in agree with the results obtained by other authors for 
F. hepatica IgG ELISA in-house assays: 100% and 100% (O´NEILL et al., 1998; 
ROKNI et al., 2002), 92,4% and 83,6% (ESPINOZA et al., 2007), 97,2% and 100% 
(RAHIMI et al., 2011), 97% and 96,6% (CORNEJO et al., 2010), and 100% and 
95,6% (FIGUEROA-SANTIAGO et al., 2011). Commercial kits offer advantages over 
in-house assays: they save time and provide quality control reagents for better 
reproducibility within and between laboratories, which hampers the comparison 
between in-house and commercial tests. Furthermore, only very few commercial 
kits, such as the DRG F. hepatica IgG ELISA test evaluated here, are presently 
available for the diagnosis of human fascioliasis. Comparing DRG test results only 
with commercial assays results in sensitivity and specificity below the 100% 
sensitivity, respectively, specificity obtained by SeroFluke strips (MARTINEZ-
SERNANDEZ et al., 2011). 
The results obtained show the test to be highly sensitive and specific. The 
sensitivity of this assay did not detect differences in positive samples from different 
epidemiological situations. Nevertheless, PPVs calculated for diverse epidemiological 
situations are very different. Thus, PPVs in hypoendemic areas were below 2,2%, in 
mesoendemic situations PPVs oscillated between 2,2% and 71,2%, while in 
hyperendemic situations PPVs were above 71,17%, making this test 
recommendable in such situations. Contrarily, NPVs calculated for diverse 
epidemiological situations were similar. NPVs for hypoendemic areas reached values 
above 99,9%, in mesoendemic situations NPVs oscillated between 99,5% and 
99,9%, while in hyperendemic situations NPVs were below 99,5%. 
4.2. FIELD EVALUATION OF A COPROANTIGEN DETECTION TEST FOR 
FASCIOLIASIS DIAGNOSIS AND SURVEILLANCE IN HUMAN HYPERENDEMIC AREAS 
OF ANDEAN COUNTRIES 
The present chapter evaluates the coproantigen technique MM3-COPRO 
ELISA under field conditions for human fascioliasis diagnosis, using classical 
coprological techniques for egg detection (rapid sedimentation and Kato-Katz) and 
the Copro-ELISA test as gold standards in human hyperendemic areas of Andean 
countries. Thus, two endemic areas were chosen: Huacullani (Bolivia) representing 
the Altiplanic pattern with high prevalences and intensities, and the rural areas of 
Cajamarca (Peru), representing the valley pattern with high prevalences but with 
low intensities. 
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4.2.1. MATERIALS AND METHODS 
To evaluate the MM3-coproantigen detection test we used faecal samples 
collected from two endemic areas of Andean countries. Stool samples obtained are 
detailed in section 2.2.2. in Materials & Methods. 
Identification of true positive and true negative cases was carried out by 
using two criteria: i) finding of F. hepatica eggs in faeces applying the Kato-Katz 
technique (see 2.3.2.2.); ii) egg finding plus MM3-COPRO ELISA test results. The 
protocol used for MM3-COPRO ELISA is detailed in section 2.3.4.1.3. in chapter 
Materials & methods. 
Statistical analyses were done using SPSS Statistics version 19 software. For 
the evaluation of categorical variables, the chi-square test or Fisher’s exact test 
was used. Bivariant correlations (Pearson’s correlation) were calculated to assess 
the relationship between optical density (OD) and epg of F. hepatica. A P value less 
than 0.05 were considered significant. Theoretical positive predictive values (PPV) 
and negative predictive values (NPV) were calculated from sensitivity and specificity 
values obtained using only classical coprological tests for the identification of F. 
hepatica eggs in feces as ‘‘gold standard’’. The formulas were used for their 
calculation are detailed in section 2.3.5.6 in Materials & Methods. 
4.2.1.1. INSTITUTIONAL ETHICAL REVIEW PROCEDURE 
Faecal samples from schoolchildren used in the diagnostic analyses were 
obtained after informed consent had been given from the local authorities of the 
communities, the children’s parents and the heads and teachers of each school, 
following the principles expressed in the Declaration of Helsinki. Each community 
surveyed was informed in previous meetings about the public health relevance and 
impact of the intestinal and hepatic parasitic infections, and on the need for the 
development of control schemes at national, regional, district and village levels. 
In Huacullani, activities were performed in collaboration with the Servicio 
Departamental de Salud La Paz (SEDES L.P.) and the Unidad de Epidemiología of 
the Bolivian Ministry of Health and Sports (MSyD). Consent was previously obtained 
from the Comisión de Etica de la Investigación (CEI) of the Comité Nacional de 
Bioética of Bolivia. 
In Cajamarca, the initiative was performed in collaboration with the 
Dirección Regional de Salud of Cajamarca, and the Dirección General de de 
Zoonosis, Ministerio de Salud (MINSA), Lima. Consent was previously obtained from 
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the Dirección General de Zoonosis, MINSA, Lima and Centro de Investigación y 
Control de Enfermedades Transmisibles of Universidad Nacional de Cajamarca, 
Cajamarca. 
4.2.2. RESULTS 
Diagnostic parameters of the MM3-COPRO ELISA were estimated by 
choosing coprology and copro-ELISA as the “gold standard” assays to detect F. 
hepatica infection in humans. Positive cases of the MM3-COPRO ELISA and egg 
detection techniques of F. hepatica infection and performance characteristics of the 
MM3-COPRO ELISA according to study site are summarized in table 4.4. 
Huacullani positive cases were globally 24,71% using the MM3-COPRO ELISA 
and 21,51% applying an egg detection technique (Kato-Katz). No significant 
differences were encountered between either % (P=0.093).  
Cajamarca positive cases were globally 11,05% using the MM3-COPRO ELISA 
and 5,60% employing egg detection techniques (rapid sedimentation and Kato-
Katz). Significant differences were detected between both % (P=0,007). 
Differences between the two local patterns were detectable, i.e. significant 
differences were found when comparing MM3-COPRO ELISA positive cases % from 
Huacullani and Cajamarca (P=0,0025), and also when comparing egg detection 
positive cases % from Huacullani and Cajamarca (P=0,001). 
In Huacullani, sensitivity and specificity were 94,68%, respectively, 98,48%. 
In Cajamarca, these results were 94,73%, 93,58%, respectively. 
In Huacullani, of 437 samples assayed, 89 showed the presence of eggs 
through the Kato-Katz technique (20,37%). The MM3-COPRO ELISA was positive in 
108 samples (24,71 %), which included samples with Fasciola eggs (89) and 
without Fasciola eggs (19), i.e. 82,40% of the children who were positive for the 
MM3-COPRO ELISA were also positive through the Kato-Katz procedure. It should 
be emphasized that there were five children shedding eggs with emissions of 48, 
72, 96, 120 and 1248 epg, whose MM3-COPRO ELISA results were negative 
(1,14%). The stool sample showing 1248 epg was repeatedly re-analysed, and a 
negative result was always obtained with the MM3-COPRO ELISA test. 
In Cajamarca, of 362 samples assayed, 18 showed the presence of eggs 
through the rapid sedimentation and Kato-Katz techniques (4,97%), whereas the 
MM3-COPRO ELISA was positive in 40 samples, which included the samples with 
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Fasciola eggs (18) and without Fasciola eggs (22), i.e. 45,0% of the children who 
were positive for the MM3-COPRO ELISA were also positive through coprological 
egg detection procedures. Interestingly, one child shed eggs (by the rapid 
sedimentation technique) but was negative for the MM3-COPRO ELISA. The 
remaining 321 MM3-COPRO ELISA negative samples, however, included 237 
negative samples, and 84 positive samples for parasitic infections other than 
Fasciola. They involved one or more parasitic protozoans (Blastocystis hominis, 
Chilomastix mensnilii, Giardia intestinalis, Entamoeba histolytica, E. coli, Endolimax 
nana, Iodamoeba buetschlii) and helminth species (Strongyloides stercoralis, 
Ascaris lumbricoides, Trichuris trichiura, Enterobius vermicularis and Hymenolepis 
nana). 
In Huacullani, the geometric mean egg content in F. hepatica positive 
samples was 164,09 epg, and the arithmetic mean was 334,98 (with SD of ± 
992,56), with a range of 24 to 8088 epg (Table 4.4). In these samples from 
Huacullani, epg data were distributed into two groups: a high burden group (≥400 
epg) of samples whose respective infected children were in need to be hospitalized 
for prevention follow up of potential post-treatment colics, and a low burden group 
(<400 epg) of samples whose respective infected children should not be 
hospitalized. 
In Cajamarca, the geometric mean egg content in F. hepatica positive 
samples was 89,80 epg, and the arithmetic mean was 116,47 (with SD of ± 84,80), 
with a range of 16 to 376 epg (table 4.4), i.e. samples may be considered as 
belonging to a low burden group as their epg counts are <400. 
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The OD values obtained for individual F. hepatica positive and negative 
faecal samples from Huacullani and Cajamarca are shown in Figure 4.5 and Figure 
4.6, respectively. Positive samples with F. hepatica eggs showed OD values above 
the cut-off value except in five cases in Huacullani (determined by the Kato-Katz 
technique), and one case in Cajamarca (determined by the rapid sedimentation and 
Kato-Katz technique). 
Figure 4.5- MM3-COPRO ELISA in faeces from children (n = 436) from Huacullani (Northern Bolivian 
Altiplano). Data points represent the mean absorbance at 492 nm obtained from three replicates of each 
sample tested. The line represents the cut-off value 0,097 units of OD at 492 nm. 
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Figure 4.6- MM3-COPRO ELISA in faeces from children (n = 362) from Cajamarca valley (Peru). Data 
points represent the mean absorbance at 492 nm obtained from three replicates of each sample 
tested. The line represents the cut-off value 0,097 units of OD at 492 nm.
In Huacullani, in children who were positive in egg emission, the bivariant 
correlation between OD and epg data from low and high burden groups was carried 
out separately. A significant positive correlation was detected only between OD and 
low burden (r2 = 0,20) (Figure 4.7), but no significant positive correlation was 
detected when considering OD and high burden (r2 = 0,01) (Figure 4.8). 
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Figure 4.7- MM3-COPRO ELISA and intensity of F. hepatica infection in the low burden group of Huacullani. Data 
points represent the mean absorbance at 492 nm from egg positive children from Huacullani. epg represents the 
egg count per gram of feces. The dotted line represents the cut-off value 0,097 units of OD at 492 nm. 
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Figure 4.8- MM3-COPRO ELISA and intensity of F. hepatica infection in the high burden group of Huacullani. Data 
points represent the mean absorbance at 492 nm from egg positive children from Huacullani. epg represents the 
egg count per gram of feces. The dotted line represents the cut-off value 0,097 units of OD at 492 nm 
In Cajamarca, in children who were positive in egg emission, the bivariant 
correlation between OD and epg data (low burden) was carried out. No significant 
positive correlation between OD and low burden (r2 = 0,05) was detected (Figure 
4.9).
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Figure 4.9- MM3-COPRO ELISA and intensity of F. hepatica infection in the low burden group of Cajamarca. Data 
points represent the mean absorbance at 492 nm from egg positive children from Cajamarca. epg represents the 
egg count per gram of feces. The dotted line represents the cut-off value 0,097 units of OD at 492 nm. 
Theoretical PPVs and NPVs vs fascioliasis prevalence are represented in 
figure 4.10, showing the expected PPVs and NPVs depending on whether the test 
was used in low, medium or high prevalence scenarios in both highly endemic 
localities. 
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Figure 4.10-. Theoretical PPVs and NPV values vs fascioliasis prevalence. Curves show the expected PPVs (yellow 
continuous line) and NPV (red continuous line) values in low (below 1%), medium (between 1% and 10%) or high 
(above 10%) prevalence scenarios (expressed in vertical lines) in Huacullani (A) and Cajamarca (B). 
4.2.3. DISCUSSION 
Sensitivity is defined as the proportion of subjects with the disease who have 
a positive test for the disease. A sensitive test will rarely miss people with the 
disease. Specificity is the proportion of people without the disease who have a 
negative test result. A specific test will rarely misclassify people as having the 
disease when they do not (FLETCHER & FLETCHER, 2005). Knowing true positive 
and true negative cases is essential when calculating sensitivity and specificity, 
respectively. The identification of true positive and true negative cases was carried 
out by using classical coprological tests for the identification of F. hepatica eggs in 
faeces. Nevertheless, in the case of human fascioliasis, the application of the rapid 
sedimentation or Kato-Katz techniques may result in false negative cases. The 
aetiological diagnosis based on egg detection in stools is complicated because 
parasite eggs are not found along the prepatent period (LEVINE et al., 1980; CHEN 
& MOTT, 1990; MAS-COMA et al., 1999b), when juvenile worms migrate through 
the intestinal wall to the peritoneal cavity (at one week), penetrate the liver 
parenchyma (at five to seven weeks), and pass into the biliary tract where they 
ultimately reach maturity (at two months and more). Previous studies have even 
estimated that it takes at least a three-to-four-month period for F. hepatica flukes 
to attain sexual maturity in humans (WEI, 1984; CHEN & MOTT, 1990). Once the 
worms have matured, diagnosis still remains difficult because commonly employed 
microscopic techniques for quantitative diagnosis of Fasciola eggs are very specific 
but rather insensitive. On the other hand, in some cases it is also difficult during 
the biliary stage due to intermittent excretion of parasite eggs. Faecal egg counts 
are known to follow inter- and intraindividual variations in fascioliasis (EL-
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MORSHEDY et al., 2002; VALERO et al., 2011). In our case, we used the Kato-Katz 
technique as a “gold standard” because it is considered the best available for 
quantitative analysis, although taking into account that it is admittedly rather 
imperfect. 
When liver-flukes are located in the bile ducts, ES products are released, 
being eliminated via faeces. The detection of these products by means of a 
sandwich-ELISA reflects the installation of flukes in the bile ducts and the presence 
of the biliary stage of the disease (ESPINO & FINLAY, 1994). No differences were 
detected between prevalence results obtained using egg detection techniques and 
the MM3-COPRO ELISA in Huacullani, where egg intensities are higher according to 
the typical feature of the Altiplanic pattern. On the contrary, such differences were 
detected in Cajamarca, probably as a consequence of the low egg intensities 
characteristic of the valley pattern, i.e. in Cajamarca low burdens are the common 
feature and therefore the higher probability of infected subjects to intermittently 
shed very few eggs and remain unnoticed. 
Five and one case of egg emission were detected as being negative using 
the MM3-COPRO ELISA in Huacullani and Cajamarca, respectively, including one 
case of very high egg count (1248 epg) in the Bolivian locality. Such cases pose a 
question mark. Two possible explanations include (i) an intermittent release of the 
ES products from the liver to the intestine through the choledoc, and (ii) the 
existence of food remains in the intestine masking or interfering with the detection 
of the fluke ES antigens. However, the sensibility of antigens to high temperatures 
during the transport or/and an inadequate handling of the samples at a given 
moment throughout the whole procedure cannot be ruled out. 
In both Huacullani representative of the fascioliasis Altiplanic pattern and 
Cajamarca representing the fascioliasis valley pattern, cases of coproantigens 
present in the faeces of humans without the appearance of F. hepatica eggs in 
stools were detected. Previous time-course studies in animals on the detection of F. 
hepatica coproantigens by ELISA indicated that coproantigens were detectable prior 
to patency (ESPINO et al., 1997). Furthermore, a marked increase in the levels of 
these coproantigens around the beginning of the faecal egg output was observed 
(VALERO et al., 2009b). Considering the positivity/negativity of MM3-COPRO ELISA 
and the presence/absence of eggs in faeces, two situations were established in the 
current study: the Altiplanic pattern with a correlation between positivity of the 
MM3-COPRO ELISA and the presence of eggs, and the valley pattern with a larger 
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number of positive cases applying the MM3-COPRO ELISA but without presence of 
eggs in faeces. 
The Altiplanic pattern, characterized by higher prevalences and intensities, 
showed no statistical differences between the percent of children who were positive 
in coproantigens and eggs in faeces. Thus, it may be concluded that the majority of 
children with liver-flukes in the biliary ducts shed eggs. Nevertheless, in the valley 
pattern, characterized by high prevalences but low intensities, differences were 
detected between the percentage of children who were positive in coproantigens 
and the reduced number of these children that shed eggs in faeces. This suggests 
that children did not shed eggs or only a much reduced, undetectable number of 
them even though they   presented parasites in their biliary canals. In Europe, for 
instance, the diagnosis of human fascioliasis is frequently established using 
serological tests, because the detection of F. hepatica eggs in stools is not always 
possible. Thus, in an epidemiological survey from 1970 to 1999 to record cases of 
human fascioliasis detected in the Limousin region (central France), egg detection in 
stools was positive in only 27,6% of a total of 711 subjects with fascioliasis 
(RONDELAUD et al., 2006). 
Negativisation of results in the MM3-COPRO ELISA, which takes 
approximately one to three week in animals, is usually considered when 
determining the efficacy of anthelminthic treatment of biliary fascioliasis (MEZO et 
al., 2004). Contrarily, serological methods have limitations when determining the 
efficacy of anthelminthic treatment because the presence of antibodies indicates 
previous exposure to the parasite rather than the existence of a current infection. 
Additionally, once the anthelminthic treatment has been administered, several 
months have to go by for the serological antibody-detecting tests to become 
negative. Hence, the detection of specific antigens in faeces enables the 
confirmation of a current infection, whereas antibody detection tests need to be 
complemented by another technique to confirm the results obtained in treated 
subjects. However, future studies should be carried out to determine the time 
required for negativisation of MM3-COPRO ELISA results after effective treatment in 
humans. 
The MM3-COPRO ELISA is also a reliable method for detecting F. gigantica 
coproantigens in faecal samples from experimentally infected sheep (VALERO et al., 
2009b). Although most reported cases of human fascioliasis are caused by F. 
hepatica, infections by F. gigantica have also been reported (VALERO et al., 
2009a). The fact that the MM3-COPRO ELISA can detect infections by both species 
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may be of great value to ensure diagnosis of human and animal fascioliasis in 
countries where F. gigantica predominates, or where both species of Fasciola are 
present (VALERO et al., 2009a; UBEIRA et al., 2009). 
Determining a patient’s parasitic burden is crucial given the necessity to 
monitor the drug treatment in order to prevent a hepatic colic as the consequence 
of the massive expulsion of liver-flukes (WHO, 2007), similarly as in other helminth 
diseases (MONTRESOR et al., 1998). The Kato-Katz is usually employed as a 
coprological quantitative technique. Nevertheless, this technique has a low 
sensitivity, and the elaboration of several slides from the same individual stool 
sample is indispensable. Additionally, the microscopic egg count is rather slow in 
cases of heavy egg burdens. For all of these reasons, the application of the Kato-
Katz technique in community surveys becomes problematic because (i) it is 
pronouncedly time consuming when the number of samples is high, and (ii) 
requires an additional technique to increase the sensitivity in areas where subjects 
shed a very low number of eggs in an intermittent way. 
Results obtained in the samples from Huacullani showed that the 
concentration of coproantigens in faeces is correlated with epg in the low burden 
group (<400 epg). This result agrees with a previous study using the MM3-COPRO 
ELISA in cattle, which showed that the concentration of coproantigens in faeces is 
also correlated with the number of flukes found in the livers of animals collected 
after slaughter (MEZO et al., 2004), as well as with the results of positive 
correlation found with another coproantigen test in fascioliasis infected patients in 
Cuba (ESPINO & FINLAY, 1994). Nevertheless, our findings in the high burden 
group (≥400 epg) showed that the concentration of coproantigens in faeces is not 
correlated with epg. This result agrees with the absence of any correlation between 
egg shedding in human samples from Hospital patients, measured by the Kato-Katz 
technique, and coproantigen concentration, measured by the MM3-COPRO ELISA 
(UBEIRA et al., 2009). One possible explanation for this discrepancy may be that 
the positive cases analysed in Cuba (ESPINO & FINLAY, 1994) probably 
corresponded to recent infections of less than a year of evolution (early chronic 
stage), whereas our samples were from patients with chronic infections, in which 
egg excretion is probably more erratic. It must be kept in mind that fasciolid flukes 
may survive up to 13,5 years inside humans (MAS-COMA et al., 1999b), and the 
pattern of egg shedding is not linear but fluctuates between maximum and 
minimum values (VALERO et al., 2002, 2011). Comparatively, the kinetics of 
coproantigen release versus the kinetics of egg shedding showed a similar pattern 
but with a two-week time-lag in epg (VALERO et al., 2009b). Moreover, the 
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influence of the crowding effect on Fasciola egg shedding should also be taken into 
account (VALERO et al., 2006b). 
In Cajamarca, chronic fascioliasis in valley samples, coproantigen levels did 
not show a good correlation with epg. Therefore, the use of only a coproproantigen 
technique appears to be insufficient to evaluate the fluke burden. 
In these hyperendemic areas, the number of subjects who participate in 
surveys of this kind is very large, which implies the problem of transporting and 
preserving the faecal samples, as the coproantigen degrades at ambient 
temperature within a few days and the faecal material cannot be treated with any 
classical fixative. One possible alternative is freezing the samples at -20º C, but this 
poses the additional problems of (i) the difficulty and expensiveness of transporting 
frozen samples to the laboratory where the determination should take place, and 
(ii) the inappropriateness of frozen samples for the diagnosis of several coinfecting 
parasites. Another solution is the use of Coproguard®, which has been 
demonstrated to be convenient for sample preservation in this kind of surveys 
including the application of a coproantigen detection test (UBEIRA et al., 2009). 
Current efforts for the control of human fascioliasis need diagnostic 
techniques which allow for high sensitivity and specificity, mass screening, 
detection in the acute phase, early detection of treatment failure or re-infection in 
post-treated subjects, and usefulness for surveillance programmes. Our results 
indicate that a coproantigen-detection test such as the MM3-COPRO ELISA fulfils all 
these aspects. It provides a good tool to detect biliary fascioliasis in humans under 
field conditions in Andean hyperendemic countries, including a higher sensitivity 
than egg detection techniques, especially in areas where burdens tend to be low, 
such as in areas of the valley transmission pattern. Hence, the MM3-COPRO ELISA 
appears not only to be useful for individual diagnosis in hospitals, but also in human 







Fascioliasis is a zoonotic parasitic disease caused by Fasciola hepatica and F. 
gigantica. Of both species, F. hepatica is the only one described in the Americas, 
where human fascioliasis endemic areas are mainly located in high altitude areas of 
Andean countries. Emergence of human fascioliasis prompted a worldwide control 
initiative including a pilot study in several countries. Given the necessity to 
characterize the fasciolid populations involved, the overall aim of the present 
research is, first, the phenotypic characterization of faciolid adults and eggs 
implicated in human endemic areas, where this initiative has been implemented, 
through a computer image analysis system (CIAS) applied on the basis of 
standardized measurements. Second, new immunological techniques and their 
potential use as immunological diagnostic tests in those areas are evaluated. The 
specific results have been grouped into five parts. 
A) Characterization of eggs of both F. hepatica and F. gigantica for their
differential diagnosis. The influence of both the geographical location and 
the host species (human and livestock) were analysed in eggs shed in 
faeces from fascioliasis human endemic areas, where only F. hepatica is 
present (the Northern Bolivian Altiplano and the Cajamarca valley in Peru), 
and from areas where F. hepatica and F. gigantica coexist (the Kutaisi 
region of Georgia, the Nile Delta in Egypt, and the Quy Nhon province in 
Vietnam). The study revealed that eggs shed by humans show 
morphological traits different from eggs shed by animals. In humans, F. 
hepatica eggs are bigger and F. gigantica eggs are smaller than reported to 
date from livestock, and their measurements overlap when compared. The 
material analysed in this study shows that the size of eggs shed by humans 
from Georgia and Egypt corresponds to the F. hepatica morph, while the 
size of eggs shed by humans from Vietnam corresponds to the F. gigantica 
morph. Measurements of F. hepatica and F. gigantica eggs originating from 
humans and animals from sympatric areas overlap, and, therefore, they do 
not allow differential diagnosis when within this overlapping range. 
B) Study of the correlation between egg-shedding and uterus development in 
F. hepatica human and animal isolates. Uterus area (UA) development of 
adult F. hepatica obtained at different days post infection (dpi) in a Wistar 
rat model with isolates obtained from cattle, sheep, pigs and humans from
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the endemic human fascioliasis zone of the Northern Bolivian Altiplano was 
analysed and compared with the number of eggs shed per gram of faeces 
as obtained through the Kato–Katz technique. The multiple regression 
model showed that UA is dependent on dpi and isolate. The evolution of UA 
vs dpi followed a damped model. This work shows a positive correlation 
between liver fluke UA and egg production. The complete absence of eggs 
in the uteri of some parasite individuals at 300 dpi was observed, which 
corresponds to the cessation of egg shedding in the advanced chronic 
stage. 
C) Study of F. hepatica phenotypic characterization in Andean human endemic 
areas. The phenotypic features of fasciolid adults infecting sheep present in 
the Cajamarca Valley and Mantaro Valley (valley transmission patterns) and 
the Northern Bolivian Altiplano (altiplanic transmission pattern) were 
analysed. The aforementioned highland populations were compared to 
standard lowland natural and experimental populations of European origin. 
The results showed that two phenotypic patterns could be distinguished in 
F. hepatica adult size: the valley pattern (Cajamarca and Mantaro, Peru) 
and the altiplanic pattern (Northern Altiplano, Bolivia). Furthermore, the 
Andean valley population and European standard populations presented 
phenotypic homogeneity. The Altiplano population showed a large size 
range with a pronouncedly lower minimum size, indicating that uterus 
gravidity is reached at a smaller size than in valley populations.
D) Study of the DRG Fasciola hepatica IgG ELISA test as a serological
diagnostic tool of human fascioliasis in different epidemiological situations 
To validate this kit, the sera of 54 fascioliasis cases, originating from three 
endemic areas, were used: (i) a hyperendemic F. hepatica area where 
humans usually shed a large number of parasite eggs in faeces (11 sera); 
(ii) an epidemic F. hepatica area where humans usually shed small 
amounts of parasite eggs (24 sera) and (iii) an overlap area of both 
Fasciola species where human shedding of parasite eggs in faeces is 
usually scarce or non-existent (19 sera). One hundred and sixty-eight 
patients with other parasitic infections and 89 healthy controls were also 
analysed. Sensitivity and specificity of the DRG assay were 95,3% (95% 
confidence intervals, 82,9–99,2%) and 95,7% (95% confidence intervals, 
92,3–97,5%), respectively. No correlation between egg output and the 
optical density (OD) values of the test was observed.  
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E) Field evaluation of the MM3 coproantigen detection test for fascioliasis 
diagnosis and surveillance in human hyperendemic areas of Andean 
countries. As part of the above-mentioned control initiative, two 
hyperendemic areas were chosen: Huacullani, Northern Altiplano, Bolivia, 
representing the Altiplanic transmission pattern with high prevalences and 
intensities; the Cajamarca valley, Peru, representing the valley pattern 
with high prevalences but low intensities. Coprological sample collection 
and study procedures were analysed to improve individual diagnosis, 
subsequent treatments and surveillance activities. Therefore, a 
coproantigen-detection technique (MM3-COPRO ELISA) was evaluated, 
using classical techniques for egg detection for comparison. A total of 436 
and 362 stool samples from schoolchildren of Huacullani and Cajamarca, 
respectively, were used. Positivity in samples from Huacullani was 24,77%
using the MM3-COPRO technique, and 21,56% applying Kato-Katz. Positivity 
in samples from Cajamarca was 11,05% using MM3-COPRO, and 5,24% 
using rapid sedimentation and Kato-Katz. In Huacullani, using Kato-Katz as 
gold standard, sensitivity and specificity were 94,68% and 98,48%, 
respectively, and applying Kato-Katz and COPRO-ELISA test together, 
values were 95,68% and 100%. In Cajamarca, using rapid sedimentation 
and Kato-Katz together, results were 94,73% and 93,58%, and using rapid 
sedimentation, Kato-Katz and copro-ELISA together, values were 97,56%
and 100%, respectively. There was no correlation between coproantigen 
detection by OD and infection intensity by eggs per gram of feces (epg) in 
Cajamarca low burden cases (<400 epg), nor in Huacullani high burden 
cases (≥ 400 epg), although there was in Huacullani low burden cases 
(<400 epg). Six cases of egg emission appeared negative by MM3-COPRO, 
including one with a high egg count (1248 epg). It can be concluded that 
the coproantigen-detection test allows for high sensitivity and specificity, 
fast mass screening, detection in the chronic phase, early detection of 
treatment failure or reinfection in post-treated subjects, and is convenient 
in surveillance programmes. However, this technique falls short when 
evaluating the fluke burden on its own.
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5.2. CONCLUSIONS 
The conclusions obtained from our work are numerous and varied according 
to their different contents. To facilitate their presentation, they are listed according 
to groups depending on their objectives. 
A. With regard to the results obtained in the study on fluke egg characteristics 
for the diagnosis of human and animal fascioliasis by F. hepatica and F. 
gigantica: 
 Fasciolid egg size in human stool samples ought to be corrected in books 
and monographs related to medical parasitology and/or tropical 
medicine as well as in guides for clinicians and diagnosticians. When 
dealing with human fascioliasis globally, F. hepatica egg length/width 
data should be 100,6–162,2/65,9–104,6 µm in human stools and 73,8–
156,8/58,1–98,1 µm in animal faeces when referring to areas where F. 
gigantica is absent (as in the Americas and Europe). When referring to 
areas where both fasciolid species are present (as in many parts of Africa 
and Asia), F. hepatica egg length/width data should be 106,5–
171,5/63,9–95,4 µm in human stools and 120,6–163,9/69,2–93,8 µm in 
animal faeces, and F. gigantica egg length/width data should be 150,9–
182,2/85,1–106,2 µm in human stools and 130,3–182,8/74,0–123,6 µm 
in animal faeces.
 For areas where both fasciolid species co-exist, the size of fasciolid eggs
shed by humans may be intermediate between the reported data for F.
hepatica and that for F. gigantica in humans and such situations might
be interpreted as infections by intermediate or hybrid forms.
 With regards to F. gigantica, egg length/width data should also be 
increased to 129,6–204,5/61,6–112,5 µm in animal faeces when 
referring to areas where F. hepatica is absent (as in great parts of Africa)
 Future studies in other areas are likely to modify the above-mentioned
maximum and minimum size measurements for fasciolid eggs shed in
humans stools, but the present exhaustive study suggests that only very
slight differences may be found, if any.
 In endemic areas of Asia and Africa where both fasciolid species overlap,
a human subject may be simultaneously infected by fluke adults
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belonging to both F. hepatica and F. gigantica. Consequently, an 
appropriate coprological diagnosis in such an area may not rely on the 
measurement of only one or very few eggs. Whenever possible, 
measuring a sufficient amount of eggs to appropriately assess egg size 
variability could facilitate the verification of whether only one or the 
other, or perhaps both species simultaneously infect the patient. 
Moreover, it has to be considered that, if adult flukes of both species co-
infect the patient, intermediate hybrid eggs may additionally appear in 
stools in case some flukes have crossbred. 
B. With regard to the results obtained in the study on the correlation between 
egg-shedding and uterus development in F. hepatica human and animal 
isolates: 
 Our work shows a relationship between liver fluke uterus area and egg
production.
 The variability detected in egg production in different F. hepatica isolates
in the experimental Wistar model, implies the necessity to characterize
the isolates employed in fascioliasis studies in which egg production is
used as a biological tag.
C. With regard to the results obtained in the study on F. hepatica phenotypic 
characterization in Andean human endemic areas, analysing valley versus 
altiplanic patterns in liver flukes from sheep from Cajamarca and Mantaro, 
Peru: 
 Flukes from Andean endemic areas may be catalogued according to 
two phenotypic patterns, the valley pattern including Andean human 
endemic areas of high altitude (Cajamarca: 2500–3100 m; Mantaro: 
3400–3500 m) where F. hepatica egg production by the fluke 
oogenotop and minimum body size when reaching gravidity are 
similar to those in lowland populations of Europe (Spain, Poland). 
Furthermore, the Altiplanic pattern including Andean human endemic 
areas of very high altitude (Northern Altiplano: 3800–4100 m) where 
F. hepatica egg production by the fluke oogenotop begins earlier and 
minimum body size when reaching gravidity is smaller than in 
lowland populations of Europe (Spain, Poland) as well as in Andean 
valleys (Cajamarca, Mantaro).
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D. With regard to the results obtained in the study on the DRG Fasciola 
hepatica IgG ELISA test as a serological diagnostic tool of human 
fascioliasis in different epidemiological situations: 
 The DRG test could be used both as an individual serodiagnostic test for
human fascioliasis when backed up by a clinical history, together with a
second diagnostic technique in certain situations of possible
crossreactions (patients co-infected with other helminths) and in future
large-scale epidemiological studies of human fascioliasis worldwide
(recommended for mass screening, especially when considering its
convenient handling).
E. With regard to the results obtained in the study on the field evaluation of a 
coproantigen detection test for fascioliasis diagnosis and surveillance in 
human hyperendemic areas of Andean countries: 
 Considering the positivity/negativity of MM3-COPRO ELISA and the
presence/absence of eggs in faeces, two situations were established in
the current study: the Altiplanic pattern with a correlation between
positivity of the MM3-COPRO ELISA and the presence of eggs, and the
valley pattern with a larger number of positive cases applying the MM3-
COPRO ELISA but without presence of eggs in faeces.
 The Altiplanic pattern, characterized by higher prevalences and
intensities, showed no statistical differences between the percentage of
children who were positive in coproantigens and eggs in faeces. Thus, it
may be concluded that the majority of children with liver-flukes in the
biliary ducts shed eggs. Nevertheless, in the valley pattern,
characterized by high prevalences but low intensities, differences were
detected between the percentage of children who were positive to
coproantigens and the reduced number of these children that shed eggs
in faeces. This suggests that children did not shed eggs or only a much
reduced, undetectable number even despite presenting parasites in their
biliary canals.
 The present validation of the MM3-COPRO ELISA is expected to facilitate 
the improvement of human fascioliasis diagnosis in endemic areas. The 
practical application of this sensitive and convenient method for large 
scale surveillance in the control programmes in the Northern Bolivian 
Altiplano and Cajamarca could improve screening of human fascioliasis 
in these endemic areas by detecting infected humans in the biliary stage 
of the disease, as a large number of samples can easily be processed. 
Keeping in mind that the most affected subjects are usually children, the
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attainment of faecal samples is easier and faster than taking blood 
samples, which is considered invasive. The former does not pose 
difficulties for community elders, school head teachers and parents who 
usually give their consent. Moreover, to many of these indigenous 
communities, blood extraction is culturally not acceptable. 
 Our experience in Huacullani and Cajamarca indicates that MM3-COPRO
ELISA offers the easiest and fastest way to adequately face large mass
screenings, by initially applying the coproantigen technique to all of the
coprological samples obtained in the community survey and thereafter
applying the Kato-Katz technique only or first to the coproantigen
positive samples. Those subjects in whose coproantigen positive
samples no eggs were found are better recommended to be treated
anyway. This allows for a quick selected treatment action, lending the
positive effects of (i) fast respond to the communities surveyed that
verify that infected subjects are treated in only a few days after the
survey was made, and (ii) reduces the probability of drug resistance
appearance. The remaining coproantigen negative samples may finally
be analyzed for the eventual detection and subsequent selected
treatment of very few subjects shedding eggs, although this last step
will unavoidably be time-consuming.
 The coproantigen-detection test allows for high sensitivity and
specificity, fast large mass screening capacity, detection in the chronic
phase, early detection of treatment failure or reinfection in post-treated
subjects, and usefulness in surveillance programmes. However, this
technique falls short when evaluating the fluke burden on its own.
 Future studies are needed in Cajamarca (and other endemic areas in
valleys of the Andean countries) to verify whether in these cases the
non-detection of eggs implies that the parasite (i) has not reached the
biliary ducts or is located in the bile-ducts but oviposition has not yet
started (suggesting a more or less recent infection) or (ii) oviposition is
taking already take place but with only very low egg numbers or with
intermittent shedding (indicating that subjects present only one or a
very few flukes in the chronic stage).
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5.3. CONCLUSIONES 
Las conclusiones que cabe extraer de nuestro trabajo son numerosas y 
variadas. Para facilitar su exposición, procedemos a enumerarlas por grupos según 
sus diferentes objetivos. 
A. En lo que se refiere a las características morfológicas de los huevos de los 
fasciólidos como herramientas en el diagnóstico de la fascioliasis humana y 
animal causada por F. hepatica y F. gigantica: 
 El tamaño de los huevos de fasciólidos en muestras humanas debe ser
corregido en libros y monografías relacionados con la Parasitología
Médica y/o con la Medicina Tropical, así como en guías para clínicos y
analistas. Cuando se trate globalmente de Fascioliasis humana, los
valores de longitud/anchura de los huevos de F. hepatica en zonas
donde F. gigantica no está presente (como es el caso de las Américas y
Europa), deben ser de 100,6-162,2/65,9-104,6 µm en muestras
humanas y de 73,8-156,8/58,1-98,1 µm en heces de animales. Cuando
nos referimos a áreas en las cuales ambas especies de fasciólidos están
presentes (como es el caso de muchas zonas de África y Asia), los
valores de longitud/anchura de los huevos de F. hepatica deben ser de
106,5-171,5/63,9-95,4 µm en muestras humanas y de 120-163,9/69,2-
93,8 µm en heces de animal, mientras que los valores de
longitud/anchura de los huevos de F. gigantica deben ser de 150,9-
182,2/85,1-106,2 µm en muestras humanas y de 130,3-182,8/74,0-
123,6 µm en heces animales.
 En áreas donde ambas especies de fasciólidos coexisten, el tamaño de
los huevos de fasciólido emitidos por humanos puede ser de un valor
intermedio entre F. hepatica y F. gigantica, interpretándose esta
situación como una infección por formas hibridas o intermedias.
 Los valores de longitud/anchura de los huevos de F. gigantica
procedentes de heces animales de áreas donde F. hepatica está ausente
(como ocurre en la mayor parte de África) son 129,6-204,5/61,6-112,5
µm.
 Futuros estudios en otras áreas quizás puedan modificar el tamaño
mínimo y máximo de las medidas realizadas en los huevos de fasciólidos
encontrados en muestras humanas, si bien el exhaustivo estudio
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realizado sugiere que sólo encontraremos ligeras diferencias respecto a 
los datos anteriormente indicados. 
 En el caso de áreas endémicas, tanto de Asia como de África donde
ambas especies de fasciólidos coexisten, un paciente puede estar
afectado simultáneamente por adultos de F. hepatica y F. gigantica. En
consecuencia, un diagnóstico apropiado en este tipo de áreas no debe
consistir en la medida de unos pocos huevos, sino que, en la medida de
lo posible, se debe realizar las medidas de una gran cantidad de huevos
para asegurar la variabilidad del tamaño del huevo y poder facilitar la
verificación de la infección del paciente por una u otra especie, o de
quizás ambas especies simultáneamente. Más aun, hay que considerar
también que, si el paciente está infectado por adultos fasciólidos de
ambas especies, cabe la posibilidad de que algunos de los adultos de
ambas especies se hayan cruzado, apareciendo huevos híbridos o
intermedios en la muestra.
B. En lo que respecta a los estudios sobre la correlación entre la emisión de 
huevos por heces y el desarrollo uterino de F. hepatica en aislados 
humanos y animales: 
 Nuestro estudio experimental demuestra una relación directa entre el
tamaño del útero de F. hepatica y el número de huevos por gramo de
heces emitidos.
 Las diferencias detectadas en la producción de huevos entre diferentes
aislados de F. hepatica en el modelo experimental Wistar, implica la
necesidad de caracterizar los aislados empleados en los estudios de la
fascioliasis en donde la producción de huevos se utiliza como un
marcador biológico.
C. En lo que se refiere a la caracterización fenotípica de F. hepatica en áreas 
Andinas humanas endémicas y el análisis del patrón valle versus patrón 
altiplánico de fasciólidos procedentes de ovinos: 
 Los adultos de F. hepatica de zonas endémicas Andinas procedentes de
ovinos se pueden catalogar de acuerdo a dos patrones fenotípicos: el
patrón valle, incluyendo áreas Andinas endémicas humanas de alta
altitud (Cajamarca: 2500-3100 m; Mantaro: 3400-3500 m) en donde la
producción de huevos de F. hepatica y el tamaño corporal mínimo para
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alcanzar la madurez es similar a las poblaciones en baja altitud europeas 
(España, Polonia). Además, el patrón Altiplánico, incluyendo áreas 
Andinas endémicas humanas de gran altitud (Altiplano Norte: 3800- 4100 
m) donde la producción de huevos de F. hepatica comienza antes y el 
tamaño corporal mínimo para alcanzar la madurez es menor que el que 
presenta tanto las poblaciones europeas de baja altitud (España, Polonia) 
como las poblaciones de los valles Andinos (Cajamarca, Mantaro). 
D. En lo que se refiere a la evaluación del test DRG ELISA IgG Fasciola 
hepatica para el diagnóstico de la Fascioliasis humana en diferentes 
situaciones epidemiológicas cabe destacar: 
 El test DRG puede ser utilizado, en situaciones de posibles reacciones
cruzadas (pacientes co-infectados con otros helmintos), tanto como una
prueba de serodiagnóstico individual respaldado con el historial clínico
del paciente y con una segunda técnica de diagnóstico, como, en el
futuro, en estudios epidemiológicos a gran escala en todo el mundo
(sobre todo en estudios epidemiológicos masivos).
E. En lo que se refiere a la evaluación de campo de un test de detección de 
coproantígeno para el diagnóstico y la vigilancia de la Fascioliasis en áreas 
hiperendémicas de países andinos: 
 En el presente estudio se establecen dos situaciones considerando la
positividad/negatividad del ELISA MM3-COPRO y la presencia/ausencia
de huevos en heces. La primera es el patrón Altiplánico, donde existe
una correlación positiva entre los casos positivos del ELISA MM3-COPRO
y la presencia de huevos. La segunda es el patrón valle, con un gran
número de casos positivos utilizando el ELISA MM3-COPRO, pero sin
presencia de huevos en las heces.
 En el patrón Altiplánico, caracterizado por altas prevalencias e
intensidades, no han encontraron diferencias estadísticas entre el
porcentaje de niños positivos por coproantigeno y el porcentaje de niños
positivos por la presencia de huevos del parásito en heces. Estos
resultados permiten concluir que en el patrón Altiplánico la gran mayoría
de niños presentan adultos parásitos en los conductos biliares que
emiten huevos. Por el contrario, en el caso del patrón valle,
caracterizado por altas prevalencias pero bajas intensidades, se han
detectaron diferencias estadísticas entre el porcentaje de niños positivos
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por coproantigenos y el reducido porcentaje de niños que emitían 
huevos del parásito en heces. Esto sugiere en el patrón valle, los niños 
no emiten huevos o emiten muy pocos huevos a pesar de presentar 
parásitos adultos en el canal biliar. 
 Con la validación del ELISA MM3-COPRO se espera facilitar el
diagnóstico de la fascioliasis humana en áreas endémicas. La aplicación
de este sensible y conveniente método en la vigilancia a gran escala de
los programas del Altiplano norte de Bolivia y Cajamarca permitirá
mejorar el screening de la fascioliasis humana en esas áreas endémicas
y facilitará la detección de humanos parasitados en la fase biliar de la
enfermedad al permitir procesar un gran número de muestras
fácilmente. Cabe recordar que la mayoría de la población afectada por la
enfermedad suele ser niños, por lo que la obtención de muestras fecales
es más rápida y fácil que la toma de muestras de sangre, la cual es
considerada invasiva. Los ancianos de la comunidad, directores y
profesores de escuela y los profesores suelen dar su consentimiento
para la obtención de muestras fecales. Además, en muchas
comunidades indígenas, la extracción de sangre es culturalmente
inaceptable.
 Nuestra experiencia en Huacullani y Cajamarca indica que el ELISA
MM3-COPRO es una herramienta fácil y rápida para detectar la
enfermedad en fase crónica a gran escala, utilizando inicialmente la
técnica de detección de coproantígeno en todas la muestras coprológicas
obtenidas en la comunidad estudiada, para posteriormente aplicar la
técnica de Kato-Katz únicamente o en primer lugar en las muestras
positivas por la anterior técnica. Se recomienda tratar a aquellos sujetos
en los cuales la técnica de detección de coproantígeno es positiva
aunque no se encuentre huevos en heces. De esta manera se asegura
una rápida respuesta de selección de tratamiento obteniendo la ventaja
de (i) una rápida respuesta en las comunidades estudiadas, donde los
sujetos infectados son tratados pocos días después del estudio, y (ii)
reduce la probabilidad de la aparición de resistencia al medicamento. El
resto de muestras negativas se analizaran para la detección y posterior
tratamiento de los sujetos que emiten pocos huevos, aunque este último
paso consumirá mucho tiempo.
 El test de detección de coproantígeno presenta una alta especificidad y
sensibilidad, capacidad para realizar la detección de la enfermedad en
fase crónica a gran escala, una rápida detección del fallo terapéutico o
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de posibles re-infecciones, siendo además también útil en los programas 
de vigilancia. No obstante, esta técnica falla en la evaluación de la carga 
parasitaria. 
 Es necesario realizar más estudios en Cajamarca (y otras áreas
endémicas en los valles de países Andinos) para verificar si la ausencia
de detección de huevos en heces implica que el parásito (i) no ha
alcanzado los conductos biliares o están en los conductos biliares pero
no ha comenzado la oviposición (lo que sugiere una infección más o
menos recientes) o (ii) se está produciendo la oviposición pero o bien la
cantidad de huevos que se emiten con las heces es muy baja o bien la
emisión es intermitente (lo que indica que el sujeto presenta muy pocos
adultos en fase crónica).
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a b s t r a c t
In trematodiases, shape and size of the ﬂuke eggs shed with faeces are crucial diagnostic features because
of their typically reduced intraspeciﬁc variability. In fascioliasis, the usual diagnosis during the biliary
stage of infection is based on the classiﬁcation of eggs found in stools, duodenal contents or bile. The aim
of the present study is to validate the identiﬁcation of Fasciola species based on the shape and size of
eggs shed by humans, characterizing their morphometric traits using a computer image analysis system
(CIAS). The inﬂuence of both the geographical location and of the host (human and livestock) has been
analysed. Coprological studieswere carriedout in fascioliasishumanendemicareas,whereonly F. hepatica
is present (the northern Bolivian Altiplano and the Cajamarca valley in Peru), and where F. hepatica and
F. gigantica coexist (the Kutaisi region of Georgia, the Nile Delta in Egypt, and the Quy Nhon province in
Vietnam). Classically, it is considered that at the abopercular end of the shell of Fasciola eggs there is often
a roughened or irregular area. Nevertheless, results show that the frequency of the presence of this feature
in F. hepatica is population-dependent, and therefore is not a pathognomonic criterion in diagnosis. The
study reveals that eggs shed by humans showmorphological traits different fromeggs shed by animals. In
humans, F. hepatica eggs are bigger and F. gigantica eggs are smaller than reported to date from livestock,
and their measurements overlap when compared. The material analysed in this study shows that the size
of eggs shed by humans from Georgia and Egypt corresponds to the F. hepatica morph, while the size of
7. ANEXO: PUBLICACIONES POR ORDEN CRONOLOGICOeggs shed by humans from Vietnam corresponds to the F. gigantica morph. Measurements of F. hepatica
and F. gigantica eggs originating from humans and animals from sympatric areas overlap, and, therefore,
they do not allow differential diagnosis when within this overlapping range. In this sense, the new results
should aid clinicians since the application of the classic egg size range in human samples may lead to
erroneous conclusions. Fasciolid egg size in human stool samples ought to be corrected in books and
monographs related to medical parasitology and/or tropical medicine as well as in guides for clinicians
nosisand parasitic disease diag
. Introduction
Fascioliasis is an important parasitic disease caused by two liver
uke species: Fasciola hepatica and F. gigantica (Trematoda). Fasci-
la hepatica has a cosmopolitan distribution, mainly in temperate
ones, while F. gigantica is found in tropical regions of Africa and
sia. Thus, the two fasciolid species overlap in large regions (Mas-
oma and Bargues, 1997). Fascioliasis in livestock has always been
ecognized as a veterinary problem on a worldwide scale, but in
umans the disease was only considered of secondary importance
ntil the end of the 1980s owing to the relative small number of
uman reports. Only about 2000 human cases were reported in the
5 years previous to 1990 (Chen and Mott, 1990). This scenario dra-
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matically changed after the initiative launched by theWorld Health
Organization at the beginning of the 1990s. At present, estimations
for all continents reach 17 million people to be infected, and this
may even be an underestimation if the total lack of data concerning
numerous Asian and African countries is considered (Mas-Coma,
2005).
Today, several geographical areas have been described as
endemic for the disease in humans, including hypoendemic,
mesoendemic and hyperendemic situations, with prevalences and
intensities ranging from low to very high (Mas-Coma, 2005). In
thesehumanendemic areas, childrenand females aremost severely
affected by both prevalences and intensities (Mas-Coma et al.,
2005). In developed countries, patients are diagnosed in hospi-
tals or other health centres usually during the acute phase or
at the beginning of the chronic phase. On the contrary, infected
subjects detected in surveys in human endemic areas of devel-































































aM.A. Valero et al. / Acta
hen not already re-infected due to the high contamination risk,
s the liver ﬂuke is able to survive up to 13.5 years in human
eings (Mas-Coma et al., 2005). The public health impact of this
cenario is reaching an importance never expected before, owing
o (i) the great pathogenicity of long-term liver ﬂuke infection
roven experimentally (Valero et al., 2003, 2006a, 2008) and (ii)
he immune-modulation of fasciolids in the acute phase (Brady
t al., 1999) and their immune suppression effect in chronic and
dvanced chronic phases (Girones et al., 2007),which is in the back-
round of co-infections with other parasitic and infectious diseases
Mas-Coma et al., 2005).
WHO decided in October 2006 to launch a worldwide initiative
gainst this disease (WHO, 2007) based on the success of obtain-
ng a donation of Egaten®, the only highly efﬁcient drug presently
vailable for human treatments (WHO, 2008). After an initial pilot
cheme in Vietnam, Egypt, Peru and Bolivia, this initiative is cur-
ently being extended to many other countries. Therefore, the
apacity to correctly diagnose human fascioliasis becomes crucial.
nfortunately, there are some unavoidable difﬁculties in human
ascioliasis diagnosis in human endemic areas of developing coun-
ries: (i) indirect tests, either serological or using coproantigens,
re useless for intensity estimation; (ii) immunological tests are
enerally expensive and require a minimum of laboratory infras-
ructure; and (iii) indirect tests have so far never proved to be able
o differentiate between infection by F. hepatica and F. gigantica, an
mportant aspect considering the higher pathogenicity of the lat-
er due to its larger ﬂuke size but also because of their different
pidemiology, transmission and control characteristics. Molecular
ests have shown to be useful for differential diagnosis (Marcilla et
l., 2002), but are often unaffordable, too.
Therefore, direct coprological analysis for the detection and
dentiﬁcation of fasciolid eggs continues to be themost appropriate
iagnostic strategy for both detection of infection and estimation of
ntensity, not only for those human endemic rural areas but also for
he implementation of the WHO treatment drive. This conclusion
s reached even in spite of the recognized lower sensitivity of egg
etection in faecal samples and its uselessness for the diagnosis of
atients in the acute phase (Hillyer, 1999), as well as the lack of an
ccurate relationship between egg counts per gram of faeces and
he ﬂuke burden (Valero et al., 2006b).
Moreover, in areas of Africa and Asia where the two fasci-
lid species overlap, ﬂuke egg size was believed to be the only
ethod allowing the differential diagnosis between F. hepatica
nd F. gigantica. However, identifying ﬂuke adults obtained during
n endoscopy either by microscopic morphometry (Periago et al.,
006) or by molecular tools (Marcilla et al., 2002) may also be per-
ormednowadays, although this is not only difﬁcult butmay also be
roblematic in humans. Moreover, the infrastructure for such tech-
iques is evidently not available in rural endemic areas. The use of
erological tests or the lack of a calibrated microscope for measure-
ents with an ocular micrometer explains why subjects diagnosed
rom areas where both species co-exist are currently referred to as
nfected by Fasciola sp. (Mas-Coma et al., 2005). In such a situation
t is surprising that an analysis of the size of eggs shed by humans
as never been carried out, so that in fact an extrapolation of the
ize of the ﬂuke eggs shedby livestock species has always beenused
or human diagnosis.
Each trematode species has its own particular egg shape and the
ength and width of the eggs are generally within a speciﬁc range
WHO, 1991). In fascioliasis, the usual diagnosis during the biliary
tage of infection is based on the classiﬁcation of eggs found in
tools, duodenal contents or bile. However, large variations were
rst observed in the size of F. hepatica eggs in livestock from differ-
nt geographical locations (Tinar, 1984). Furthermore, it has been
xperimentally shown that the ﬁnal host species (sheep, cattle, pig
nd donkey) decisively inﬂuences the size of the F. hepatica eggs
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even within the same endemic area (northern Bolivian Altiplano)
(Valero et al., 2001a).
The problem has even been further increased by the conﬁr-
mation of the existence of morphologically intermediate forms
between the two fasciolid species and genetic hybrids of both
in overlapping areas, endemic for animals (Itagaki et al., 2005;
Semyenova et al., 2006) and humans in Africa (Periago et al., 2008)
and Asia (Ashraﬁ et al., 2006; Le et al., 2008). The existence of these
intermediate forms has been molecularly veriﬁed to be not only
common but even the rule in these overlapping areas (Bargues et
al., in prep.) and poses a questionmark onwhether egg characteris-
tics are suitable as a tool for the differential diagnosis of fascioliasis
caused by either species. A concrete example of this problem has
been recently emphasized in the diagnosis of fascioliasis in humans
(Inoue et al., 2007).
The aim of the present study is to validate the identiﬁcation of
Fasciola speciesbasedon the shapeandsizeof eggs shedbyhumans,
characterizing their morphometric traits using a computer image
analysis system (CIAS). The inﬂuence of both the geographical ori-
gin (samples from South America, Europe, Africa and Asia) and the
host species (humanand livestock) has beenanalysed. Added to this
global analysis, the measurements of eggs shed by humans from
several geographical areas are also compared with the eggs from
livestock of the same geographical origins to illustrate the situation
within a local endemic area. The areas selected for this study are
important human fascioliasis endemics zones, where our team had
the opportunity to carry out ﬁeld work within the WHO initiative.
In the New World, the northern Bolivian Altiplano (Mas-Coma et
al., 1999) and the Cajamarca valley in Peru (Espinoza et al., 2007)
where chosen because of their high prevalences and intensities in
humans caused by F. hepatica only. In Europe, the Kutaisi region
in Georgia was chosen as F. hepatica is widely distributed there,
but F. gigantica was also sporadically detected several decades ago
(Gigitashvili, 1969) and human fascioliasis is currently emerging
(Zenaishvili et al., 2004; Valero et al., in prep.). In Africa, the study
was performed in the Nile Delta region of Egypt, where both F. hep-
atica and F. gigantica are encountered, and endemic areas present
high prevalences and intensities in humans (Esteban et al., 2003;
Curtale et al., 2007). In Asia, the analysiswas carried out inVietnam,
where this disease has emerged in humans throughout the whole
country in recent years (De et al., 2003; Le et al., 2008; Valero et al.,
in prep.).
2. Materials and methods
Non-embryonated eggs from humans and livestock analysed in
this study originated from 13 isolates of Fasciolidae (see Table 1),
including one from Bolivia, one from Peru, two from Georgia,
three from Egypt and two from Vietnam. Four previously described
animal-isolates from Bolivia (Valero et al., 2001a) were included
for comparative purposes. As ﬁxation is known to inﬂuence size
and shape of helminth eggs, for the present study egg materials
used were always without ﬁxation, suspended in water, preserved
in darkness at 4 ◦C until required andmeasured in the shortest time
possible, within the next fortnight after obtaining them.
2.1. Egg materials from humans
A total of 1049 eggs from human faeces were analysed. The
material from Bolivia, Peru, and Egypt originated from school sur-
veys, the material from Georgia originated from total population
surveys, and material from Vietnam originated from adult patients
of the Quy Nhon Hospital. The following materials were analysed:
154 eggs from 5 children (6–12 years old) from Huacullani (in the
northern Altiplano, Bolivia), 167 eggs from 4 children (7–14 years
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ld) from Santa Rosa de Chaquil (in the valley of Cajamarca, Peru),
3 eggs from3 individuals (10–40years old) fromAkhali Terjola and
tkhvisi (in the Kutaisi region, Georgia), 608 eggs from 13 children
8–11 years old) from Abis, Ola Garbea, Hosh Essa, and El Waquad
in theNileDelta, Egypt), and67 eggs from2adults (17, 27 years old)
rom Quy Nhon (Vietnam). The surveys were made at random on a
iven day among all consenting individuals. A clean 30ml plastic,
ide-mouthed, numbered container with a snap-on lid was given
o each individual, who was then asked to try to ﬁll the container
ith his/her own faeces and to return it immediately. Stool speci-
ens were collected from all consenting individuals and personal
ata was noted on delivery of the container. Faecal specimens were
ransported to the laboratory within the following 5h. From each
tool sample, a Kato–Katz slide (helm-Test®, AK test, AK Industria e
omèrcio Ltda, Belo Horizonte, Brazil) was taken. Fluke eggs were
ecovered from the positive samples.
.2. Egg materials from livestock
Data in this paper corresponds to eggs from liver ﬂukes from
omestic animals living in the same or neighbouring areas to those
here human samples were collected. For comparison with eggs of
uman samples from the northern Bolivian Altiplano and the Peru-
ian Cajamarca valley, data from F. hepatica eggs from the most
ommon reservoir host species (104 eggs from sheep, 168 from
attle, 186 from pigs and 161 from donkeys) in the human hyperen-
emic area of theBolivianAltiplano (Valero et al., 2001a)wereused.
rom Georgia, a total of 117 F. hepatica eggs obtained from 3 cattle
n the Kutaisi region were included in the study. In the Nile Delta
egion of Egypt, 35 F. hepatica eggs and 73 F. gigantica eggs from 3
nd 4 cattle, respectively, were analysed. A total of 101 F. gigantica
ggs from3 cattle fromVietnam’s area ofQuyNhonwere added. For
omparison with F. gigantica, data known to be from “pure” spec-
mens of that species were also used: 142 eggs from cattle in the
obo Dioulasso area, Burkina Faso, where F. hepatica is absent and
adix natalensis is the only lymnaeid vector species present (Periago
t al., 2006).
.3. Criteria for the speciﬁc classiﬁcation of eggs from humans
nd animals
In Bolivia and Peru, the only liver ﬂuke species present infecting
oth humans and livestock in the Bolivian Altiplano (Mas-Coma
t al., 1999) and the Cajamarca valley (Espinoza et al., 2007) is F.
epatica, because F. gigantica never colonized the New World.
In Georgia, Egypt and Vietnam, however, special precautions
ere taken because of the distribution overlap of the two fasci-
lid species in each one of the respective endemic areas where
gg samples studied came from. Adult fasciolid specimens tend
o crossbread despite being hermaphroditic (Hurtrez-Bousses et
l., 2004). So, the problem in these overlap areas is that adults of
he two species hybridise and hybrid adult ﬂukes found are known
o show morphologically intermediate forms (Ashraﬁ et al., 2006;
eriago et al., 2008; Le et al., 2008). Eggs in these endemic areas
ayphenotypically differ fromeggs typical of oneor theotherpure,
arental species. Hence, the only way to assure the speciﬁc classi-
cation of eggs was by obtaining the eggs directly from the ﬂuke
dult and afterwards processing this adult for speciﬁc classiﬁca-
ion. Unfortunately, this was only feasible for animal samples but
ot for human samples. Therefore, adult liver ﬂukes were obtained
rom the livers of cattle from slaughterhouses in localities also fur-
ishing the human samples here studied. The ﬂukeswere classiﬁed
s F. hepatica or F. gigantica following the criteria of Periago et al.
2006, 2008). To avoid immature eggs from the uterus which could
henotypically differ from the mature eggs found in bile and fae-
es as those used for diagnosis, eggs were obtained from mature
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adult ﬂukes by applying a light pressure on the acetabulum to force
mature eggs to come out through the genital pore. When needed
to obtain more eggs, a small hole in front of the acetabulum can
be made with two needles to facilitate the ejection of eggs. It shall
be taken into account that, in Fasciola, the uterus is not only an
organ for egg maturation but also for egg storage (Valero et al.,
2001b). This means that eggs in the ﬁnal part of the uterus are (i)
completely shaped, (ii) mature, and (iii) viable. The absence of dif-
ferences in size, maturity and viability between eggs from the ﬁnal
uterine part and eggs from bile and faeces was veriﬁed in differ-
ent animal individuals. To obtain eggs in that way is easy because
mature fasciolids are very big ﬂukes andmost of its uterus is postac-
etabular but it ends preacetabularily. Eggs obtained by this simple
technique are the same size and shape than the ones found in bile
and faeces (i.e., no immature eggs included among those obtained
by that technique). Results showed that only F. hepatica was con-
cerned in Georgia, forms of both fasciolid species were involved
in Egypt, and only F. gigantica forms were present in the animals
analysed in Vietnam.
2.4. Measurement techniques
The measurements were taken by means of CIAS, including
a computer connected to a 3CCD colour video camera (Sony
DXC-930P) linked to a microscope, using image analysis software
(ImagePro® Plus 4.5, Media Cybernetics Inc., Silver Spring, USA).
According to the standardized methodology (Valero et al., 2005),
egg characteristics studied were: egg length (EL), egg width (EW),
egg perimeter (EP), egg area (EA), EL/EW ratio, and egg roundness
(ER).
The egg roundness measurement (ER=EP2/4EA) was used to
quantify theegg shape. It is ameasurementofhowcircular anobject
is (the expected perimeter of a circular object divided by the actual
perimeter). A circular object will have a roundness of 1.0, while
more irregular objects will have larger values (Periago et al., 2008).
2.5. Statistical analyses
Comparison of the average egg measurements between human
and animal samples was carried out using the one-way ANOVA, a
post hoc test (Bonferroni) and t-test (software SPSS v.15). Morpho-
metric data was explored using two multivariate analyses in ﬁve
measurements (EL, EW, EP, EA, EL/EW):
A) The principal component analysis (PCA), a technique for sum-
marizing most of the variation in a multivariate dataset in
few dimensions (Rohlf and Marcus, 1993; Klingenberg, 1996;
Dujardin and Le Pont, 2004). The ﬁrst principal component
(PC1) is the lineal combination that accounts for the maximum
variance. Geometrically, it corresponds to the direction of the
longest axis through the scatter of datapoints. Subsequentprin-
cipal components take up maximal variance, subject to being
orthogonal to all preceding component axes (Klingenberg,
1996). Size-free canonicaldiscriminantanalysiswasusedon the
covariance matrix of transformed logarithms. This technique
consists of regressing each character separately on the within
group ﬁrst principal component (PC1), which is a multivariate
estimate of size (Bookstein, 1989; Dos Reis et al., 1990). The
analyses were carried out using the BAC v.2 software (Dujardin,
2002). The statistical methodology used for egg measurements
is very similar to that performed by Periago et al. (2008) on
adults of F. hepatica and F. gigantica species from the same geo-
graphical area.
(B) All the populations were also studied by means of discriminant
analysis using the geographic area of origin and host species as
the grouping variables. A stepwise discriminant function pro-
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Fig. 1. Shape and size variability of fasciolid eggs shed in human stools: (A–G) Fasciola hepatica of the Northern Altiplano, Bolivia; (H–P) F. hepatica of the Cajamarca Valley,
P hepat
a , J and
a A–D, H
3
aeru; (Q–S) F. hepatica of the Kutaisi region, Georgia; (T–V) fasciolid eggs (mainly F.
rea, Vietnam. Note the presence of lateral irregularities on the egg shell surface in I
nd X, and their absence on the same abopercular shell end in M and Y. Scale bars:
cedure was applied using Wilks’  (SPSS v.15). Values were
considered statistically signiﬁcant when P<0.05.. Results
In the egg samples from Fasciola species shed by humans, the
bopercular end of the shell is often roughened or irregular (more
155ica phenotypes) of the Nile Delta region, Egypt; (W–Y) F. gigantica of the Quy Nhon
R, presence of such irregularities on the abopercular end of the shell in C, E–G, N–P
–L, Q–X=150m; E–G, M–P, Y =50m.
or less pronounced) (Fig. 1). Nevertheless, this irregularity is some-
times laterally located. The morphological analysis of the eggs
shows that this irregularity on the shell surface is very common
in Bolivia (99 cases with a protuberance out of 154 eggs: 64.3%)
as well as in Peru (121 cases out of 167: 72.5%). This irregularity is
less frequent in the human samples from Egypt (30.1%). However,
it is very infrequent in the human samples from Georgia (it was


















%ig. 2. Factor map corresponding to Fasciola eggs shed by humans from Bolivia,
eru, Georgia, Egypt andVietnam. Samples are projected onto theﬁrst (PC1, 74%) and
econd (PC2, 19%) principal components. Each group is represented by its perimeter.
etected in only one egg out of 53: 1.9%) and Vietnam (only in eight
ggs out of 67: 11.9%).
.1. Study of the inﬂuence of the geographical location
The size of F. hepatica eggs obtained from human and animal
amples are shown in Table 1. The study of the inﬂuence of the
eographical location on the size of fasciolid eggs shed by humans
as carriedoutbyPC1analysis andcanonical discriminant analysis.
or comparison, a similar study with the same purpose on the size
f fasciolid eggs obtained in cattle infections was also carried out:
A) Eggs from humans: The fasciolid egg variables from human
samples from Bolivia, Peru, Georgia, Egypt and Vietnam all sig-
niﬁcantly correlated with PC1, which contributed 78% to the
overall variation. The resulting factor maps (Fig. 2) clearly illus-
trate global size differences in the populations analysed. Two
zones can be distinguished: one zone is made up of Bolivia,
Peru, Georgia and Egypt, while the other zone consists only of
Vietnam and overlaps with the Bolivian and Peruvian samples.
The results show that Georgian and Egyptian data is included
in F. hepatica global size. Canonical discriminant functions had
statistically signiﬁcant values of Wilks’  (P<0.001). The func-
tions y1 and y2, including 99.4% of accumulate variance, are the
following:y1 = 0.908EL + 0.696EW − 5.366EP + 3.668EA + 1.693
EL
EW




redicted group classiﬁcation results of eggs of human origin from: (1) Fasciola hep-
tica, Bolivia; (2) Fasciola hepatica, Peru; (3) Fasciola hepatica, Georgia; (4) Fasciola
p., Egypt; (5) Fasciola gigantica, Vietnam.
1 2 3 4 5 Total number
riginal
1 103 36 11 3 1 154
2 61 92 12 2 0 167
3 7 25 7 15 2 56
4 0 0 3 596 9 608
5 0 0 0 0 67 67
1 66.9 23.4 7.1 1.9 0.6 100.0
2 36.5 55.1 7.2 1.2 0.0 100.0
3 12.5 44.6 12.5 26.8 3.6 100.0
4 0.0 0.0 0.5 98.0 1.5 100.0
5 0.0 0.0 0.0 0.0 100.0 100.0
156Fig. 3. Factor map corresponding to Fasciola eggs from naturally infected cattle
from Bolivia, Georgia, Egypt and Vietnam. Samples are projected onto the ﬁrst (PC1,
94%) and second (PC2, 5%) principal components. Each group is represented by its
perimeter.
The discriminant linear functions (axes 1, y1 and 2, y2) clearly
differentiate eggs of F. hepatica from Bolivia and Peru from eggs
of F. gigantica from Vietnam. The results of the classiﬁcation
according to the predicted group obtained with these discrim-
inant functions are given in Table 2. Specimens from Georgia
overlap with some specimens from Bolivia, Peru, Egypt and
Vietnam. Nevertheless, specimens from Egypt form a different
group from either F. hepatica or F. gigantica standard specimens
and only overlapwith some specimens fromVietnam. The aver-
age data obtained in human samples shows very similar values
in all egg measurements from Bolivia, Peru, Georgia and Egypt.
Summing up, the length and width range of F. hepat-
ica eggs from humans in altitude Andean areas, where
only F. hepatica is present, is 100.6–161.0/65.9–104.5m,
values very close to values obtained from human samples
from Georgia (104.5–162.0/72.1–96.6m) and from Egypt
(106.5–171.5/63.9–95.4m), where F. hepatica and F. gigantica
co-exist. The human samples from Vietnam have the high-
est values, 150.9–182.2/85.1–106.2m, overlapping with those
obtained from all other human samples analysed.
(B) Eggs from cattle: The fasciolid egg variables from cattle sam-
ples from Bolivia, Georgia, Egypt and Vietnam all signiﬁcantly
correlated with PC1, which contributed 94% to the overall vari-
ation. The resulting factor maps (Fig. 3) clearly illustrate global
size differences in the populations analysed. This factor map
shows that, although the egg size of F. hepatica and F. gigan-
tica from cattle does not overlap when allopatric populations
from geographically extremely distant areas are compared, e.g.
Table 3
Predicted group classiﬁcation results of eggs of cattle origin from: (1) Fasciola hepat-
ica, Bolivia; (2) Fasciola hepatica, Georgia; (3) Fasciola hepatica-like, Egypt; (4) Fasciola
gigantica-like, Egypt; (5) Fasciola gigantica, Vietnam.
1 2 3 4 5 Total number
Original
1 57 9 1 1 0 68
2 0 0 0 9 92 101
3 15 56 40 6 0 117
4 1 2 3 60 7 73
5 8 4 20 3 0 35
%
1 83.8 13.2 1.5 1.5 0.0 100.0
2 0.0 0.0 0.0 8.9 91.1 100.0
3 12.8 47.9 34.2 5.1 0.0 100.0
4 1.4 2.7 4.1 82.2 9.6 100.0
5 22.9 11.4 57.1 8.6 0.0 100.0
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Table 4
Predicted group classiﬁcation results of eggs from different deﬁnitive animal host
species and humans sampled in Bolivia: (1) Fasciola hepatica, cattle; (2) Fasciola
hepatica, sheep; (3) Fasciola hepatica, donkey; (4) Fasciola hepatica, pig; (5) Fasciola
hepatica, human.
1 2 3 4 5 Total number
Original
1 19 22 7 12 8 68
2 16 45 26 13 4 104
3 0 13 36 12 0 61
4 3 18 23 41 1 86
5 20 2 5 1 126 154
%








c2 15.4 43.3 25.0 12.5 3.8 100.0
3 0.0 21.3 59.0 19.7 0.0 100.0
4 3.5 20.9 26.7 47.7 1.2 100.0
5 13.0 1.3 3.2 0.6 81.8 100.0
Bolivia and Vietnam, the egg size of F. hepatica and F. gigan-
tica overlaps when sympatric populations are compared, e.g.
from Egypt. Canonical discriminant functions had statistically
signiﬁcant values of Wilks’  (P<0.001). The functions y1 and
y2, including 97.7% of accumulate variance, are the following:
y1 = −1.028EL + 2.228EW − 0.103EP − 1.654EA + 2.299
EL
EW
y2 = −3.469EL − 0.053EW − 0.300EP + 2.911EA + 3.089
EL
EW
The discriminant linear functions (axes 1, y1 and 2, y2) clearly
differentiate eggs of F. hepatica fromBolivia and eggs of F. gigan-
tica from Vietnam. The results of the classiﬁcation according
to the predicted group obtained with these discriminant func-
tions are given in Table 3. Specimens from Georgia overlap
with some specimens from Bolivia and Egypt. Nevertheless,
F. gigantica specimens from Egypt form a different group but
overlapwith somespecimensofF. hepatica fromBolivia,Georgia
and Egypt and F. gigantica from Vietnam.
.2. Study of the inﬂuence of the host speciesThe study of the inﬂuence of the host species on the egg size
as carried out by PC1 analysis in two geographical areas, namely
olivia and Vietnam. Fasciola hepatica egg variables from the north-
rn Bolivian Altiplano from humans and domestic animals (sheep,
ig. 4. Factormap corresponding to Fasciola eggs fromhumans and livestock (cattle,
heep, pig and donkey) from the same endemic area in the northern Bolivian Alti-
lano. Samples are projected onto theﬁrst (PC1, 86%) and second (PC2, 11%) principal
omponents. Each group is represented by its perimeter.
157Fig. 5. Factor map corresponding to Fasciola eggs from humans and cattle from the
same endemic area in Vietnam. Samples are projected onto the ﬁrst (PC1, 70%) and
second (PC2, 13%) principal components. Each group is represented by its perimeter.
cattle, pig and donkey) all signiﬁcantly correlated with PC1, thus
contributing 86% to the overall variation. The resulting factor maps
(Fig. 4) clearly illustrate global size differences in the human pop-
ulation analysed versus domestic animal host species, including a
bigger size in eggs from humans. Canonical discriminant functions
had statistically signiﬁcant values of Wilks’  (P<0.001). The func-
tions y1 and y2, including 95.0% of accumulate variance, are the
following:
y1 = 0.074EL + 1.930EW − 1.394EP − 1.224EA + 1.518
EL
EW
y2 = −3.915EL + 3.853EW + 0.867EP − 1.563EA + 5.366
EL
EW
The discriminant linear functions (axes 1, y1 and 2, y2) clearly
differentiate the egg population of F. hepatica from humans and the
egg population of F. hepatica from other host species. The results of
the classiﬁcation according to the predicted group obtained with
these discriminant functions are given in Table 4. Specimens from
humans form a different group but overlap with some specimens
either from sheep, cattle, pig or donkey. The analysis of the aver-
age of all absolute egg measurements obtained from the northern
Bolivian Altiplano shows that F. hepatica egg average values from
human samples are greater than the average values of eggs from
the remaining host species. The signiﬁcant differences obtained
when comparing pair-wise each egg measurement from human
and animal samples using the Bonferroni test are shown in Table 1.
The results conﬁrm that the F. hepatica egg size in human samples
possesses its own morphological identity.
Fasciola gigantica egg measurements from Vietnamese humans
and cattle all signiﬁcantly correlated with PC1, contributing 74%
to the overall variation. The resulting factor maps (Fig. 5) clearly
illustrate global size differences in the human population analysed,
including a global size of F. gigantica eggs from humans smaller
than that of eggs from cattle. Canonical discriminant functions had
statistically signiﬁcant values of Wilks’  (P<0.001). The results of
the classiﬁcation according to the predicted group obtained with
these discriminant functions are given in Table 5. The signiﬁcant
Table 5
Predicted group classiﬁcation results of eggs from Vietnam: (1) Fasciola gigantica,
human; (2) Fasciola gigantica, cattle.
1 2 Total number
Original
1 67 0 67
2 6 95 101
%
1 100.0 0.0 100.0
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ifferences obtainedwhen comparing pair-wise each eggmeasure-
ent from human and animal samples using the t-test are shown
n Table 1. The results conﬁrm that the F. gigantica egg size in the
uman samples possesses its own morphological identity, and that
. gigantica eggs from human samples have smaller average values
han the average values of eggs from cattle.
. Discussion
Until theendof the1990s,human fascioliasiswasmerely consid-
red a rarely encountered disease sporadically acquired in animal
ndemic areas. Thus, the majority of published studies have dealt
nly with individual cases or family group reports. In such situa-
ions, eggs are usually present in a very small number at irregular
ntervals. Sometimes, repeated stool examinations might even be
ecessary to detect eggs (Arjona et al., 1995). However, prevalences
nd intensities are pronouncedly higher, especially in children, in
umanhyperendemicareas (Mas-Comaet al., 2005).Unfortunately,
tudies performed in those areas include only large scale human
pidemiological surveys, but so far there is no report including an
xhaustive egg morphometric analysis. Eggs of Fasciola species are
perculated, large, light yellowish-brown, broadly ellipsoidal and
on-embryonated when excreted in faeces, and their length and
idth are generally within a speciﬁc range, which is one of the
ost frequently used criteria for the diagnosis of human fasciolia-
is.
Classically, it is considered that at the abopercular end of the
hell of Fasciola eggs there is often a roughened or irregular area
hat is not seen in Fasciolopsis eggs (Ash and Orihel, 1997). Never-
heless, our observations show that the frequency of the presence
f this feature in F. hepatica is population-dependent, and therefore
s not a pathognomonic criterion in diagnosis. Whether the pecu-
iar abopercular and/or lateral irregularities in the egg shell surface
bserved in this study are related to the geographical origin or due
o egg production abnormalities caused by human treatment (as,
or instance, the usual albendazole treatments in the two Andean
ountries) could neither be analysed nor established.
Fascioliasis is traditionally considered a worldwide veterinary
roblem, and consequently the egg size range found in the liter-
ture applied to human diagnosis was in fact obtained through
he analysis of samples from domestic animal hosts: F. hepat-
ca 130–148/60–90m (Boray, 1982), 130–145/70–90m (WHO,
991) or 130–150/63–90m (Mas-Coma and Bargues, 1997), and
. gigantica 150–196/90–100m (Boray, 1982; Mas-Coma and
argues, 1997). Therefore, the borderlines allowing differentia-
ion between the two species were traditionally considered to be
50m in length and 90m in width, lower values representing F.
epatica and higher values F. gigantica.
Our study reveals that humans, in comparison to other host
pecies, have a decisive inﬂuence on the size of F. hepatica and
. gigantica eggs, showing a greater variation than the above-
entioned classic size range, i.e. in humans F. hepatica eggs are
igger and F. gigantica eggs are smaller than the classic sizes
eported. Moreover, these intraspeciﬁc size variabilities overlap
hen both species are compared. These Fasciola egg-size variabili-
ies also intersectwith the sizeof eggsbelonging toother trematode
pecies able to infect humans and presenting a similarmorphology,
.g. species of the genera Fasciolopsis, Gastrodiscoides (Mas-Coma et
l., 2005) and Echinostoma (WHO, 1991), and may lead to confusion
n egg classiﬁcation when carried out by inexperienced personnel,
f other diagnostic criteria are not considered (see, for example,
elisario et al., 2007).
The overlap distribution of F. hepatica and F. gigantica also led to
long ranging controversy on the taxonomic identity of the Fasciola
pecies found in Far East countries, in which some resemble F. hep-
tica, whereas others resemble F. gigantica, with morphologically
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intermediate forms also being present and involving phenom-
ena such as abnormal gametogenesis, diploidy, triploidy and
mixoploidy, parthenogenesis, and hybridisation events between
different genotypes (see review in Mas-Coma and Bargues, 1997).
At present, the easiest way to genetically conﬁrm that a specimen
collected in nature is an hybrid is by detecting introgression. Intro-
gression refers to the permanent incorporation of genes from one
set of differentiated populations into another, i.e. the incorporation
of alien genes into a new, reproductively integrated population sys-
tem (Dowling and Secor, 1997; Mas-Coma and Bargues, 2009). In
Fasciola, the existence of hybrid forms was conﬁrmed when it was
shown that Japanese fasciolids from animals presented ribosomal
DNAsequences almost identical to thoseof one fasciolid species and
mitochondrial DNA sequences almost identical to those of the other
fasciolid species (Itagaki and Tsutsumi, 1998; Itagaki et al., 1998).
Moreover, in Asian areas sympatric for both liver ﬂuke species, a
large overlap of egg measurements was detected (Watanabe, 1962;
Sahba et al., 1972; Kimura et al., 1984; Srimuzipo et al., 2000). In
Vietnam, the adult ﬂukes found in animals and human patients fall
into two morphological categories, one typical of F. gigantica and
the other closely resembling F. hepatica (Le et al., 2008). Le et al.
(2008) reported data indicating that hybrid/introgressed popula-
tions of Fasciola occur in Vietnam and that these are implicated in
human infection. The eggmaterial analysed in our study shows that
the size of eggs shed by humans from Vietnam only corresponds to
the F. gigantica morph.
Fasciola gigantica is the main fasciolid species in Africa. Mor-
phometric values of fasciolid eggs from European and African
bovines were analysed by Periago et al. (2006) using CIAS. The
results showed that the range of egg measurements intersects
between F. hepatica and F. gigantica allopatric populations (EL:
107.3–152.7m in F. hepatica from Spain, 100.2–155.6m in F. hep-
atica from the French island of Corsica, and 129.6–204.5m in F.
gigantica from Burkina Faso; EW: 52.4–89.1m in F. hepatica from
Spain, 55.0–87.7m in F. hepatica from Corsica, and 61.6–112.5m
in F. gigantica from Burkina Faso). In Egypt, both F. hepatica and
F. gigantica are present, but usually the terminology Fasciola sp. is
used for human fascioliasis in the Nile Delta (Esteban et al., 2003;
Curtale et al., 2007). Phenotypic F. hepatica/F. gigantica intermedi-
ate forms of liver ﬂuke adults from this human endemic area have
been described in cattle, and the F. hepatica morph appears to be
more frequent than the F. gigantica morph in this animal species
(Periago et al., 2008). This fact agrees with our results since the size
of eggs shed by humans from Egypt corresponds to the F. hepatica
morph.
In conclusion, measurements of F. hepatica and F. gigantica eggs
obtainablewith amicroscope suchasEL, EWandEL/EW,originating
from both humans and animals, partly overlap in areas where both
fasciolid species co-exist, such as in Egypt, and therefore caution
must be taken when using egg size as the only criterion for dif-
ferential diagnosis (Table 1). A similar conclusion is reached when
comparing other measurements obtainable by CIAS such as EP, ER
and EA (Table 1). In this sense, our ﬁndings should aid clinicians
in these areas since the application of the classic egg size range in
human samples may lead to erroneous conclusions.
The measurements of the ﬂuke eggs found in the stools shed by
a Japanese patient (Inoue et al., 2007) constitute a good example to
illustrate the problemhere in question. The living ﬂuke removed by
balloonextractionafter endoscopic sphincteromyshowedmorpho-
metric characteristics ﬁtting F. hepatica. The ribosomal DNA ITS-2
and ITS-1 sequences (fragments of 327 and 351bp of the complete
364 and 432bp spacer sequences, respectively) obtained from a
ﬂuke egg pull isolated from the patient’s faeces were also in agree-
ment with this fasciolid species. The mitochondrial COI sequence
(unfortunately only a short 493-bp fragment and not the com-
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lthough all these features indicated that the parasite was F. hep-
tica, the egg size of 153–175/75–95m (average 164.7/83.7m)
Inoue et al., 2007) did not ﬁt the egg size characteristics tra-
itionally considered for F. hepatica (130–150/63–90m), but it
id for F. gigantica (150–196/90–100m) (Mas-Coma and Bargues,
997). When compared with the new egg size data reported for
uman samples in the present study, the size of the Japanese
ggs ﬁts well with the egg size noted for F. hepatica in areas
hereboth fasciolid species overlap, except for themaximumrange
or the egg length (175m), which very slightly surpasses that
etected in humans from Egypt (171.5m). The egg width aver-
ge of the Japanese ﬂuke (83.7m) is closer to that of F. hepatica in
eruvian (80.2m) or Georgian subjects (82.1m), and the min-
mum range for the Japanese egg width (75m) is pronouncedly
maller than the minimum egg width (85.1m) noted for F. gigan-
ica in Vietnamese subjects. This comparison suggests that the
apanese ﬂuke was probably a specimen from a long-term orig-
nated, introgressed lineage in which the introgression was not
etectable in the short COI sequence fragment obtained. It shall
e taken into account that introgression may involve the substi-
ution of only a part of the mitochondrial genome, not necessarily
f all mtDNA genes, and that an accumulation of many genetically
ifferent introgressed hybrid forms resulting from back-crossing
ay be expected in an area of overlap (Mas-Coma and Bargues,
009).
Fasciolid egg size in human stool samples ought to be corrected
n books and monographs related to medical parasitology and/or
ropical medicine as well as in guides for clinicians and diagnosis
nalysts. When dealing with human fascioliasis globally, F. hepat-
ca egg length/width data should be 100.6–162.2/65.9–104.6m in
uman stools and 73.8–156.8/58.1–98.1m in animal faeces when
eferring to areas where F. gigantica is absent (as in the Americas
nd Europe). When referring to areas where both fasciolid species
re present (as in many parts of Africa and Asia), F. hepatica egg
ength/width data should be 106.5–171.5/63.9–95.4m in human
tools and120.6–163.9/69.2–93.8minanimal faeces, and F. gigan-
ica egg length/width data should be 150.9–182.2/85.1–106.2m
n human stools and 130.3–182.8/74.0–123.6m in animal fae-
es. For areas where both fasciolid species co-exist, the size of
asciolid eggs shed by humans may be intermediate between the
bove-mentioned data for F. hepatica and that for F. gigantica in
umans in overlapping areas and such situations might be inter-
reted as infections by intermediate or hybrid forms. With regards
o F. gigantica, egg length/width data should also be increased
o 129.6–204.5/61.6–112.5m in animal faeces when referring to
reas where F. hepatica is absent (as in great parts of Africa). Future
tudies in other areas may perhaps modify the above-mentioned
aximumandminimumsizemeasurements for fasciolid eggs shed
nhumanstools, but thepresent exhaustive studysuggests thatonly
ery slight differences may be found, if any.
Finally, it has to be added that in endemic areas of Asia and
fricawhere both fasciolid species overlap, a human subjectmaybe
imultaneously infectedbyﬂukeadultsbelonging toboth F. hepatica
nd F. gigantica. Consequently, an appropriate coprological diagno-
is in such an area shall not rely on the measurement of only one or
ery few eggs. Whenever possible, measuring a sufﬁcient amount
f eggs to appropriately assess egg size variability could facilitate
he veriﬁcation of whether only one or the other, or perhaps both
pecies simultaneously have infecting the patient. Moreover, it has
o be considered that, if ﬂuke adults of both species co-infect the
atient, intermediate hybrid eggsmay additionally appear in stools
n case some ﬂukes have crossbred.
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MM3-SERO and MM3-COPRO ELISA tests
A B S T R A C T
During an experimental infection of sheepwith Fasciola hepatica or F. gigantica, MM3-SERO
andMM3-COPRO ELISA tests were applied to compare the kinetics of antibody production
and coproantigen release between the 2nd and 32nd week post-infection (wpi). The Kato-
Katz technique was used to measure the kinetics of egg shedding by both Fasciola species
(eggs per gram of feces, epg). The kinetics of IgG antibodies for all sheep infected with F.
hepatica and F. gigantica followed a similar pattern. Optical density (OD) increased rapidly
between the 4th until the 12th wpi, when the highest values were reached and then
decreased slowly until the 32ndwpi. Coproantigen levels increased above the cut-off value
between 6 and 9 wpi in the F. hepatica group, and between 9 and 11 wpi in the F. gigantica
group. The comparison between coproantigen levels and epg indicated that F. hepatica-
infected sheep had detectable amounts of coproantigens 4–7 weeks before patency (egg
shedding), while F. gigantica-infected sheep had detectable amounts of coproantigens 3–6
weeks before patency. When comparing the kinetics of coproantigen release vs the
kinetics of epg, a similar pattern emerged, but with a two-week time-lag in epg, for both F.
hepatica and F. gigantica infections. The amount of coproantigen release by each adult was
not burden dependent for F. hepatica infection (burden of 33–66 adults), while it was for F.
gigantica infection (burden of 17–69 adults). The results demonstrate the usefulness of the
MM3-SERO andMM3-COPRO ELISAs as tools for the diagnosis of early as well as long-term
fascioliasis infections, and suggest that they can potentially be applied to human
fascioliasis even in countries where F. hepatica and F. gigantica co-exist. These tests can be
employed not only in the diagnosis, but also in studies on epidemiology as well as
pathogenesis and treatment in animals and humans since they allow post-treatment
infection monitoring.
 2008 Elsevier B.V. All rights reserved.
Contents lists available at ScienceDirect
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1611. Introduction
Fasciola hepatica and F. gigantica are two trematode
species having an important impact on public health due to
the infections they cause in humans and livestock. F.
hepatica has a cosmopolitan distribution, mainly in
M.A. Valero et al. / Veterinary Parasitology 159 (2009) 77–8178temperate zones, while F. gigantica is found in tropical
regions of Africa and Asia (Torgerson and Claxton, 1999;
Mas-Coma et al., 2005). Although the majority of cases is
attributed to F. hepatica, human infections with F. gigantica
are also present in many countries (Ashraﬁ et al., 2006a,b;
Le et al., 2007).
The diagnosis of fascioliasis is complicated due to the
liver ﬂuke’s biological cycle within the deﬁnitive host.
After ingestion of metacercariae, juvenile worms migrate
through the intestinal wall to the peritoneal cavity,
penetrate the liver parenchyma through which they
migrate (time depends on the host species), and pass into
the biliary tract, where they ultimately reach maturity and
start oviposition. Consequently, eggs are present in stool
several weeks after the ingestion of metacercariae.
Immunodiagnosis has traditionally been used in animal
and human fascioliasis, and numerous methods and
techniques have been developed for the detection of F.
hepatica infection (see global review in Hillyer, 1999). The
majority of methods based on coproantigen detection are
applied to F. hepatica infection, but only few are applied to
F. gigantica infection (Endah Estuningsih et al., 2004). The
MM3-SERO and MM3-COPRO ELISA tests developed by
Mezo et al. (2004, 2007) to detect serum antibodies and
fecal antigens have shown to be highly speciﬁc, sensitive
and simple for the diagnosis of acute and chronic F.
hepatica infections in cattle and sheep. However, the
usefulness of these methods for diagnosis of F. gigantica
infections has never been investigated. In the present
study, these two tests are evaluated by analyzing the
kinetics of antibody production and coproantigens
released during an experimental infection of sheep with
F. gigantica and F. hepatica for comparative purposes.
2. Materials and methods
2.1. Experimental procedures
F. hepatica and F. gigantica metacercariae were experi-
mentally obtained in the Department of Parasitology of the
University of Valencia as previously described (Mas-Coma
et al., 2001). Fasciola gigantica and its snail host Lymnaea
callaudi originated from Egypt, while F. hepatica and the
lymnaeid Galba truncatula originated from Spain.
The experimental group consisted of 12 four-to-ﬁve-
week-old sheep (Guirra autochthonous breed) divided into
threegroups of four animals each. Twogroupswere infected
per os with 200 F. hepatica or F. gigantica metacercariae,
respectively, and the third group was used as control. Food
and water were provided ad libitum. Permission for animal
research was obtained from the Ethics Animal Research
Committee of the University of Valencia. Animal ethics
guidelineswerestrictly adhered to in thecareof theanimals.
Post-mortem examinationswere carried out on all animals.
Thebile ducts and liver parenchymawere examined and the
ﬂukes inside were collected.
2.2. Fecal samples
Fecal pellets were collected fresh from each animal on
the day of infection and once a week, starting at 5 weeks162post-infection (wpi). Fecal egg detectionwas carried out by
analyzing 3–8 Kato-Katz slides (Helm-Test1, AK test, AK
Industria e Come´rcio Ltda, Belo Horizonte, Brazil) per
weekly sample (Valero et al., 2002). The average egg output
per day was calculated as eggs per g of feces (epg). For
coproantigen determination, aliquots of each fecal sample
were stored frozen at 20 8C until use.
2.3. Serum samples
Whole blood was collected from the external jugular
every 2 weeks from the day of infection (week 0) until
32 wpi. The blood samples were centrifuged at 760 g at
4 8C for 10 min, and the obtained serum samples were
stored at 80 8C until analysis.
2.4. ELISA procedures
Coproantigen detection in fecal sampleswas carried out
using the MM3-COPRO ELISA test following the procedure
described by Mezo et al. (2004). The presence of anti-
Fasciola IgG antibodies in serum from infected sheep was
determined using the MM3-SERO capture ELISA following
the procedure described byMezo et al. (2007). Commercial
versions of MM3-COPRO (BIO K 201) and MM3-SERO (BIO
K 211) are available from Bio-X Diagnostics (La Jemelle,
Belgium).
2.5. Statistical analysis
Each assay was repeated twice, and the results were
expressed as the mean OD492 of each determination. Fluke
F. hepatica vs F. gigantica burdenwas compared by the non-
parametric Mann–Whitney test. IgG levels in F. hepatica
and F. gigantica-infected sheep vs control were compared
using the T test. Bivariant correlations (Pearson’s correla-
tion) were calculated for coproantigen levels vs epg values
corresponding to a two-week time-lag in both F. hepatica
and F. gigantica sheep groups. The relationship between
antigen concentrations (ng/ml) divided by the parasitic
burden vs parasitic burden in both F. hepatica and F.
gigantica infection was analyzed by linear and curvilinear
regressions. Egg counts were conducted after converting
individual values to logarithms (log e) with the (n + 1)
transformation [ln(epg)] (Stephenson, 1987). Statistical
analyses were carried out with SPSS 15 and Origin 6.0
(Microcal Software, Inc., Northampton, MA, USA). Results
were considered statistically signiﬁcant when p < 0.05.
3. Results
Experimental monitoring conﬁrmed that all sheep
infected with metacercariae developed a liver-ﬂuke
infection. In the F. hepatica infection group, the ﬂuke
recovery percentage with respect to the number of
metacercariae inoculated ranged from 16.5% to 33%. The
egg shedding prepatent period (PP) ranged from 10 to
14 wpi (12.3  1.7). One F. gigantica-infected sheep was put
down in the 13th wpi due to development of clinical
fascioliasis, presenting a ﬂuke recovery of 25%, and a PP of
11 wpi. In the rest of the F. gigantica-infected sheep the ﬂuke
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ranged from 14 to 16 wpi (15.0  1.0). The F. hepatica burden
recovered at necropsy oscillated between 33 and 66 adult
ﬂukes, with a mean  SD of 51.5  13.7. The F. gigantica
burden oscillated between 17 and 69 adult ﬂukes
(44.0  21.6), without any signiﬁcant differences between
the two groups (Mann–Whitney test, p < 0.05).
The kinetics of IgG antibodies recognizing the antigen
captured by mAb MM3 was studied every two weeks
between the 2nd and 32nd wpi. The kinetics of antibodies
for all sheep infected with F. hepatica and F. gigantica
followed the same pattern. OD increased rapidly between
the 4th and the 12th wpi, when the highest values were
reached, and then decreased slowly until the 32nd wpi
(Fig. 1). OD values for control sheep always remained
below the cut-off value. Using the T test, signiﬁcant
differences between infected and control sheep were
assessed (p < 0.05).Fig. 1. Mean OD values (SD) obtained in MM3-SERO (closed squares), MM3
experimentally infected sheep at different times after infection (weeks). (A) Fasciol
MM3-SERO andMM3-COPRO for sera and fecal samples from uninfected controlsma
for MM3-COPRO (OD = 0.082) was calculated as 4 standard deviations (SD) from
animals used in this study during the ﬁrst 4 wpi. Cut-off value forMM3-SERO (DO = 0
COPRO and MM3-SERO ELISAs are represented as dashed and continuous horizon
163The kinetics of coproantigens recognized by mAb MM3
was studied weekly between the 2nd and 32nd wpi. In the
F. hepatica group, coproantigen levels increased quickly
above the cut-off, reaching higher OD values, although
showing strongweek-to-week ﬂuctuations in the course of
the experiment (Fig. 1). The comparison between coproan-
tigen levels and fecal egg counts (epg) indicated that F.
hepatica-infected sheep had detectable amounts of
coproantigens between the 6th and the 9th wpi (at
6 wpi coproantigens were detected in 25% of sheep, at
7 wpi in 50%, at 8 wpi in 75%, and at 9 wpi in 100%),
whereas eggs began to appear in feces fromweeks 10 to 14
(at 10 wpi eggs were detected in 25% of sheep, at 11 wpi in
25%, at 12 wpi in 50%, at 13 wpi in 75% and 14 wpi in 100%).
Comparing both methods, the MM3 test allowed detection
of infection four to seven weeks before PP. Comparatively,
the kinetics of coproantigen release vs the kinetics of egg
shedding showed a similar pattern but with a two-week-COPRO (open circles) and eggs per gram of feces (open triangles) from
a hepatica infection. (B) Fasciola gigantica infection. OD values obtained with
intained below the cut-off values during the entire experiment. Cut-off value
the mean absorbance values for the fecal samples obtained from the same
.074) was previously established (Mezo et al., 2007). Cut-off values forMM3-
tal lines, respectively.
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positive correlation (r = 0.92, p < 0.05) was observed when
contrasting coproantigen levels and the epg values of two
weeks later.
Concerning the F. gigantica-infected group, it is
noteworthy that the coproantigen detection took place
precociously at 7 wpi for the sheep that was put down in
the 13th wpi. In the remaining groups, coproantigen
release increased quickly until maximum values were
reached. Similar to F. hepatica, OD values showed strong
week-to-week ﬂuctuations along the experiment (Fig. 1).
The comparison between coproantigen levels and fecal egg
counts (epg) indicated that F. gigantica-infected sheep
presented detectable amounts of coproantigens from the
7th to the 11th wpi (at 7 wpi coproantigens were detected
in 25% of sheep, at 8 wpi in 25%, at 9 wpi in 50%, at 10 wpi
in 75%, and at 11 wpi in 100%), whereas eggs began to
appear in feces from weeks 11 to 16 (at 11 wpi egg
detection was possible in 25% of sheep, at 12 wpi in 25%, at
13 wpi in 25%, at 14 wpi in 50%, at 15 wpi in 75%, and at
16 wpi in 100%). Comparing bothmethods, theMM3 ELISA
test allows detection of F. gigantica infection 3–6 weeks
before PP. The comparison of the kinetics of fecal excretion
of the antigens vs the kinetics of egg shedding showed a
similar pattern but with a two-week time-lag in epg,
similar to that seen in the F. hepatica-infected group
(Fig. 1). A signiﬁcant positive correlation (r = 0.89,
p < 0.005) was also observed when contrasting coproanti-
gen levels and the epg values of 2 weeks later.
For F. hepatica no signiﬁcant correlation was observed
between the amount of the coproantigen released per
ﬂuke and parasite burden in any of the correlationmodels
tested. In contrast, in F. gigantica infection, the exponen-
tial model y(x) = y0 + a exp(x/b), where y0 = 2.029 
0.625, a = 66.122  3.229, b = 18.426  1.297 (R2 = 0.999;
p < 0.001) provided a suggestive description of the inverse
relationship between the coproantigen released per ﬂuke
and parasitic burden.
4. Discussion
The main goal of the present study is to evaluate the
application of MM3-SERO ELISA and MM3-COPRO ELISA
for the diagnosis of F. gigantica infection. Our study shows
that MM3-SERO ELISA detects the presence of IgG
antibodies in sheep infected with 200 metacercariae of
either F. gigantica or F. hepatica at 4 wpi. Our results also
show that the kinetics of IgG levels follow the same pattern
regardless of the Fasciola species, although their patency
periods vary. Anti-Fasciola IgG antibodies are detected in
all infected animals as early as 4 wpi, and reach their
maximum values around the 12th wpi. These results are in
agreement with other studies on ﬂuke-speciﬁc IgG
(Santiago and Hillyer, 1988; Chauvin et al., 1995; Moreau
et al., 1998; Zhang et al., 2004; Raadsma et al., 2007).
Comparatively, it is also observed that the anti-Fasciola IgG
response is slightly lower in the animals infected with F.
gigantica, which can be explained by small antigenic
differences between the species-speciﬁc antigens recog-
nized bymAbMM3, or by differences in the kinetics of each
antigen released by each species.164Similar to F. hepatica (Mezo et al., 2007), MM3-COPRO
ELISA proves to be useful for monitoring coproantigen
release in feces of sheep infected with F. gigantica. In our
study, the ﬁrst detection of F. gigantica coproantigens took
place 3–6 weeks before the appearance of eggs in feces,
which was similar to the 4–7 weeks observed for F.
hepatica. Moreover, coproantigen release was maintained
along the entire duration of the experiment (32 wpi). These
results underline the usefulness of the MM3-COPRO ELISA
test for the diagnosis of both early and long-term
fascioliasis in endemic F. gigantica areas. Similar to our
results, several studies have already shown that the
detection of F. hepatica/F. gigantica coproantigens through
ELISA is prior to patency, andwith amarked increase in the
levels of these antigens around the beginning of the fecal
egg output (Espino et al., 1998; Moustafa et al., 1998;
Endah Estuningsih et al., 2004).
In F. hepatica infection, the maturation time of juvenile
ﬂukes in the bile duct and the initiation of egg laying may
depend on the infection dose (see review in Valero et al.,
2006). In this sense, it was reported that in sheep infected
with 200 metacercariae, the egg shedding patency period
was 63 days, whereas in those with heavy infections (i.e.
infected with 2000 metacercariae) eggs appeared 13–15
weeks after ingestion (Boray, 1969). The crowding effect
becomes manifest through a delayed ﬂuke migration from
the liver parenchyma into the common bile duct. Using a
dose of 200 metacercariae, a density-dependence phe-
nomenon for the coproantigen release by F. gigantica can
be observed. However, this is not the case for F. hepatica,
whichmight be related to the greater individual biomass of
the former.
The results of the present study show the suitability of
MM3-SERO and MM3-COPRO for the diagnosis of F.
hepatica and F. gigantica infections in sheep, which are
also of interest in human infections. Once conﬁrmed for
human use, MM3-SERO and MM3-COPRO tests may
potentially be applied in human fascioliasis endemic
areas, even in countries where F. hepatica and F. gigantica
co-exist. It is expected that these tests may be useful not
only for individual diagnosis in hospitals, but also for
human surveys in epidemiological studies as well as for
analyses on pathogenesis, treatment efﬁciency and sur-
veillance as they allow the continuous monitoring of the
infection status.
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 Abstract.  In this study, we evaluate the MM3-COPRO method for detection of  Fasciola coproantigens in human 
fecal samples, and the usefulness of a new preservative/diluent, CoproGuard, developed for preservation of  Fasciola 
coproantigens. The MM3-COPRO assay was evaluated with 213 samples from healthy patients, 30  Fasciola positive fecal 
samples (according to the Kato-Katz method), and 83 samples from patients with other parasitic infections. All  Fasciola 
positive specimens were detected with the MM3-COPRO assay (100% sensitivity) and there was no cross-reactivity with 
other common parasites present in the clinical specimens analyzed (100% specificity). The use of CoproGuard enhanced 
coproantigen extraction without affecting the detection limit of the assay, and the antigenicity of  Fasciola coproantigens 
in fecal samples stored at 37°C was retained throughout the entire observation period (120 days). We concluded that 
the MM3-COPRO ELISA combined with the use of CoproGuard may be a very useful tool for the diagnosis of human 
fascioliasis. 
 INTRODUCTION 
 The genus  Fasciola includes the species  F. hepatica and 
 F. gigantica , both of which can cause infections in humans 
and animals. 1,2 In general, human fascioliasis is less frequent 
than animal fascioliasis, but the former is re-emerging, with 
reported cases in more than 51 countries throughout the 
world. 3–5 Indeed, fascioliasis is recognized as a major public 
health problem by the World Health Organization (WHO), 
with an estimated 17 million people infected worldwide, 4,6,7 
and 180 million at risk from infection. 8 
 Although damage depends on the number of infecting 
flukes, 9,10 this trematode can produce considerable pathology, 
which is first provoked by young flukes migrating through the 
liver parenchyma (acute phase), and then by the adults estab-
lished in the biliary ducts (latent/chronic phase). 11 Pathologic 
changes have also been observed in the gallbladder, which 
may sometimes harbor adult flukes. 12,13 
 Human fascioliasis may be suspected after examination of 
epidemiologic and clinical data. During this phase the illness 
may present with prolonged fever, epigastric and right upper 
quadrant pain, hepatomegaly, urticaria, leukocytosis, mild 
eosinophilia to hypereosinophilia, and anemia. 3,12,14,15 In addi-
tion, the computer tomography (CT) scan may reveal single 
or multiple hypodense liver lesions that change over time on 
sequential scans. 15–17 The latent/chronic phase of human fas-
cioliasis is frequently asymptomatic. 18 However, when pres-
ent, several clinical, laboratory, and radiologic findings related 
to biliary obstruction and cholangitis can be observed. These 
include upper abdominal pain, intermittent jaundice, intrahe-
patic cystic abscesses with prolonged fever, eosinophilic chole-
cystitis, and extrahepatic cholestasis with elevation of liver 
enzymes. 15 
 Several coprologic techniques for showing the presence of 
eggs in stools have long been used by various authors to con-
firm the diagnosis of human fascioliasis. However, these meth-
ods are often unreliable because parasite eggs are not found 
in feces until 3–4 months after infection, 14 and their low sen-
sitivity to low-burden infections—which limits their clinical 
application—is recognized. 3,18 The enzyme-linked immuno-
sorbent assay (ELISA) methods developed for determina-
tion of  Fasciola coproantigens in stool samples from animals 
and humans provide an alternative to coprologic exami-
nation. 19,20 One of these methods is MM3 capture ELISA 
(MM3-COPRO), which we previously showed to be useful for 
detection of  Fasciola hepatica and  Fasciola gigantica coproan-
tigens in experimental and natural  Fasciola infections of sheep 
and cattle. 21,22 This test proved to be highly sensitive (confirmed 
by necropsy) and specific (no cross reaction was observed 
with antigens from other helminths), and enabled detection of 
 Fasciola infections 1–5 weeks before patency. 21 Furthermore, 
other researchers recently tested a commercial version of the 
test, and its usefulness for detection of  F. hepatica infections in 
cattle was confirmed under field conditions. 23 However, until 
now MM3-COPRO has not been evaluated for coproantigen 
measurement in fecal samples from infected humans. 
 MM3-recognized  Fasciola coproantigens in human stools 
are probably more concentrated than in cattle, but determi-
nation of these antigens may be complicated by the action of 
proteases in the samples, or by the presence of substances that 
may interfere in the capture ELISA, such as lipids, antibodies, 
salts, organic residues, and other compounds that may be pres-
ent in different proportions in human and animal fecal sam-
ples. In the present study, we evaluated the usefulness of the 
MM3-COPRO method for detection of  Fasciola coproantigens 
in human stools, 21 and also tested the validity of a new fecal 
preservative (CoproGuard) specifically developed to prevent 
degradation of the MM3-recognized  Fasciola coproantigens in 
stool samples over time. 
 MATERIAL AND METHODS 
 Fecal samples.  Parasitologically negative fecal samples (213 
samples), positive fecal samples containing parasites other 
than  Fasciola (83 samples; see  Table 1 ), and positive fecal sam-
ples containing different amounts of  Fasciola eggs (30 samples) 
were obtained from the  Complejo Hospitalario Universitario 
de Santiago de Compostela (Service of Microbiology) and 
from the  Departamento de Parasitología, Facultad de Farmacia, 
167
157MM3-ELISA DETECTION OF FASCIOLA COPROANTIGENS IN HUMAN STOOLS
Universidad de Valencia , Spain, respectively. The presence of 
parasite forms in fecal samples was tested by microscopy by 
1) direct examination of fresh stools, 2) the phenol-auramine
stain, 24 3) the Kato-Katz method (see later), and 4) the sodium 
acetate-acetic acid-formalin (SAF)-ethyl acetate sedimen-
tation technique as recommended by the manufacturer of 
the Para-Pack Plus SAF specimen collection kit (Meridian 
Biosciene Europe, Nice, France). To avoid possible cross-
reactions with other parasites, mixed infections of  Fasciola and 
other parasites were not included in the study. The  F. hepatica 
positive and negative samples used in this study were collected 
during a 5-year period (2004–2008) and stored frozen at −20°C 
without addition of preservatives. All the  F. hepatica positive 
samples corresponded to chronic cases of fascioliasis of an 
unknown period of evolution. Eleven samples were obtained 
from adult patients (> 18 years of age; range: 19–77 years) and 
19 samples were obtained from young patients (< 18 years of 
age; range: 7–17 years). The overall mean age was 23.5 years of 
age (SD = 19.16). 
 Kato-Katz determinations.  Eggs were detected in fresh 
stools after analysis of 3–8 Kato-Katz slides (Helm-Test, AK 
test, AK Industria e Comércio Ltda, Belo Horizonte, Brasil) 
per sample, depending on the concentration of  Fasciola eggs. 
The average egg output was calculated as eggs per g of feces 
(epg). 
 Processing of fecal samples for ELISA determinations. 
 To research the conditions of coproantigen extraction, a pool 
of 5 parasitologically negative fecal samples was mixed with 
 F. hepatica excretory-secretory antigens (ESAs), obtained from 
adult cultured  Fasciola , as previously described. 21 The sample-
antigen mixtures were then homogenized with the aid of a 
spatula, and diluted 1:10 v/v in distilled water or in CoproGuard 
solution to provide fecal suspensions of final concentrations of 
10, 25, or 50 ng/mL diluent. The samples were then resuspended 
on a vortex mixer, and centrifuged for 10 min at 1,500  g . Finally, 
the supernatants were collected and stored at −20°C until analysis 
by MM3-COPRO ELISA. The CoproGuard preservative 
contains biocidal substances, proteins, and surfactants, and is 
available from the Laboratorio de Parasitología, Universidad 
de Santiago de Compostela, Spain. 
 To test the stability of  Fasciola coproantigens in fecal 
samples, aliquots of 5 individual positive human stools were 
diluted 1:10 v/v with 1) distilled water; 2) 0.2% sodium azide 
(VWR International, Barcelona, Spain) in distilled water; 3) 
0.03% thimerosal (VWR International) in distilled water, or 
4) CoproGuard. All of the samples were resuspended on a
vortex mixer, centrifuged at 1,500  g for 10 min and the super-
natants divided in aliquots, which were stored at 4°C, room 
temperature (RT), frozen at −20°C, or at 37°C (to acceler-
ate degradation of the fecal samples diluted in CoproGuard). 
Finally, the stored samples were assayed in duplicate at regular 
intervals by use of the MM3-COPRO ELISA. The results were 
expressed as percentage of optical density (OD) obtained for 
each test sample with respect to the OD obtained for control 
samples stored frozen at −20°C. 
 To evaluate the conditions of incubation for the MM3-
COPRO ELISA, a pool of 5 negative fecal samples were 
mixed with  F. hepatica ESAs and diluted 1:10 in CoproGuard 
to a final concentration of 25 ng/mL. The coproantigen was 
then extracted as described previously, and subjected to MM3-
COPRO ELISA under several incubation conditions. The fol-
lowing times and temperatures were considered: 1 hr at RT, 
2 hr at RT, and one night at 4°C. The effect of orbital shaking 
(100 rpm) was also tested. 
 MM3-COPRO ELISA detection of  Fasciola hepatica 
coproantigens in fecal samples.  The MM3-ELISA test was 
performed as previously described with some modifications. 21 
Polystyrene microtiter 1 × 8 F strip plates (Greiner Bio-One 
GmbH, Frickenhausen, Germany) were coated overnight with 
100 μL/well of a solution containing 10 μg/mL of rabbit anti-
 Fasciola polyclonal IgG antibody in phosphate buffered saline 
(PBS) (wells from odd-numbered rows), or with 100 μL/well 
of a solution containing 10 μg/mL of IgG polyclonal antibodies 
from non-immunized rabbits (wells from even-numbered 
rows). Uncoated sites were blocked with 1.5% of sodium 
caseinate in (PBS) for 1 hr at RT, and each fecal supernatant 
(100 μL) was then added in quadruplicate (2 odd-numbered 
wells plus 2 even-numbered wells), and incubated overnight 
at 4°C. After washing 6 times with PBS containing 0.2% 
Tween-20 (PBS-T), 100 μL of a solution containing 0.3 μg of 
biotinylated MM3 antibodies in PBS-T plus 1% bovine serum 
albumin (PBS-T-BSA) was added to each well and incubated 
for 1 hr at 37°C. After washing as above, bound MM3 antibody 
was detected by incubation, first with peroxidase-conjugated 
neutravidin (Pierce, Rockford, Illinois; dilution 1:2000 in 
PBS-T-BSA) for 1 hr at 37°C, and then with the substrate 
(buffered H 2 O 2 and o–phenylenediamine [OPD], Sigma-
Aldrich , Madrid, Spain). After incubation for 20 min at RT, 
the reaction was stopped by addition of 3 N H 2 SO 4 . Finally, 
the optical density (OD) was measured at 492 nm. The OD 
value for each sample was calculated as OD1–OD2, where 
OD1 is the mean for the 2 even-numbered wells (coated with 
anti- Fasciola polyclonal antibodies), and OD2 is the mean for 
the 2 odd-numbered wells (coated with irrelevant polyclonal 
antibodies). 
 Limit of detection of the assay.  The limit of detection 
of the MM3-COPRO ELISA was calculated by testing 
serial dilutions of known amounts of  F. hepatica ESAs in 
 Table 1 
 Parasite content in the fecal samples ( N = 113) used to evaluate the sensitivity and specificity of MM3-COPRO ELISA* 
 F. hepatica Protozoa  S. stercoralis  H. nana  A. lumbricoides  E. vermicularis  T. trichiura TOTAL
 Fasciola hepatica 30 30
Protozoa 35 35
 Strongyloides stercoralis 1 2 3
 Hymenolepis nana 12 7 19
 Ascaris lumbricoides 3 2† 11 16
 Enterobius vermicularis 1† 4 5
 Trichuris trichiura 1 2 2 5
TOTAL 30 52 2 10 13 4 2 113
 * The presence of oocysts of  Cryptosporidium parvum and/or cysts and trophozoytes of  Giardia intestinalis or  Entamoeba histolytica was referred to here as “protozoa.” (†): indicates the pres-
ence of  Entamoeba coli cysts in the samples. 
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CoproGuard. Protein concentrations were determined with 
the MICRO BCA Protein Assay Kit (Pierce), with the BSA 
internal standard provided in the kit. The OD values obtained 
were used to produce a calibration curve with a Sigmoidal 
Logistic function (Microcal Origin 6.0 software, Microcal 
Software, Inc., MA), with which the MM3-recognized coproan-
tigen concentrations in stool samples were calculated. The 
concentration value obtained at the intersection point of the 
standard curve with the cut-off value of the MM3-COPRO 
ELISA was considered as the limit of detection of the assay. 
The concentrations of ESAs assayed ranged from 0.27 to 400 
ng/mL. The cut-off value was calculated as the mean OD plus 
4 standard deviations from the OD values obtained with the 
213 coprologically negative fecal samples. 
 The antigen concentrations in positive fecal samples were 
calculated by interpolating the mean OD values obtained 
in the MM3-COPRO ELISA in the standard logistic curve 
described previously (see also  Figure 4 ). 
 Statistics.  Multiple comparisons between groups were made 
with the Tukey-Kramer Multiple Comparison Test available 
in the Microcal Origin 6.0 software package. The relationship 
between  Fasciola egg output (Kato-Katz values) and OD 
values, measured by the MM3-COPRO test, was calculated by 
a linear correlation test with the same software package. 
 Ethical aspects.  The present study was approved by the 
Ethics Committee of the University of Santiago de Compostela. 
 RESULTS 
 MM3-COPRO ELISA parameters.  The results presented 
in  Figure 1 showed that the yield of coproantigens extracted 
from stool samples with CoproGuard was higher than classic 
extraction with distilled water, for all concentrations tested 
( P < 0.01). As expected, the results also showed that the use of 
shaking increased the OD values obtained when fecal samples 
were incubated at RT ( P < 0.01), but that this procedure was 
not relevant when samples were incubated overnight at 4°C 
( Figure 2 ). In addition, we did not observe any significant 
differences in OD values among samples incubated for 1 or 
2 hours at RT. 
 Stability of the  F. hepatica  coproantigens in preserved and 
non-preserved human fecal samples, and limit of detection 
of the MM3-COPRO ELISA.  The stability of  Fasciola 
coproantigens in human fecal samples was investigated in 
5 Kato-Katz  F .  hepatica positive samples (range 7.1 to 25.1 
ng/mL, determined at 1:10 v/v dilution in CoproGuard) 
maintained under different preservation conditions, including 
refrigeration and the use of biocides. The stability of the 
antigen was observed during a period of 5 weeks, except for 
samples preserved in CoproGuard, which were observed for 
17 weeks ( Figure 3 ). Comparison of the different preservation 
conditions revealed that even when maintained at 37°C, 
only the antigenicity of coproantigens in the samples diluted 
with CoproGuard did not vary throughout the observation 
period ( Figure 3 ). In contrast, biocides such as sodium azide 
and thimerosal did not preserve the antigenicity, as the start 
signal decreased to approximately 30% by the end of the 
observation period. When the samples were maintained at 
4°C, the  F. hepatica coproantigens retained about 70% of 
their initial antigenicity after 5 weeks. Significant differences 
( P < 0.01) between the OD values obtained for samples 
stored at 4°C and those obtained for samples stored with 
either sodium azide or thimerosal were observed. The OD 
signal produced by samples stored in CoproGuard at 37°C 
tended to be higher than that produced by the corresponding 
frozen controls ( Figure 3 ); this suggests that extraction of the 
 F. hepatica antigen from the fecal particles is facilitated at the 
higher temperature. 
 With respect to the total protein content in the  F. hepatica 
ESAs, a detection limit of 1.1 ng/mL was obtained for  F. hepat-
ica coproantigens diluted in CoproGuard, as deduced from 
 Figure 1.  Effect of the use of CoproGuard or distilled water for 
extraction of  Fasciola hepatica coproantigens from fecal samples 
mixed with  F. hepatica excretory-secretory antigens (ESAs) at differ-
ent concentrations. After antigen mixing, the samples were diluted 1:10 
in distilled water or in CoproGuard, centrifuged, and assayed by the 
MM3-COPRO ELISA, with an incubation time of 2 hr at room tem-
perature (RT) and orbital shaking (100 rpm). Vertical bars represent 
mean optical density (OD) values ± SD obtained for water extraction 
(white bars) and CoproGuard extraction (crossed bars). (*):  P < 0.01. 
 Figure 2.  Effect of the incubation time and shaking on the MM3-
COPRO ELISA detection of  Fasciola hepatica coproantigens. Pooled 
fecal samples containing 25 ng/mL of excretory-secretory antigens 
(ESAs) were diluted 1:10 in CoproGuard and tested by MM3-COPRO 
ELISA under the following incubation conditions: ( A ) 1 hr at room 
temperature (RT); ( B ) 2 hr at RT; ( C ) overnight at 4°C. Horizontal 
bars represent mean optical density (OD) values ± SD obtained for 
the different enzyme-linked immunosorbent assay (ELISA) condi-
tions assayed. White bars indicate orbital shaking (100 rpm); crossed 
bars indicate that orbital shaking was not used. (*):  P < 0.05; (**): 
 P < 0.01. 
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the intersection of the curve shown in  Figure 4 with the cut-
off value of 0.097 OD (horizontal line), previously calculated 
for the 213 samples from uninfected subjects (see  Figure 5 ). 
This detection limit was not influenced by the use of the 
CoproGuard as diluent/preservative, as the same response 
was obtained by diluting  F. hepatica ESAs in PBS (data not 
shown). 
 Sensitivity and specificity of the MM3-COPRO test.  The 
sensitivity and specificity of the MM3-COPRO ELISA were 
evaluated by comparing the OD values obtained with  Fasciola 
positive and  Fasciola negative samples, as shown in  Table 1 . For 
this, 30 coprologically positive  Fasciola samples and 83 samples 
from patients with parasitic infections other than  Fasciola 
were analyzed. These included 35 samples containing one or 
more pathogenic protozoans ( Giardia intestinalis ,  Entamoeba 
histolytica , and  Cryptosporidium parvum ) and 48 samples from 
patients reported to be infected by one or more helminth species 
( Strongyloides stercoralis ,  Ascaris lumbricoides ,  Trichuris 
trichiura ,  Enterobius vermicularis , and  Hymenolepis nana ). 
Among these, 15 samples corresponded to mixed infections 
of helminths and protozoans. Considering helminths alone, 22 
samples corresponded to patients with double infections. 
 The OD values obtained for individual  F. hepatica positive 
and negative fecal samples are shown in  Figure 5 . As can be 
seen, only positive samples with  F. hepatica eggs, as determined 
by the Kato-Katz technique, showed OD values above the cut-
off value. The mean value for positive samples was 14.83 ± 6.08 
ng/mL with a range from 4.5 to 25.5 ng/mL. Considering the 
obtained cut-off value of 1.1 ng/mL, the MM3-COPRO ELISA 
was able to discriminate as positive 100% of the positive 
fecal samples evaluated by the Kato-Katz technique. Indeed, 
among the  Fasciola positive samples, 27/30 samples (90%) 
presented OD values higher than 0.5 OD, and the lowest OD 
value obtained (0.37 OD) was 3.8 times higher than the cut-
off value. No differences were observed between the OD val-
ues corresponding to fecal samples from patients with parasitic 
infections other than  Fasciola and fecal samples classified as 
negative by microscopy ( P = 0.198). The mean egg content in 
the  F. hepatica positive samples was 130 ± 20 epg, with a range 
of 16 to 496 epg. There was no significant correlation between 
OD values of the  Fasciola positive samples and the egg output 
determined by the Kato-Katz technique ( Figure 6 ;  P = 0.12). 
 DISCUSSION 
 Antibody-based antigen detection of  Fasciola antigens may 
be advantageous over microscopic examination in terms of 
 Figure 3.  Analysis of the stability of  Fasciola hepatica coproanti-
gens in fecal samples under different storage conditions. Kato-Katz 
positive fecal suspensions containing 7.1 to 25.1 ng/mL of  F. hepat-
ica coproantigens were preserved in CoproGuard at 37°C (filled cir-
cles), 0.2% sodium azide in distilled water at room temperature (RT) 
(open triangles), 0.03% thimerosal in distilled water at RT (inverted 
triangles), or in distilled water without biocides, at RT (open circles) 
and at 4°C (open squares). The values shown were obtained from the 
mean optical densities (ODs) ± SDs of 5 individual fecal samples, 
and expressed as percentages with respect to control. Enzyme-linked 
immunosorbent assay (ELISA) determinations were carried out after 
up to 35 days, except for samples stored in CoproGuard (120 days). 
 Figure 4.  Calibration curve for the MM3-COPRO ELISA, 
obtained by plotting optical density (OD) at 492 nm against known 
concentrations (0.27–400 ng/mL) of whole  Fasciola hepatica excre-
tory-secretory antigens (ESAs) diluted in CoproGuard. Experimental 
OD values were adjusted to a sigmoidal (logistic) curve ( r 2 = 0.997) 
with the Microcal Origin 6.0 software package. The dashed line shows 
the cut-off value calculated for human fecal samples (OD = 0.097; see 
 Figure 5 ). 
 Figure 5.  Individual MM3-COPRO ODs obtained for individ-
ual  Fasciola hepatica positive and negative fecal human samples. ( A ) 
 Fasciola positive samples ( N = 30); ( B )  Fasciola negative samples from 
patients with other parasitic infections ( N = 83); ( C ) fecal samples from 
uninfected subjects ( N = 213). The dashed line shows the cut-off value 
(OD = 0.097) calculated for group C (mean OD plus 4 SD mean). 
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sensitivity and facility of use, particularly for epidemiologic 
studies in endemic areas. Moreover, because the release of 
 Fasciola coproantigens takes place before egg shedding, 20,25 
immunologic methods are also preferable to egg examination 
for detection of acute infections. However, because micro-
scopic examination is currently the only method that is 100% 
specific for diagnostic of human fascioliasis, we used the Kato-
Katz method as a “gold standard” for comparisons in the pres-
ent study. 
 In the last two decades, several ELISA methods based on 
the use of polyclonal and monoclonal antibodies have been 
reported to be useful for detection of ESAs from  F. hepatica 
and  F. gigantica in sheep and cattle feces. 19,21,26,27 Among these, 
the ELISA method based on the use of the ES78 monoclo-
nal antibody is the only method that has been successfully 
adapted for detection of human cases of fascioliasis, 20 although 
the method is not still available commercially. In this study, 
we optimized our previous MM3-COPRO ELISA method 
for detection of  Fasciola coproantigens in human stools. 21 
With CoproGuard as diluent/preservative, the test showed a 
detection limit of 1.1 ng/mL, which is more than one order 
lower than that reported for the ES78 sandwich ELISA 
(15 ng/mL). 20 This low detection limit enabled the MM3-
COPRO ELISA to detect 100% of positive samples in 1:10 
dilutions rather than the 1:4 dilutions used in the ES78 method. 
Because fecal antigen suspensions are dense at low dilutions, 
the use of more diluted antigen preparations is advantageous 
in terms of preventing obstruction of the aspiration systems 
and facilitating washing, particularly when automatic ELISA 
devices are used. The 1.1 ng/mL detection limit obtained for 
the MM3-COPRO ELISA in the present study was only 
slightly higher than that previously reported for bovine sam-
ples (0.6 ng/mL). 21 We attribute these small differences to the 
changes in the secondary ELISA reagents used with the MM3-
COPRO ELISA in the present study. 
 As regards the specificity of the MM3-COPRO ELISA, 
there were no problems related to cross-reactivity when com-
mon protozoans or helminths were present (see  Figure 5 ). 
This is not surprising because the specificity of the test mainly 
depends on the recognition of a single epitope by the MM3 
monoclonal antibody on the  Fasciola coproantigens, and the 
test already proved to be highly specific in previous studies 
with fecal samples of bovine and ovine origin. 21,28 Nevertheless, 
it will be necessary to carry out new studies in countries where 
other types of human trematodosis occur (e.g., opisthorchia-
sis, chonorchiasis, echinostomiasis) to confirm the usefulness 
of the MM3-COPRO assay in countries where these diseases 
are endemic. 
 As deduced from the results shown in  Figures 1 and  3 , the 
use of the CoproGuard diluent/preservative improved anti-
gen extraction, thus rendering the antigen more accessible to 
the anti- Fasciola capture polyclonal antibodies immobilized 
in the ELISA plate. This effect was probably partly mediated 
by the presence of tensoactive agents in the composition of 
the preservative. Moreover, CoproGuard was able to preserve 
the antigenicity of the fecal samples stored either at RT or 
at 37°C, which may be very useful for facilitating sample col-
lection and storage in endemic areas in tropical and subtropi-
cal countries where the high temperatures and long distances 
from hospitals may make adequate storage of samples diffi-
cult. To our knowledge, this is the first preservative capable 
of maintaining the antigenicity of  Fasciola coproantigens for 
ELISA determinations. 
 The antigenicity of  F. hepatica coproantigens was not pre-
served by biocides such as sodium azide or thimerosal, but 
degradation was lowered when samples were refrigerated at 
4°C. However, we observed that the antigens are relatively sta-
ble in some stools, as can be deduced from the large standard 
deviations observed for samples not preserved in CoproGuard 
( Figure 3 ). This suggests that degradation of MM3-recognized 
 Fasciola coproantigens depends on the presence of particular 
protease species, or other factors, which differ for each patient. 
Interestingly, in previous studies carried out with CoproGuard 
in our laboratory, we have observed that this preservative is 
also suitable for preserving  F. hepatica antigens in fecal sam-
ples from cattle and sheep (results not shown). 
 We have recently showed that the MM3-COPRO ELISA 
is also a reliable method of detecting  F. gigantica coproanti-
gens in fecal samples from experimentally infected sheep. 22 
Although most reported cases of human fascioliasis are caused 
by  F. hepatica , infections by  F. gigantica have been reported in 
countries such as Vietnam, Iran, and Egypt. 29–31 The fact that 
the MM3-COPRO ELISA can detect infections by both spe-
cies may be of great value to ensure diagnosis of human and 
animal fasciolosis in countries where  F. gigantica predomi-
nates, or where both species of  Fasciola are present. 
 One of the main difficulties with the current methods avail-
able for diagnosis of human fascioliasis is in detecting chronic 
infections or infections where only one or a few adult flukes are 
present in liver ducts (low-burden infections). In these cases 
egg shedding may be very low or absent, 2 which makes diag-
nosis by direct coprologic analysis difficult or impossible. This 
may be further complicated because egg excretion in  Fasciola 
infections is frequently intermittent. 11,25 Interestingly, the high 
sensitivity and favorable signal-to-noise ratio shown by the 
MM3-COPRO ELISA is very promising for detection of these 
cases, although field studies must be carried out in areas where 
fascioliasis is endemic to confirm the usefulness of the test. 
 Finally, it should be emphasized that quantitative analysis of 
 Fasciola eggs in feces (Kato-Katz) is frequently used for indi-
rect estimation of fluke burden before treatment of human 
infections, to prevent obstruction of biliary ducts in patients 
 Figure 6.  Plot of the number of eggs per gram in positive  Fasciola 
samples, determined by the Kato-Katz method, against the anti-
gen concentration measured by the MM3-COPRO ELISA. The lin-
ear regression analysis did not reveal any significant correlation 
( P = 0.12). 
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with heavy infections. 32,33 Fecal egg counting may also be used 
to monitor the efficiency of flukicide treatment. 34 In a previ-
ous study with MM3-COPRO ELISA in cattle, it was observed 
that the concentration of coproantigens in feces is also cor-
related with the number of flukes found in the livers of ani-
mals collected after slaughter, 21 and that this method is better 
than egg counting for evaluating the efficacy of flukicide treat-
ment. In the present study, we did not observe any correlation 
between egg shedding, measured by the Kato-Katz technique, 
and coproantigen concentration, measured by MM3-COPRO 
(see  Figure 5 ). This result contrasted with the positive cor-
relation reported by Espino and Finlany 20 for the ES78 test. 
One possible explanation for this discrepancy may be that the 
positive cases reported by Espino and Finlay probably cor-
responded to recent infections of less than a year of evolu-
tion, whereas our samples were from patients with chronic 
infections, in which egg excretion is probably more erratic. 
Moreover, the influence of the crowding effect on  Fasciola egg 
shedding should also be taken into account. 35 
 In summary, we provide experimental evidence that 1) the 
MM3-COPRO ELISA is highly specific and at least as sensi-
tive as the Kato-Katz method for diagnosis of  Fasciola infec-
tions in humans, and 2) the detected coproantigens can be 
stored at RT in CoproGuard. However, further field studies 
are necessary to evaluate whether the MM3-COPRO test is 
as sensitive as in sheep and cattle for detection of low-burden 
 Fasciola infections in humans. 
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Eggs per gram of faeces
Biomarker
Wistar
a b s t r a c t
Theemissionof Fasciola hepatica eggs in faeces is usually subject to oscillations along time in
animals as well as humans. Thus, looking for alternative biological markers reflecting eggs
shed per gram of faeces (epg) with lower oscillations may be useful. This study analyzes
the possible relationship between liver-fluke uterus area and epg. Uterus area (UA) devel-
opment of adult F. hepatica obtained at different days post infection (dpi) in a Wistar rat
modelwith isolates obtained from cattle, sheep, pigs and humans from the endemic human
fascioliasis zone of the Northern Bolivian Altiplano was analyzed and compared with the
number of eggs shed per gram of faeces as obtained through the Kato–Katz technique. The
morphometric study of the UA of liver flukes was carried out using image analysis soft-
ware. The multiple regression model shows that UA is dependent on dpi and isolate. The
evolution of UA vs dpi followed a damped model. This work shows a positive relationship
between liver-fluke UA and egg production. The complete absence of eggs in the uteri of
some parasite individuals at 300dpi was observed, which corresponds to the cessation of
egg shedding in the advanced chronic stage. The results obtained suggest the necessity to
characterize the isolates employed with regard to geographical as well as host origin in
fascioliasis studies in which egg production is used as a biological tag.
© 2011 Elsevier B.V. All rights reserved.
1. Introduction
Fascioliasis is an important human and animal dis-
ease caused by the trematode species Fasciola hepatica
and F. gigantica. At present, fascioliasis is emerging or
re-emerging in numerous regions. The highest human fas-
cioliasis prevalence and intensities are encountered in the
NorthernBolivianAltiplano (Mas-Comaet al., 1999),where
F. hepatica is the only fasciolid species present (Valero
et al., 1999), and Galba truncatula the only intermediate
snail host species (Bargues and Mas-Coma, 2005). In this
endemic region, sheep and cattle may be considered the
main reservoir host species, with pigs and donkeys play-
∗ Corresponding author. Tel.: +34 963544490; fax: +34 963544769.
E-mail address:madela.valero@uv.es (M.A. Valero).
ing a secondary role (Mas-Coma et al., 1997). Valero and
Mas-Coma (2000) have demonstrated that the viability
and infectivity of metacercariae experimentally obtained
from eggs shed by sheep, cattle, pigs and donkeys (i.e.
their respective isolates) are similar, and that adult liver
fluke body development in a common experimental ani-
mal model such as the Wistar rat (see Valero et al., 2000,
2003,2006a,b, 2008) isnot influencedby theanimal species
isolate source (Valero et al., 2001a). Uterus size vs age in
F. hepatica experimental adult isolates from the Northern
Bolivian Altiplano human hyperendemic area was stud-
ied in the Wistar model under standardized infective dose
conditions with a very long follow-up of up to 300 days
including the advanced chronic stage. This is the first study
on the relationship between uterus size and epg measured
by the Kato–Katz technique, a common diagnostic tool for
human helminth infections. Liver fluke uterus area vs time
0304-4017/$ – see front matter © 2011 Elsevier B.V. All rights reserved.
doi:10.1016/j.vetpar.2011.07.003
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has been modeled and the influence of different factors
such as isolate and advanced chronic stage has been ana-
lyzed.
2. Materials and methods
2.1. Liver flukes from experimentally infected rats
Only F. hepatica and G. truncatula specimens from the
Northern Bolivian Altiplanowere used. Snails shedding the
cercariae which gave rise to the metacercariae were from
a laboratory-reared strain (in Heraeus–Vötsch HPS 1500
and HPS 500 climatic chambers; experimental conditions:
temperature20 ◦C;photoperiod12/12h light/darkness;RH
90%). These snails were in turn monomiracidially infected
with F. hepatica eggs found in faeces of naturally infected
sheep, cattle, pigs and humans (Mas-Coma et al., 2001).
Thus 4 metacercariae isolates (cattle isolate, sheep iso-
late, pig isolate and human isolate) were obtained. These
metacercariae were stored in fresh water at 4 ◦C in dark-
ness until required. A total of 73 male Wistar (Iffa Credo,
Barcelona, Spain) aged 4–5 weeks were used for infec-
tion with metacercariae inoculated orally by means of
an orogastric syringe. Rats were housed in micro-isolator
boxes (Iffa Credo, Barcelona, Spain) and maintained in
a pathogen-free room, electrically heated with a 12/12h
light/darkness cycle (conditions in compliance with the
European Agreement of Strasbourg, 18 March 1986). Food
and water were provided ad libitum. Wistar rats were
divided into 4 sets according to the isolate: cattle (12 rats),
sheep (24), pig (19) and human (18), and were infected
with doses of 20 metacercariae each. Infection was estab-
lished by dissection and by detection of eggs in faeces.
Dissection was carried out at different days post-infection
(dpi) (between40and300dpi) to obtainwormsat different
stages ofmaturity, body size and gravid uteri. Infectionwas
confined to the commonbile duct from40dpi onwards. The
detection of eggs in faeceswas carried out by theKato–Katz
technique (Helm-Test®, AK test, AK Industria e Comercio
Ltda, Belo Horizonte, Brazil). Infection intensity was char-
acterized by the number of adults located in the liver. To
avoid possible effects of liver fluke burden in egg produc-
tion (Valero et al., 2006b) only material from low level
infections (≤4 liver flukes/rat) was used. Likewise, to pre-
vent possible host pathological effects in egg production
(Valero et al., 2000, 2006a) onlymaterial from rats without
lithiasis was used in this study.
2.2. Obtaining F. hepatica adults
The 73 rats were sacrificed at different times between
40 and 300dpi (see Table 1). The following fluke numbers
were obtained: (A) cattle isolate: 14 adults (50dpi: 1 in one
rat, 1 in another rat; 75dpi: 1, 1; 100dpi: 1, 1; 150dpi: 3, 1;
200dpi: 1, 1; 225dpi: 1, 1; average: 1.2±0.6, range: 1–3;
(B) sheep isolate: 51 adults (40dpi: 1, 1; 75dpi: 3, 3, 2, 3;
100dpi: 3, 2, 3, 1; 150dpi: 2, 1, 1, 1; 225dpi: 2, 2, 1; 300dpi:
3, 3, 3, 4, 2, 2, 2; average: 2.1±0.9; range 1–4; (C) pig iso-
late: 22adults (40dpi: 1, 1; 50dpi: 1, 1; 75dpi: 1, 1; 100dpi:
1, 1; 150dpi: 1, 1; 175dpi: 1, 1, 1; 200dpi: 2, 1; 225dpi: 2,
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isolate: 29 adults (50dpi: 1, 2; 75dpi: 1, 2; 100dpi: 1, 2;
150dpi: 1, 2; 175dpi: 2, 2, 2, 2, 3; 225dpi: 1, 2; 300dpi: 1,
1, 1; average: 1.6±0.6; range 1–3). Liver fluke adult spec-
imens were fixed with Bouin’s solution between slide and
cover-slip (placing the cover-slip on the parasite without
external pressure), stainedwithGrenacher’s borax carmine
andmounted inCanadabalsam(Panreac, Barcelona, Spain).
2.3. Follow-up study of eggs
Faecal pellets were collected from 73 rats fresh at 9:00
a.m. once a day from each animal and stored in closed
Petri dishes to avoid drying before examination. Faecal egg
detection was carried out by analyzing 1 Kato–Katz slide
per daily sample and epg was calculated. Analyses were
carried out daily from 30dpi up to 300dpi in the sheep and
human isolates, up to 225dpi in the cattle isolate, and up to
261dpi in thepig isolate. In this experiment itwas assumed
that deparasitization had not taken place, and the number
of adultflukesdidnotvary throughout theexperiment. This
premise is supported by the fact that the number of eggs
detected in faeces did not decrease abruptly in any rat ana-
lyzed. Egg production per worm was calculated dividing
eggsper gramof faecesby thenumberofwormsdetected in
the common bile duct. The average egg output in all shed-
ding per fluke and day and average of eggs per gram of
faeces shed between 10 and 25 days prior to the day when
corresponding UA data was obtained (=animal necropsy,
40, 50, 75, 100, 150,175, 200, 225, 261 and 300dpi).
2.4. Measurement techniques and data analyses
Adult uterus measurements were carried out accord-
ing to the method proposed for fasciolids by Valero et al.
(2001b), using a Computer Image Analysis System (CIAS),
including a computer work station-connected to a stereo-
microscope equipped with a digital colour video camera
(DX 20, Kappa) and employing image analysis software
(Image-Pro1Plus4.5,USA) (Valero et al., 2005). Flukeuterus
area (UA) measurements are expressed in mm2.
2.5. Analytical methods
Graphic plots of morphometric measurements against
age (t) provide empirical ontogenetic trajectories for F. hep-
atica adults (Valero et al., 2006b). In the present study,
an ontogenetic trajectory describes the change of UA as
a function of its age in days. Ontogenetic trajectories are
obtained as solutions of differential equations that express
mathematical statements of growth rules of morphologi-
cal variables (Alberch et al., 1979). These growth rules are
explicit expressions of the derivative of the morphological
variable referring to age (t). The solutions of these differ-
ential equations do not only contain parameters included
in the growth rule but also initial conditions. A prelim-
inary analysis of the results indicated that a “damped”
model gives the best representation of thedata. ForUA, two
models for ontogenetic trajectories, saturated (a) (y= ym
[1− z0 exp(−kt)) and logistic (b) (y= ym/[1 + z0 exp(−kt)])
were verified, where ym is the maximum value attained
by UA, and z0 and k are constants or parameters of the tra-
jectories; z0 is related to the initial value of uterus area (y),
i.e. y0 at t=0, and exhibits a different expression in each
case. The parameter k is a growth rate in either case. The
Mc Curve fit statistics packagewas used to fit themodels to
data in place of the iterative trials as suggested by De Renzi
(1988). This procedure minimizes the least square sum of
residuals (sse), i.e. (yi− y¨i)2, with the rawdata yi’s and their
estimates y¨i’s.
2.6. Statistical analyses
For a proper description, some transformations were
necessary. Egg counts were considered after converting
individual values to logarithms (log e) with the (n+1)
transformation ln(epg) (Stephenson, 1987). Bivariant cor-
relations (Pearson’s correlation)were calculated forUAand
ln(epg). The analysis of the relation between UA obtained
for a determined day p.i. and the transformed ln(epg)
count (average of eggs per gram of faeces shed between
10 and 25 days prior to the day when corresponding
UA data was obtained) was carried out using one-way
ANOVA. Effect–size samples were controlled by power
(Lenth, 2009).Adjustednon-lineal curveswere testedusing
r2 and sse. GRAPHPAD PRISM 5.0 was used to represent
ontogenetic trajectories. To analyze the factors influencing
the UA at different dpi, multiple regression analysis using
UA as dependent variable was performed. The variables
were dpi and type of isolate. Data processing was done
with PASW Statistics 17 software. Results were considered
statistically significant when P<0.05.
3. Results
3.1. Follow-up study of eggs and uterus area
(40–300dpi)
The evolution of average epg/adult/day obtained for
each isolate vs time is represented in Fig. 1. The results
showed that faecal egg counts have strong day-to-day fluc-
tuations in rats in all isolates. The ANOVA analysis of the
correlation of UA vs ln(epg): (a) epg average shed between
10 day prior to the day when corresponding UA data was
obtained; (b) epg average shed between 25 days prior
to the day when corresponding UA data was obtained.
The ANOVA correlation only proved to be statistically sig-
nificant when UA was correlated with ln(epg) average
of the last 10 days (cattle: F=10.233, P<0.033, power:
42%; sheep: 11.215, 0.020, 99%; pig: 11.215, 0.020, 52.2%;
and human: 7.444, 0.041, 25.5%). The evolution of the UA
according to dpi in rats inoculated with the 4 isolates and
10 days prior to day when corresponding UA data was
obtained are shown in Table 1 and Fig. 2, respectively.
3.2. Uterus area growth
Themultiple regressionmodel shows that UA is depen-
dent on dpi (P<0.000) and isolate (P<0.000). The general
analysis of all parasite individuals aged 225–300dpi
shows an elevated dispersion of UA, which usually tends
to decrease up to 225dpi. Interestingly, the complete
absence of eggs in the uteri of some parasite individu-
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Fig. 1. Eggs per gram of faeces (epg)/adult/day along days post infection obtained in the four Fasciola hepatica isolates analyzed: (A) cattle isolate (); (B)
sheep isolate (△); (C) pig isolate (♦) and (D) human isolate (©). Each symbol represents the average for each day analyzed. The bars represent SD.
Human

































































Fig. 2. Evolution of liver-fluke uterus area (UA) and eggs per gram of faeces (epg)/adult along days post infection in the four Fasciola hepatica isolates
analyzed: (A) cattle isolate; (B) sheep isolate △; (C) human isolate© and (D) pig isolate ♦. Each symbol represents the average for each day analyzed. UA:
each symbol represents the average UA of each liver-fluke group at different days. Epg: each symbol represents epg average shed between 10 days prior
to the day when corresponding UA data was obtained; , UA; - - -, epg/adult.
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Fig. 3. Ontogenetic trajectory of uterus area (UA) (in mm2) as a function of time (days) with the saturated model y= ym[(1− z0exp(−kt)] in adults obtained
in experimentally infected Wistar rats in the four Fasciola hepatica isolates analyzed: (A) cattle isolate (); (B) sheep isolate (△); (C) pig isolate (♦) and (D)
human isolate (©). Each symbol represents the average UA in the corresponding day.
als at 300dpi was observed (8%), which corresponds to
the cessation of egg shedding in the advanced chronic
stage. Hence, UA average development in each isolate was
analyzed exclusively between 40 and 225dpi in liver-
flukes. UA follows a damped model until 225dpi, and
thereafter decreases. The ontogenetic trajectories of liver-
fluke UA measures were studied. The results obtained
are reflected in Fig. 3. Table 2 compares the fit of the
two models for each biometric measure. The saturated
model (Eq. (a)) fits better than its logistic counter-
part.
4. Discussion
The determination of epg shed by helminths is a fre-
quently applied approach in experimental assays. For
instance, the efficacy of anthelmintic treatment is usu-
ally experimentally determined by the reduction of faecal
egg counts (McConville et al., 2009). Apart from reducing
fluke burdens, some vaccines can elicit a concurrent reduc-
tion in parasite egg production (Hillyer, 2005; Piedrafita
et al., 2010). Practically applied studies will benefit from
an increased precision, since reliable estimates of fae-
Table 2
Comparison between the saturated and logistic models applied to Fasciola hepatica adults experimentally obtained in Wistar rats (zo , k constants that
appear in both models, r2 correlation coefficient, ym maximal value of uterus area in both models, sse least-squares residual in both models).
Isolate ym z0 ± SE −k± SE r
2 sse
Logistic model (b)
Cattle 8.5 30.913 ± 2.0734 0.045 ± 0.000 0.99 0.0014
Sheep 9.8 40.587 ± 199.829 0.086 ± 0.064 0.90 0.8533
Pig 8.9 21.790 ± 16.467 0.048 ± 0.012 0.97 0.7668
Human 13.1 29.814 ± 45.167 0.046 ± 0.019 0.88 9.2548
Saturated model (a)
Cattle 11.6 1.390 ± 0.001 0.0103 ± 0.000 0.99 0.00002
Sheep 9.8 720.424 ± 4750.640 0.100 ± 0.087 0.94 0.47784
Pig 9.0 1.937 ± 0.332 0.022 ± 0.003 0.98 0.28987
Human 13.3 3.0043 ± 1.1650 0.025 ± 0.006 0.93 5.22824
ay= ym(1− z0 exp(−kt).
by= ym/(1 + z0 exp(−kt))
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cal egg counts are essential in this context. Commonly
employed microscopic techniques in quantitative diagno-
sis of helminth eggs are very specific but rather insensitive.
Amounts of epg in faeces are often very variable (data else-
where) and various factors have to be taken into account.
However, the technique applied in the epg count is of par-
ticular importance (Ebrahim et al., 1997). The Kato–Katz
technique is routinely employed to diagnose and quantify
the burden in the majority of human helminthiases (Katz
et al., 1972). The simplicity of the test and its ease of per-
formance under field conditions have ensured its universal
application. However, the sensitivity of a single exami-
nation may be very low due to a combination of factors
such as: (i) small amounts of stool in each examination;
(ii) variation in the distribution of eggs within a single
stool specimen; (iii) differences inwormburdens; (iv) daily
fluctuations within an individual due to faecal production
and consistency; (v) daily fluctuationswithin an individual
related to oviposition patterns of the parasite (Hall, 1982;
DeVlaset al., 1992;Engels et al., 1997;Utzingeret al., 2001).
Moreover, the consistency of the faecal material depends
upon the parasite burden, i.e. moderate to heavy infections
may cause diarrhoea (Teesdale et al., 1985; Feldmeier and
Poggensee, 1993). Also, the amounts of fibre or fat in the
host’s diet have to be taken into account. These factors limit
the value of the quantitative techniques applied when cal-
culating epg, thus posing potential sources of inaccuracy
and therefore compromise experimental assays (Ebrahim
et al., 1997; Utzinger et al., 2001). Consequently, little con-
fidence can be attached to a single epg quantification, in
turn numerous samples are required for the detection of
differences between groups of hosts or parasites.
Recent years have seen a dramatic resurgence of
fascioliasis which has been attributed to, among other
factors, climate change (Mas-Coma et al., 2009b). More-
over, resistance to commercially available fasciolicides
such as triclabendazole (Fasinex) and nitroxynil (Trodax)
(Overend and Bowen, 1995; Fairweather and Boray, 1999;
Gaasenbeek et al., 2001) has been widely reported. There-
fore, further experimental studies on drug or vaccine
efficacy are pressing and are currently being carried out.
In these studies, drug or vaccine efficacy is usually deter-
mined using the decrease in egg production as biomarker.
Nevertheless, the emission of F. hepatica eggs in faeces is
usually subject to oscillations along time in animals as well
as humans (Valero et al., 2002; El-Morshedy et al., 2002). To
avoid these inaccuracies, some authors have quantified the
condition of the reproductive structures (testes, vitellaria,
ovary and uterus) according to a scoring scheme (Hanna
et al., 2006; McConville et al., 2009).
This work shows a relationship between liver-fluke UA
and egg production, which is consistent with similar find-
ings in other helminths. A positive correlation between
worm size and egg production is commonly described in
nematodes of animals (Skorping et al., 1991; Stear et al.,
1997; Stear and Bishop, 1999; Richards and Lewis, 2001;
Irvine et al., 2001; Dezfuli et al., 2002; Ugland et al., 2004)
as well as in Ascaris lumbricoides infections of humans
(Sinniah and Subramaniam, 1991; Walker et al., 2009). For
instance, inA. lumbricoides, a relationshipbetweeneggpro-
duction and weight, length and diameter of worms was
described (Sinniah and Subramaniam, 1991). Interestingly,
after female A. lumbricoidesworms had reached their max-
imum growth, there was a decline in egg production, just
as seen here in F. hepatica.
Fasciolid adults follow an established development pro-
cess in their definitive hosts (Valero et al., 2001a, 2006b;
Periago et al., 2008). In F. hepatica, the length of the uterus
indifferent stagesofdevelopment correlateswithbodysize
(Neuhaus, 1978). In populations from naturally infected
cattle, sheep and pigs from the Northern Bolivian Alti-
plano, UA vs body area follows a damped model (Valero
et al., 2001b). In this experimental study it was demon-
strated that F. hepatica UA development along time fitted
a saturated model, while body growth follows a logistic
model characterized by two phases (Valero et al., 1998):
the ‘exponential’ part of logistic growth corresponds to
body development during migration through the abdomi-
nal cavity and liver parenchyma as well as to development
and sexual maturation in the biliary duct system up to
the onset of egg production. From this moment onwards,
development follows the ‘saturated’ part of logistic growth
with a considerable persistenceof bodygrowthafter sexual
maturity. Oviposition is the inflection point of the logistic
growth marking the end of the ‘exponential’ period and
the beginning of the ‘saturated’ period, i.e. the beginning
of egg shedding to the external environment constitutes
the biological factor thatmarks the inflection point (Valero
et al., 2006b). This work shows for the first time that the
UA follows a saturated model vs dpi and also agrees with
the above-mentioned studies on body size development,
i.e. after egg shedding liver-fluke body area and UA follow
a synchronized growth model.
The variability inherent in different F. hepatica iso-
lates and the relationship between these differences vs the
fecundity of the parasite has been analyzed (Walker et al.,
2006). These authors compared in vitro egg production of
two distinct isolates, namely Oberon and Fairhurst, and
showed that the latter produced four times more eggs. In
the present study differences in egg production between
the isolates analyzed were also detected. These results
imply the necessity to characterize the isolates employed
in fascioliasis studies in which egg production is used as a
biological tag.
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E-mail address: madela.valero@uv.es (M.A. ValeroFascioliasis is a zoonotic parasitic disease caused by Fasciola hepatica and Fasciola gigantica. Of both spe-
cies, F. hepatica is the only one described in the Americas, mainly transmitted by lymnaeid snail vectors of
the Galba/Fossaria group. Human fascioliasis endemic areas are mainly located in high altitude areas of
Andean countries. Given the necessity to characterize F. hepatica populations involved, the phenotypic
features of fasciolid adults infecting sheep present in human fascioliasis endemic areas were analysed
in the Cajamarca Valley and Mantaro Valley (valley transmission patterns) and the northern Bolivian Alti-
plano (altiplanic transmission pattern). A computer image analysis system (CIAS) was applied on the
basis of standardized measurements. The aforementioned highland populations were compared to stan-
dard lowland natural and experimental populations of European origin. Liver ﬂuke size was studied by
multivariate analyses. Two phenotypic patterns could be distinguished in F. hepatica adult size: the valley
pattern (Cajamarca and Mantaro, Peru) and the altiplanic pattern (northern Altiplano, Bolivia). Results
showed that the Andean valley population and European standard populations presented a phenotypic
homogeneity. The Altiplano population showed a large size range with a pronouncedly lower minimum
size indicating that uterus gravidity is reached at a smaller size than in valley populations. The results of
this study demonstrate that there is no apparent relationship between the shape of fasciolid adults with
regard to altitudinal difference or geographical origin and that allometry-free shape appears as a more
stable trait than size in fasciolid species. Results are analysed in terms of intensity/crowding effect
aspects and permanent/seasonal transmission characteristics.
 2012 Elsevier B.V. All rights reserved.1. Introduction
Fascioliasis is a parasitic disease of different epidemiological,
pathological and control characteristics depending on the causal
agents, Fasciola hepatica and Fasciola gigantica. Classically it has
been accepted that F. hepatica is present worldwide, while the dis-
tribution of the two species overlaps in many areas of Africa and
Asia (Mas-Coma et al., 2005, 2009). Their speciﬁc identiﬁcation
poses problems in the aforementioned overlap areas. It has been
demonstrated that differentiation of both species cannot be made
by traditional diagnostic methods (Marcilla et al., 2002; Valero
et al., 2009) but only by adult morphometric markers (Periago
et al., 2006, 2008; Ashraﬁ et al., 2006), molecular tools (Marcilla
et al., 2002) and DNA sequences (Mas-Coma et al., 2009).ll rights reserved.
x: +34 963 544 769.
).
183Of both species, F. hepatica is the only one described in the
Americas (Mas-Coma et al., 2009), mainly transmitted by lymnaeid
snail vectors of the Galba/Fossaria group (Bargues et al., 2007). Hu-
man fascioliasis cases have been reported from many Latin Amer-
ican countries, including high impact areas, described in the last
two decades, focusing on Andean countries, above all on high
and very high altitude areas where fascioliasis transmission ap-
pears to be enhanced as a consequence of the adaptation of both
the liver ﬂuke and its lymnaeid vectors to the extreme altitudinal
environmental conditions (Mas-Coma et al., 2001).
In Andean countries, fascioliasis is a serious public health prob-
lem. Human fascioliasis hyperendemic areas have been described
in the northern Altiplano of Bolivia (Esteban et al., 1997a,b, 1999;
Mas-Coma et al., 1999) and also Peru (Esteban et al., 2002), as well
as in Andean valleys such as the Peruvian valleys of Cajamarca (Ortiz
et al., 2000; Hillyer et al., 2001; Espinoza et al., 2007; Gonzalez
et al., 2011) and Mantaro (Stork et al., 1973; Marcos et al., 2004).
404 M.A. Valero et al. / Infection, Genetics and Evolution 12 (2012) 403–410Within the human fascioliasis high altitude transmission pat-
tern related to F. hepatica, two different subpatterns of the general
Andean pattern have been distinguished in South America accord-
ing to physiographic and seasonal characteristics (Mas-Coma,
2005; Mas-Coma et al., 2009):
(a) The altiplanic subpattern, with very high prevalences and
intensities in humans, endemicity distributed throughout
an area of homogeneous altitude and transmission along
the entire year due to high evapotranspiration rates leading
lymnaeid vectors to concentrate in permanent water bodies
(Mas-Coma et al., 1999), e.g. the northern Bolivian Altiplano
(Esteban et al., 1997a,b, 1999) and the Peruvian Altiplano of
Puno (Esteban et al., 2002).
(b) The valley subpattern, with very high prevalences but some-
what lower intensities in humans, endemicity distributed
throughout an area of heterogeneous altitude, including
prevalences correlating with altitude (Gonzalez et al.,
2011), and seasonal transmission related to climate (Claxton
et al., 1997, 1999),e.g. the valleys of Cajamarca and Mantaro,
both in Peru.
In recent years, the availability of a very effective drug against
fascioliasis, triclabendazole (Savioli et al., 1999), prompted WHO
to launch a worldwide initiative against human fascioliasis
(WHO, 2007, 2008). This initiative focuses on human fascioliasis
endemic areas presenting different epidemiological situations
and transmission patterns (Mas-Coma, 2005). Bolivia and Peru
were selected for priority intervention due to the very large public
health problem posed by this disease. Various pilot schemes were
designed to assess the best control strategies according to the dif-
ferent epidemiological situations and transmission patterns. The
northern Bolivian Altiplano and Cajamarca province were selected
as models of the altiplanic and valley patterns of human hyperen-
demic areas, respectively.
The present study is a further step in the characterization of
fascioliasis in human hyperendemic areas of the valley pattern, fur-
nishing the baseline on which to design appropriate control mea-
sures for each South American disease transmission pattern.
Although metacercarial infectivity does not appear to differ in iso-
lates from different livestock species (Valero andMas-Coma, 2000),
the animal species affected pronouncedly inﬂuences the pheno-
type of both adult stage and egg of the liver ﬂuke, mainly due to
the different size of the liver duct microhabitat (Valero et al.,
2001a, b, 2002, 2009). Therefore, a computer image analysis sys-
tem (CIAS) method (Valero et al., 2005) was applied to ﬂukes from
sheep only, considering the typical host species for F. hepatica
worldwide. Studies were performed on the basis of standardized
measurements known to be useful for the differentiation of both
fasciolid species (Periago et al., 2006). To complete the character-
ization, all these South American highland populations were com-
pared to standard lowland populations of (i) F. hepatica natural
infection from Valencia, Spain, and (ii) F. hepatica experimental
adults from Bialowieza National Park, Poland.2. Materials and methods
2.1. Parasites
Post-mortem examinations were carried out on all sheep (Ovi-
saries) immediately after death. The liver ﬂuke in the deﬁnitive host
presents parasite migration from the liver parenchyma to the adult
location in the bile duct. Valero et al. (2006) modelled through a lo-
gistic model the liver ﬂuke body growth, characterized by two
phases: the ‘exponential’ part of logistic growth corresponding to18body development duringmigration in the abdominal cavity and li-
ver parenchyma as well as to development and sexual maturation
in the biliary duct system up to the onset of egg production. From
this moment, development follows the ‘saturated’ part of logistic
growth, i.e. entry into the bile duct inducesmaturation and egg pro-
duction. In this sense, bile ducts were examined and only ﬂukes
inside were analysed. In this study only fasciolids with eggs in the
uteri were included (n = 542). The samples analysed in each of the
ﬁve geographical areas included the largest possible worm variabil-
ity (different stages of maturity, body size and gravid uteri). Adult
worms were ﬁxed in Bouin´s solution between slide and coverglass
but without coverglass pressure to avoid distortion. The specimens
were stained with Grenacher´s borax, differentiated, dehydrated
and ﬁnally mounted in Canada balsam.
2.1.1. Natural F. hepatica infections
All the sheep analysed were adults originating from areas close
to the slaughterhouses where the parasite material was obtained:
(A) Material from Cajamarca Valley (Peru): F. hepatica adults
from 8 Merino sheep (130 worms; 2,2,12,15,18,21,28,32
worms per sheep, respectively), slaughterhouse of Rodicio.
(B) Material from Mantaro Valley (Peru): 47 F. hepatica adults
from the 5 autochthonous Junin breed (47 worms; range:
3,5,8,10,21), slaughterhouses of Huayucachi, Pachacayo and
Huancayo.
(C) Material from the northern Altiplano (Bolivia): F. hepatica
adults from 12 Merino sheep (201 worms; 6,8,9,12,15,18,
19, 22,22,26,30), slaughterhouse of Batallas (altitude around
4000 m).
(D) Material from the Mediterranean coast (Spain): F. hepatica
adults from 5 Merino sheep (37 worms, range: 2,7,8,10,10),
slaughterhouse of Massamagrell (close to sea level).
2.1.2. Experimental infections with F. hepatica
Fasciola hepatica metacercariae were experimentally obtained
as previously described (Mas-Coma et al., 2001). Fasciola hepatica
and its snail host Galba truncatula originated from Bialowieza, Po-
land and Valencia Albufera, Spain, respectively. The experimental
group included four four-to-ﬁve-week-old sheep (Guirra autoch-
thonous breed) bred and kept close to sea level. The animals were
infected per os with 200 F. hepatica metacercariae, respectively.
Food and water were provided ad libitum. Permission for animal re-
search was obtained from the Ethics Animal Research Committee
of Valencia University. Animal ethics guidelines were strictly ad-
hered to in the care of the animals. Necropsy was carried out
40 weeks post-infection. A total of 127 (20, 28, 34 and 45 worms
per sheep, respectively) F. hepatica adults was recovered.
2.2. Measurement techniques
All standardised measurements of adults were made according
to methods proposed for Fasciolidae by Valero et al. (2005) and
Periago et al. (2006, 2008) (Fig. 1):
(A) Lineal biometric characters: body length (BL), maximum
body width (BW), body width at ovary level (BWOv), body
perimeter (BP), body roundness (BR), cone length (CL), cone
width (CW), maximum diameter of oral sucker (OS max),
minimum diameter of oral sucker (OS min), maximum
diameter of ventral sucker (VS max), minimum diameter of
ventral sucker (VS min), distance between the anterior end
of the body and the ventral sucker (A-VS), distance between
the oral sucker and the ventral sucker (OS-VS), distance
between the ventral sucker and the union of the vitelline
glands (VS-Vit), distance between the union of the vitelline4
Fig. 1. Standardised measurements in gravid adults of Fasciola hepatica.
M.A. Valero et al. / Infection, Genetics and Evolution 12 (2012) 403–410 405glands and the posterior end of the body (Vit-P), distance
between the ventral sucker and the posterior end of the
body (VS-P), pharynx length (PhL), pharynx width (PhW),
testicular length (TL), testicular width (TW), testicular
perimeter (TP).
(B) Areas: body area (BA), oral sucker area (OSA), ventral sucker
area (VSA), pharynx area (PhA), and testicle area (taking
both testes together, TA).Fig. 2. Factor map corresponding to Fasciola hepatica specimens from naturally infected
Valencia (Spain) and experimentally infected sheep (Fasciola hepatica = Polish isolate).
components. Each group is represented by its perimeter.
185(C) Ratios: body length over body width (BL/BW), body width at
ovary level over cone width (BWOv/CW), oral sucker area
over ventral sucker area (OSA/VSA), and body length over
the distance between the ventral sucker and the posterior
end of the body (BL/VS-P).
The body roundness measurement (BR = BP2/4pBA) was used to
quantify the body shape. It is a measurement of how circular an
object is (the expected perimeter of a circular object divided by
the actual perimeter). A circular object will have a roundness of
1.0, while more irregular objects will have larger values (Anony-
mous, 2001; Ohnuma et al., 2006).
Measurements were made with a microscope and images cap-
tured by a digital camera (Nikon Coolpix) and analysed by image
analysis software (ImagePro plus version 5.0 for Windows, Media
Cybernetics, Silver Spring, USA).2.3. Numerical methods
Morphological variation is quantiﬁed by geometrical morpho-
metrics (Rohlf and Marcus, 1993), a technique offering an estimate
of size by which different axes of growth are integrated into a sin-
gle variable (the ‘‘centroid size’’; Bookstein, 1989). The estimate of
size is contained in a single variable reﬂecting variation in many
directions, as many as there are landmarks under study, and shape
is deﬁned as their relative positions after correction for size, posi-
tion and orientation. With these informative data, and the corre-
sponding software freely available to conduct complex analyses,
signiﬁcant biological and epidemiological features can be quanti-
ﬁed more accurately (Dujardin, 2008). Current statistical tech-
niques in morphometrics make it possible to test the null
hypothesis of conspeciﬁc populations being simply the allometric
extension of each other, provided a common allometric trend is
identiﬁable (Rohlf and Marcus, 1993; Klingenberg, 1996; Dujardin
and Le Pont, 2004). Morphometric data was explored using multi-
variate analysis. Size-free canonical discriminant analysis was used
on the covariance matrix of log-transformed measurements to as-
sess morphometric variation between samples. This technique
consists of removing the effect of within-group ontogenetic varia-
tion, regressing each character separately on the within-group ﬁrst
principal component, which is a multivariate estimate of size (Dos
Reis et al., 1990). Analyses were carried out using BAC v.2 software
and the PAD (Permutaciones, Analisis Discriminante) module of
the CLIC program (http://www.npl.ird.fr/morphometrics)
(Dujardin, 2002; Dujardin and Le Pont, 2004; Dujardin et al.,
2010). Values were considered statistically signiﬁcant whensheep from the Cajamarca and Mantaro valleys (Peru), northern Altiplano (Bolivia),
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187P < 0.05. Non-redundant measurements were used (i.e. one is not
included in another one): BL, BW, BP, OS max, OS min, VS max,
VS min, A-VS, VS-Vit, Vit-P, PhL, PhW and TL, where at least one
dimension of the most important morphological structures was in-
cluded. These remaining variables were all signiﬁcantly correlated
with the ﬁrst principal component (PC1), which contributed 59% to
overall variation. PC1 could therefore be accepted as a general indi-
cator of size (Bookstein, 1989), so that the resulting factor maps
(Fig. 2) clearly illustrate global size differences in the populations
analysed. The inﬂuence of within-group allometries was then
removed by using variables equivalent to an orthogonal projection
of the data onto the ﬁrst common principal component (i.e. all the
common principal components except the ﬁrst one). The resulting
‘‘allometry-free’’, or size-free, variables were submitted to a canon-
ical variate analysis (CVA), and Mahalanobis distances were
derived (Mahalanobis, 1936; Dujardin and Le Pont, 2004). Size
variation was based on one variable only, i.e. the ﬁrst common
principal component, thus the univariate equivalent of Mahalan-
obis distance known as Pearson’s ‘‘Coefﬁcient of Racial Likeliness’’
(Dujardin and Le Pont, 2004) was used to estimate its variation.
The statistical signiﬁcance of relationships of these distances with
altitudinal variation and geographic distances (km) was explored
by a non-parametric test. Additionally, the statistical signiﬁcance
of relationships of average of PC1 of liver ﬂukes from each sheep
and ﬂuke burden was explored by a non-parametric test.3. Results
The morphometric values of F. hepatica from the highlands of
the Cajamarca valley, Mantaro valley and Northern Bolivian Alti-
plano, as well as from the lowlands of Valencia and F. hepatica
experimental material are shown in Table 1. The results shown
in Table 1 are the ﬁrst phenotypic description of the F. hepatica
adult from Peru. Furthermore, the present study shows, for the ﬁrst
time, the results of body roundness (BR) of F. hepatica populations
from sheep. Within-comparison of the values of the F. hepatica
populations shows a general overlap between them, regardless of
the geographical area of origin.
The size of liver ﬂuke adults was studied by multivariate anal-
yses. A scatter plot of the ﬁrst two principal components (PC) is
shown in Fig 2. The ﬁrst common principal component (CP1) of
the ﬁve populations can be interpreted as a measure of overall size.
The results show that F. hepatica populations of the Cajamarca and
Mantaro valleys (Peru), Spain as well as the experimental F. hepat-
ica standard population have a similar maximum size and similar
minimum size. On the contrary, the northern Bolivian Altiplano
population shares its maximum size with the aforementioned F.
hepatica populations but presents a lower minimum size (Fig. 2).
Our results indicate that liver ﬂukes from Peru and Europe (natural
and experimental) have a common minimum size from which the
parasites begin to be gravid, however, this minimum size is smaller
in Bolivian liver ﬂukes.
There was no consistent relationship between the size-free pat-
tern of variation and altitudinal differences (Fig. 3). No signiﬁcant
correlation between Mahalanobis distances and geographic dis-
tances (in km) was detected (data not shown). No signiﬁcant cor-
relation between CP1 liver ﬂuke average and worm burden was
detected (data not shown).4. Discussion
Quantitative morphological variation informs about both genet-
ic variation and external inﬂuences (Dujardin et al., 2009). In the
case of endoparasites, it is necessary to distinguish between macro
habitat (external environment according to geography) and
Fig. 3. Plots of the pairwise Mahalanobis distances derived from allometry-free variables (vertical axis) against the corresponding altitudinal differences (horizontal axis in
m). The straight line represents the linear regression prediction. 1 = naturally infected sheep from Valencia (Spain) – experimentally infected sheep (Polish isolate); 2 =
naturally infected sheep from the Cajamarca – Mantaro valleys (Peru); 3 = naturally infected sheep from the Mantaro valley (Peru) – northern Altiplano (Bolivia); 4 = naturally
infected sheep from the Cajamarca valley (Peru) – northern Altiplano (Bolivia); 5 = naturally infected sheep from the Cajamarca valley (Peru) – Valencia (Spain); 6 = naturally
infected sheep from the Cajamarca valley (Peru) – experimentally infected sheep (Polish isolate); 7 = naturally infected sheep from the Mantaro valley (Peru) – Valencia
(Spain); 8 = naturally infected sheep from the Mantaro valley (Peru) – experimentally infected sheep (Polish isolate); 9 = naturally infected sheep from the northern Altiplano
(Bolivia) – experimentally infected sheep (Polish isolate); 10 = naturally infected sheep from the northern Altiplano (Bolivia) – Valencia (Spain).
408 M.A. Valero et al. / Infection, Genetics and Evolution 12 (2012) 403–410microhabitat (parasitized organ inside the host). The geographical
environments analysed in this study included highland and low-
lands. It is worth mentioning that in a very high altitude environ-
ment, oxygen and air density decrease, temperature and humidity
are low, and there is an increase in radiation. These environmental
factors exert an inﬂuence on mammals, so that animals born and
living at very high altitude show morphological and physiological
characteristics different from those shown by mammals inhabiting
low altitudes (Jackson et al., 1987; Frisancho and Frisancho, 1992).
The results of this study show that there is no apparent rela-
tionship between the shape of fasciolid adults with regard to alti-
tudinal difference or geographical origin. However, results
obtained in the principal component analysis show that Andean
valley populations and European F. hepatica natural and experi-
mental lowland populations present a phenotypic homogeneity.
The results show that corporal minimal size of gravid adults is sim-
ilar in the material proceeding from Peruvian Valley and lowland
Europe. On the other hand, the Altiplano population shows a lower
minimum size when the adult reaches gravidity. This means that F.
hepatica from the Altiplano reaches uterus gravidity earlier in its
growth within the liver microhabitat (Fig. 2).
Additionally, uterus size and body size have been demonstrated
to be proportional (Valero et al., 2001b). It may be concluded that
ﬂukes from the Cajamarca andMantaro valleys present a minimum
uterus size larger than that in ﬂukes from the Altiplano population.
Thus, the present results demonstrate that ﬂukes from Andean
endemic areas may also be catalogued according to two pheno-
typic patterns:
– The valley pattern: Andean human endemic areas of high alti-
tude (Cajamarca: 2500–3100 m; Mantaro: 3400–3500 m)
where F. hepatica egg production by the ﬂuke oogenotop and
minimum body size when reaching gravidity are similar to
those in lowland populations of Europe (Spain, Poland).
– The altiplanic pattern: Andean human endemic areas of very
high altitude (northern Altiplano: 3800–4100 m) where F.
hepatica egg production by the ﬂuke oogenotop begins earlier
and minimum body size when reaching gravidity is smaller
than in lowland populations of Europe (Spain, Poland) as well
as in Andean valleys (Cajamarca, Mantaro).
In other organisms such as insects, allometry-free shape may
require important external changes to be signiﬁcantly modiﬁed.
For instance, in sandﬂies Dujardin and Le Pont (2004) detected that
allometry-free variation was closely associated with altitudinal18differences indicating its possible link with temperatures and/or
vegetation cover. This ﬁnding is in contrast with the results ob-
tained in our study, in which allometry-free shape appears as a
more stable trait than size in fasciolid species in conditions of dif-
ferent altitudes and latitudes.
Several mammals may serve as deﬁnitive hosts for F. hepatica
although there is considerable variation in the susceptibility and
pathology according to species (Mas-Coma et al., 2009). By using
an allometric model, it was shown that the deﬁnitive host species
(sheep, cattle, pig) decisively inﬂuences the size of F. hepatica
adults, although these inﬂuences disappear in a rodent deﬁnitive
host model when experimentally infected with the different host
isolates (Valero et al., 2001a). However, the existence of certain
morphological features (allometric differences in BW vs. BL and
BL vs. VS-P) characterizing F. hepatica adults in different host spe-
cies was demonstrated (Valero et al., 2001a). Similarly, PC analysis
of F. hepatica egg size shows characteristic morphometric traits in
each deﬁnitive host species (Valero et al., 2009).
Parasite burden is another environmental factor that affects size
variation in fasciolids. The crowding effect in F. hepatica adults is
reﬂected in a reduction of the maximum morphometric value
(ym) of the ontogenetic trajectories of body area, BP, BL and BW
due to a reduction in the growth rate (Valero et al., 2006). Thus,
in rats, worm size appears to be dependent on the level of infection
and worm size decreases when the burden increases. This phe-
nomenon is not present in light infection in sheep, with burdens
equal or below 45 adults/sheep.
In natural populations, only slight differences could be found in
allometric models (BL, BW, P vs. BA or BL) between F. hepatica
adults from Bolivian highland and Spanish lowland ﬂuke popula-
tions infecting sheep (Valero et al., 1999). Nevertheless, Bolivian
Altiplano sheep and cattle liver ﬂuke populations proved to have
a smaller uterus area than European ﬂuke populations in the same
host species (Valero et al., 2001b).
The life cycle of F. hepatica occurs in alternate aquatic and ter-
restrial ecosystems. Eggs are emitted by a deﬁnitive terrestrial
host, but egg development occurs in fresh water and larval stage
development then occurs in aquatic and amphibious lymnaeid
snails (Mas-Coma, 2005). The emission of F. hepatica eggs in faeces
is usually subject to oscillations along time in animals as well as
humans. An example of the adaptation of the chronobiology of li-
ver-ﬂuke egg shedding to seasonality was given by Valero et al.
(2002). Thus, the black rat naturally infected with the liver ﬂuke
in the Mediterranean island of Corsica shows continuous egg shed-
ding with minimal values in summer, when egg development is
8
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evapotranspiration exceeds rainfall), and maximum level shedding
peaks in spring and the autumn months, when there is substantial
rainfall and a sufﬁciently wet environment (Valero et al., 2002).
European populations of G. truncatula are markedly amphibious
(Euzeby, 1971). On the contrary, altiplanic G. truncatula specimens
are more aquatic and only rarely encountered in mud, out of water.
They mainly inhabit permanent water bodies, never temporary
water bodies such as those originating from rain during the rainy
season (October–March). Temporary water bodies originating from
rain do not remain long enough to enable colonization by lymnae-
ids and even in rainy years the dry season is too long to allow the
survival of buried and lethargic lymnaeids. This is related to the
high evapotranspiration rates proper to the high altitude, as well
as to the long duration of the dry season coincident with the lowest
temperatures of the year (April–September). Thus, lymnaeids scat-
tered throughout patchily ﬂooded pastures, which constitute the
most important transmission foci in central Europe, are almost
never found in the Altiplano. Similarly, the relationship of fascioli-
asis with rainy periods, well known in the northern hemisphere
both in animals and humans (Chen and Mott, 1990), cannot be ap-
plied to the northern Altiplano. In the Altiplano, the existence of
lymnaeid populations in the transmission foci throughout the
whole year enables parasite transmission during all seasons. In
the northern Bolivian Altiplano, seasonal differences in mean tem-
perature are very low, only 5.0–6.5 C. Great temperature differ-
ences, from 10.3 to 13.0 C (on the shores of Lake Titicaca),
respectively, from 13.4 to 22.4 C (far from the Lake) occur within
a day. Moreover, the lack of trees and shrubs implies no shade and
hence direct intense sunshine, which increases the temperature of
water bodies at midday (daily temperature range in water bodies
inhabited by lymnaeids: from 3.0–10.0 C at night to 15.0–
28.9 C during the day) (Mas-Coma et al., 1999; Fuentes et al.,
1999).
Studies performed in the northern Bolivian Altiplano showed
that there is no phase of the life cycle in which liver ﬂuke develop-
ment appears to be modiﬁed in such a way that transmission is re-
duced. However, given aspects seem to favour transmission, such
as the longer cercarial shedding period and the higher cercarial
production. These two aspects appear to be related to a longer sur-
vival of infected lymnaeid snails. When compared to lowlands,
these differences may be interpreted as adaptation strategies to
high altitude conditions (Mas-Coma et al., 2001). Our results indi-
cate that the liver-ﬂuke adult populations from Peru and Europe
(natural and experimental) show a common minimum size from
which the parasites begin to be gravid, while this minimum size
is smaller in Bolivian highland populations. This difference may
be attributable to intraspeciﬁc variability or may be related to
the inﬂuence of high altitude. The divergence detected between
the altiplanic population and the rest of populations analysed is
difﬁcult to understand, as evolutionary advantages cannot be eas-
ily envisaged. It is known that oxygen is required for egg produc-
tion in F. hepatica (Mansour, 1958; Bjorkman and Thorsell, 1963;
McGonigle and Dalton, 1995) (the transit from high altitude to very
high altitude is usually noted to be at 3200 m). Thus, high altitude
hypoxia may be the origin for a reduced egg production by the
ﬂukes. Moreover, the uterus in digeneans has traditionally not
been considered a storage organ but mainly an organ adapted to
the developmental time of the eggs (in fasciolids, eggs are laid
unembryonated and the miracidium begins its development in
eggs once in freshwater). Valero et al. (2011) have demonstrated
that there is a direct relation between F. hepatica uterus size and
the number of eggs shed per gram of faeces. In the valley transmis-
sion pattern and European lowland pattern, a larger storage capac-
ity of the uterus becomes more useful due to the typical seasonal
transmission, with continuous egg shedding but with oscillations,189with minimum values in unfavourable seasons, and maximum
shedding peaks in favourable seasons. As above-mentioned, in
the northern Bolivian Altiplano, the climatic conditions, freshwater
characteristics and lymnaeid ecology enable fascioliasis transmis-
sion to take place throughout the year (Fuentes et al. 1999; Mas-
Coma et al. 1999), earlier egg shedding and smaller uterus storage
space may be related to permanent transmission including snail
vector population availability throughout the year. Further re-
search is presently being carried out to ascertain whether the mor-
phometric differences detected in the minimum size of gravid
Bolivian F. hepatica adults are associated with transmission pattern
differences.
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Assessing the validity of an ELISA test for the serological
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Abstract objectives To improve the diagnosis of human fascioliasis caused by Fasciola hepatica and Fasciola
gigantica, we evaluated the diagnostic accuracy of an enzyme-linked immunosorbent assay (ELISA),
with Fasciola antigen from the adult liver fluke, for the detection of IgG against fascioliasis in human
sera.
methods The sera of 54 fascioliasis cases, originating from three endemic areas, were used in this
evaluation: (i) a hyperendemic F. hepatica area where humans usually shed a great number of parasite
eggs in faeces (11 sera); (ii) an epidemic F. hepatica area where humans usually shed small amounts
of parasite eggs (24 sera) and (iii) an overlap area of both Fasciola species and where human shedding of
parasite eggs in faeces is usually scarce or non-existent (19 sera). One hundred and sixty-eight patients
with other parasitic infections and 89 healthy controls were also analysed.
results The respective sensitivity and specificity of this assay were 95.3% (95% confidence intervals,
82.9–99.2%) and 95.7% (95% confidence intervals, 92.3–97.5%). No correlation between egg output
and the OD450 values of the F. hepatica IgG ELISA test was observed.
conclusions This test could be used both as an individual serodiagnostic test for human fascioliasis
when backed up by a compatible clinical history together with a second diagnostic technique for
other cross-reactive helminth infections, and in large-scale epidemiological studies of human fascioliasis
worldwide.
keywords sensitivity and specificity, Fasciola hepatica, Fasciola gigantica, IgG, ELISA, serodiagnosis
Introduction
Fascioliasis is a parasitic disease caused by liver fluke
species of the genus Fasciola: Fasciola hepatica and
Fasciola gigantica. While F. hepatica is found on a global
scale, F. gigantica can be found in humans and animals in
tropical regions of Africa and Asia (Mas-Coma et al.
2009a). However, in some parts of Africa and Asia, the
two species overlap (Ashrafi et al. 2006; Periago et al.
2008; Mas-Coma et al. 2009a). Today, fascioliasis is
considered an important human disease and several
geographic areas have been described as endemic for the
disease in humans, including hypoendemic (prevalence
< 1%), mesoendemic (prevalence between 1% and 10%)
and hyperendemic (> 10%) situations, with intensities
ranging from low to very high, and estimates of up to 17
million people infected worldwide. This may even be an
underestimate if the total lack of data from numerous
Asian and African countries is considered (Mas-Coma
et al. 1999).
Moreover, in the last two decades, human fascioliasis
has been emerging in many regions, a phenomenon that
has partly been related to climate change (Mas-Coma et al.
2009b). Recent studies have shown that the high patho-
genicity of this disease is not only restricted to the acute
phase, but also to long-term liver fluke infection (Valero
et al. 2000, 2003, 2006, 2008), the immune-modulation of
fasciolids in the acute phase (Brady et al. 1999), and their
immune suppression effect in chronic and advanced
chronic phases (Girone`s et al. 2007). All this appears to be
in the background of usual co-infections with other
parasitic and infectious diseases (Mas-Coma et al. 2005).
Considering this scenario of increasing concern, WHO
decided to launch a worldwide initiative against this
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disease (WHO 2007, 2008). Therefore, the capacity to
diagnose human fascioliasis correctly becomes imperative.
The present study assesses a qualitative microtiter
strip-based enzyme-linked immunosorbent assay (ELISA)
for the detection of IgG class antibodies against F. hepatica
in human serum, a solid phase enzyme immunoassay based
on the sandwich principle, known as ‘DRG Fasciola
hepatica IgG (human) ELISA’, in the following situations:
(i) a hyperendemic F. hepatica area where humans usually
shed large amounts of parasite eggs in faeces, (ii) an
epidemic F. hepatica area where humans usually shed small
amounts of parasite eggs and (iii) an overlap area of both
Fasciola species where human shedding of parasite eggs in
faeces is usually scarce or non-existent. Fascioliasis posi-
tivity of the samples used had been verified through egg
detection (Kato–Katz technique) or the ELISA Cathepsin
L1 (CL1) protease test. ELISA CL1 is used here as the
serological gold standard method in samples from areas
where humans usually shed small amounts of parasite eggs
or where parasite eggs in faeces are usually scarce or non-
existent.
ELISA CL1 was previously successfully employed for the
diagnosis of human fascioliasis in the northern Bolivian
Altiplano (O’Neill et al. 1998) and in Iran (Rokni et al.




Sera were obtained from the serum bank of the Depart-
ment of Parasitology, Faculty of Pharmacy, University of
Valencia, Spain (2004–2008). Each serum was aliquoted
and stored at )80 C until used. The sera were classified in
three groups: (i) 54 positive fascioliasis sera through ELISA
CL1 and eggs in faeces quantified through the Kato–Katz
technique, originating from three different epidemiological
situations; (ii) 168 serum samples from individuals with
parasitic ⁄ fungal diseases other than fascioliasis (to evaluate
potential cross-reactivity) were obtained from clinically,
serologically and sometimes parasitologically confirmed
cases and (iii) 89 sera from parasitologically negative cases
were used from serum collections stored at Centro
Nacional de Microbiologı´a (ISCIII, Madrid, Spain) and
Servicio de Microbiologia, Hospital Universitario y
Politecnico ‘La Fe’ (Valencia, Spain). The age and gender
characteristics of the individuals are detailed in Table 1.
ELISA Cathepsin L1
Cathepsin L1 (CL1) was obtained from the Molecular
Parasitology Laboratory, School of Biotechnology, Faculty
of Health and Science, Dublin City University, Dublin,
Ireland. Application of the ELISA CL1 test was carried out
as previously described (O’Neill et al. 1999). Briefly,
100 ll of CL1 antigen (5 lg ⁄ml) were incubated overnight
at 37 C in wells of microtiter plates (Nuclon, Kamstrup,
Roskilde, Denmark). The wells were blocked with a
solution of 2% bovine serum albumin ⁄0.1% Tween 20 in
phosphate-buffered saline for 30 min at 37 C, and human
sera (1:100 dilution) were then added into duplicate wells.
Bound human antibodies were detected using biotin-
conjugated anti-human IgG4 (1:2,000 dilution), avidin-
conjugated alkaline phosphatase, and the substrate 2,2-
azino-bis(3-ethylbenzthiazoline-6-suflonic acid) (all from
Sigma Chemical Co., Poole, Dorset, UK). Plates were read
Table 1 Gender and age characteristics of individuals whose serum samples were used in the validation










Individuals positive fascioliasis 54 (36.30 ± 1.09)
(7–75)
25 (34.25 ± 1.21)
(7–74)
29 (38.00 ± 1.00)
(10–75)
– –
Individuals with parasitic ⁄ fungal
diseases other than fascioliasis
168* (38.15 ± 1.07)
(1–89)
82 (40.42 ± 1.11)
(1–89)
83 (36.05 ± 1.03)
(1–89)




89 (40.28 ± 0.81)
(1–73)
55 (42.68 ± 0.68)
(22–73)





*Amoebiasis 12; leishmaniasis 3; malaria 12; toxoplasmosis 10; schistosomiasis 15; hydatidosis 15; hymenolepiasis 1; taeniasis ⁄
cysticercosis 15; trichinellosis 15; strongyloidiasis 18; ascariasis 1; toxocariasis 8; anisakiasis 25; loasis 2; gnathostomiasis 10; trichuriasis
and ascariasis coinfection 1; malaria, trichuriasis and ascariasis coinfection 2; Entamoeba coli, trichuriasis, ascariasis and
ancylostomiasis coinfection 1; trichuriasis, ancylostomiasis and enterobiasis coinfection 1; histoplasmosis 1.
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after 20 min on a multiscan ELISA plate reader at an
absorbance of 405 nm (Bio-Rad, Model 680, Hercules,
CA, USA). The cut-off point between the clusters was set at
3.09 standard deviations from the mean of the control sera
absorbance and was 0.098.
DRG kit
DRG Instruments GmbH, Germany, provided all com-
mercial kits used in this study. The test is based on
Excretion ⁄ Secretion antigens of F. hepatica predominantly
containing fluke cysteine proteases (Salimi-Bejestani et al.
2005). All steps were carried out according to the
manufacturer’s instructions. Human sera, negative and
positive controls and cut-off control (CO) (1:100 dilution)
were added into triplicate wells. Plates were read after
15 minutes on a multiscan ELISA plate reader at an
absorbance of 450 nm (Bio-Rad, Model 680, Hercules,
CA, USA). The test run may be considered valid if substrate
blank has an absorbance value below 0.100, negative
control below 0.200, CO control between 0.250 and 0.750
and positive control above 0.600. The results are given as
the mean of the optical density (OD) obtained from
triplicate samples expressed as a percentage of the CO,
using the following formula:
Percent positiveðPPÞ ¼ ððMeanODof test sampleÞ=
MeanODof CþÞ  100:
A serum is considered positive when its absorbance value is
above 10% of CO.
The results in DRG Units (DU) were calculated accord-
ing to the following formula:
DU ¼ ðsample ðmeanÞ absorbance value 10Þ=CO:
The results were negative if DU < 9, and positive if DU > 11.
To avoid any bias, all sera when being processed were
blinded with regard to the adscription of the aforemen-
tioned three groups (fascioliasis positive, other parasitoses
or negative sera).
Ethical aspects
The present study was approved by University of Valencia
Ethics Committee.
Data analysis
The diagnostic sensitivity and specificity values were
calculated (Fletcher & Fletcher 2005) with its 95%
confidence interval (95% CI; EPIINFO). The positive
predictive value (PPV) was calculated using the following
formula:
PPV ¼ ðsensitivity prevalenceÞ=ðsensitivity prevalenceÞ
þ ðð1 specificityÞ  ð1 prevalenceÞÞ:
The negative predictive value (NPV) was calculated using
the following formula:
NPV ¼ ðspecificity ð1 prevalenceÞÞ=ððð1 sensitivityÞ
 prevalenceÞ þ ððspecificityÞ  ð1 prevalenceÞÞÞ:
Student’s t-test was calculated using SPSS software.
Results
The mean of DU values for all serum groups is shown in
Figure 1A,B. DU values were significantly higher in the
proven fascioliasis group than in the groups of parasitic
diseases other than fascioliasis and the healthy controls,
respectively (P < 0.001).














Figure 1 Mean DRG Units (DU) obtained with the DRG F. hepatica IgG ELISA test in fascioliasis patients from different epidemio-
logical situations. (A) Endemic F. hepatica area where humans usually shed small amounts of parasite eggs; (B) an overlap area of both
Fasciola species where human shedding of parasite eggs in faeces is usually scarce or non-existent. Data points are the mean optical
density (OD) obtained from triplicate samples expressed as a percentage of the cut-off (CO), using the following formula:
Percent positiveðPPÞ ¼ ððMean OD of test sampleÞ=Mean ODofCþÞ  100. A serum is considered positive when its absorbance value is
above 10% of CO. The results in DRG Units (DU) were calculated according to the following formula:
DU ¼ ðsample ðmeanÞ absorbance value 10Þ=CO. The results were negative if DU <9, and positive if DU > 11 (dotted line).
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The numbers of true positive and false negative test
results in fascioliasis cases of humans with and without
detection of eggs in their faecal samples are provided in
Table 2.
In the samples from a hyperendemic F. hepatica area egg
detection in faeces through the Kato-Katz technique was
used as reference standard, and the sensitivity of the
F. hepatica IgG ELISA test was 100% (67.9–100%). No
correlation between egg output ) a measure of infection
intensity ) and the OD450 values of the F. hepatica IgG
ELISA test was observed in this study area (Figure 2).
In the samples from an epidemic F. hepatica area CL1
ELISA was used as reference standard. Sensitivity was
91.7% (95% confidence intervals, 71.5–98.5%), detecting
2 false negative cases of which one was egg positive in
faeces, while the other was not.
In the samples from an overlap area of both Fasciola
species CL1 ELISA was also used as reference standard.
Sensitivity was 100% (95.9–100%). Populations of the
two latter endemic areas were grouped as result of the
ELISA CL1 and the F. hepatica IgG ELISA test evaluation
as follows: fascioliasis positive cases by CL1 (Fas+) ⁄ sero-
positive by F. hepatica IgG ELISA test (test+) and fascio-
liasis positive cases by CL1 (Fas+) ⁄ seronegative by
F. hepatica IgG ELISA test (test-) (Figure 1A,B). Statistical
differences between the results for sensitivity values from
the two latter situations were not found, and true positive
cases (41) and false negative cases (2) for these two areas
together were used for the calculation of sensitivity,
presenting a value of 95.3% (82.9–99.2%).
Specificity was calculated from the results in Table 2
providing the numbers of false negative and true positive
test results in infected sera other than fascioliasis and
negative cases. These results can be grouped as follows:
infected positive cases other than fascioliasis
(infected+) ⁄ seropositive by F. hepatica IgG ELISA test
(test+) and infected positive cases other than fascioliasis
(infected+) ⁄ seronegative by F. hepatica IgG ELISA test
(test-) (Figure 3A). Table 2 also shows the total number of
sera without fascioliasis, and these values were used to
calculate specificity, presenting a value of 95.7% (92.3–
97.5%). Ten serum samples from a heterologous infection
cross-reacted with the kit, mainly originating from patients
with helminthiases, namely schistosomiasis (4 samples),
hydatidosis (2 samples), taeniasis ⁄ cysticercosis (1 sample),
trichinosis (1 sample), strongyloidiasis (1 sample), and
histoplasmosis (1 sample) (see Figure 3B). Theoretical
PPVs and NPVs vs fascioliasis prevalence are represented in
Table 2 Diagnostic characteristics of the F. hepatica IgG ELISA test applied to fascioliasis patients’ sera from different disease endemic
areas, sera from patients with helminthiases other than fascioliasis and negative sera from healthy subjects
True positive False negative True negative False positive
Hyperendemic F. hepatica area where humans usually shed a
great deal of parasite eggs in faeces*
11 0 – –
Epidemic F. hepatica area where humans usually shed small
amounts of parasite eggs
22 2 – –
Overlap area of both Fasciola species where human shedding of
parasite eggs in faeces is usually scarce or non-existent
19 0 – –
Total sera with fascioliasis 52 2 – –
Individuals with parasitic ⁄ fungal diseases other than
fascioliasis
– – 158 10
Individuals parasitologically negative – – 88 1
Total sera without fascioliasis – – 246 11
*Gold standard determined according to the Kato–Katz technique.
Gold standard determined according to the ELISA CL1 test.









Figure 2 DRG F. hepatica IgG ELISA test and intensity of
F. hepatica infection. Data points represent the mean absorbance
at 450 nm from copropositive patients from a hyperendemic
F. hepatica area where humans usually shed a great deal of parasite
eggs in faeces. epg = egg count per gram of faeces.
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Figure 4, showing the expected PPVs and NPVs depending
on whether the test was used in low, medium or high
prevalence scenarios.
Discussion
Coprological analysis, based on the identification of eggs
found in stools, duodenal contents or bile analysis is
still commonly employed to diagnose human fascioliasis
(Valero et al. 2009a), despite the overwhelming consensus
that this method is not wholly reliable (Hillyer 1999) for
several reasons. Eggs are not detected until the latent
period of infection when much of the liver damage has
already occurred, and similarly patients may not shed eggs
in faeces in ectopic cases known in both infection by
F. hepatica and F. gigantica (Le et al. 2007). Additionally,
eggs are released sporadically from the bile ducts and hence
stool samples of infected patients may not necessarily
contain eggs (Mas-Coma et al. 1999).
However, coprological methods of egg detection are still
usually considered the gold standard, although unfortu-
nately they are not applicable in endemic areas where: (i)
humans do not shed eggs in faeces, (ii) the shedding is often
very low and difficult to detect and also (iii) in cases of
communities that do not supply stool samples due to
ethnic ⁄ cultural customs. Hence, it is essential to have
serological techniques also available when diagnosing the
disease. Therefore, in this study, besides Kato–Katz,
another serological test, the ELISA CL1 test, was also used
as gold standard.
Serodiagnosis of fascioliasis in human and animal species
has been successfully carried out employing several anti-
genic fractions of Fasciola (Mezo et al. 2003; Sa´nchez-
Andrade et al. 2008; Demerdash et al. 2011), purified
antigens (O’Neill et al. 1998; Rokni et al. 2002), and
recombinant antigens (O’Neill et al. 1999; Carnevale et al.
2001). Cathepsins L are the most frequently used target
antigens for detecting anti-Fasciola antibodies (Carnevale
et al. 2001; Rokni et al. 2002; Mezo et al. 2004, 2007,
2010; Intapan et al. 2005; Wongkham et al. 2005; Valero
et al. 2009b; Muin˜o et al. 2011), as circulating antibodies
to these molecules remain at high levels for long periods
(Valero et al. 2009b).
The commercial DRG test was evaluated in cattle,
obtaining a sensitivity and specificity of 98% (96–100%)
and 96% (93–98%) respectively at a cut-off value of 15%
positivity (Salimi-Bejestani et al. 2005). The sensitivity and
specificity values of the DRG test herein agree with the
results obtained by other authors for F. hepatica IgG














Figure 3 Mean DRG Units (DU) obtained with the DRG F. hepatica IgG ELISA test in (A) patients with parasitoses other than fascioliasis
(B) and negative control sera. Data points represent the mean absorbance at 450 nm obtained from three replicates of each serum tested.
The dotted line represents the cut-off value of OD at 450 nm. Data points are the mean optical density (OD) obtained from triplicate
samples expressed as a percentage of the cut-off (CO), using the following formula: Percent positive ðPPÞ ¼ ððMean OD of test sampleÞ=
Mean OD of CþÞ  100. A serum is considered positive when its absorbance value is above 10% of CO. The results in DRG Units (DU)
were calculated according to the following formula: DU ¼ ðsample (meanÞ absorbance value 10Þ=CO. The results were negative if
DU < 9, and positive if DU > 11 (dotted line).















Figure 4 Theoretical PPVs and NPV values vs fascioliasis preva-
lence, showing the expected PPVs and NPV values if the test were
used in low (below 1%), medium (between 1% and 10%) or high
(above 10%) prevalence scenarios (expressed in vertical lines).
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ELISA in-house assays: 100% and 100% (O’Neill et al.
1998; Rokni et al. 2002), 92.4%, and 83.6% (Espinoza
et al. 2007), 97.2% and 100% (Rahimi et al. 2011),
97.0% and 96.6% (Cornejo et al. 2010) and 100 and
95.6% (Figueroa-Santiago et al. 2011). Commercial kits
offer advantages over in-house assays: they save time and
provide quality control reagents for better reproducibility
within and between laboratories, which hampers the
comparison between in-house and commercial tests. Fur-
thermore, only very few commercial kits, such as the DRG
F. hepatica IgG ELISA test evaluated here, are presently
available for the diagnosis of human fascioliasis. Com-
paring DRG test results only with commercial assays
results in sensitivity and specificity below the 100%
sensitivity, respectively, specificity obtained by SeroFluke
strips (Martı´nez-Serna´ndez et al. 2011).
The results obtained show the test to be highly sensitive
and specific. The sensitivity of this assay did not detect
differences in positive samples from different epidemio-
logical situations. Nevertheless, PPVs calculated for diverse
epidemiological situations are very different. Thus, PPVs in
hypoendemic areas were below 2.2%, in mesoendemic
situations PPVs oscillated between 2.2% and 71.2%, while
in hyperendemic situations PPVs were above 71.17%,
making this test recommendable in such situations. Con-
trarily, NPVs calculated for diverse epidemiological situa-
tions are similar. NPVs for hypoendemic areas reached
values above 99.9%, in mesoendemic situations NPVs
oscillated between 99.5% and 99.9%, while in hyperen-
demic situations NPVs were below 99.5%.
In conclusion, the DRG test could be used both as (i) an
individual serodiagnostic test for human fascioliasis when
backed up by a clinical history, together with a second
diagnostic technique in certain situations of possible cross-
reactions (patients co-infected with other helminths) and
(ii) in future large-scale epidemiological studies of human
fascioliasis worldwide (recommended for mass screening,
especially when considering its convenient handling).
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Abstract
Background: Emergence of human fascioliasis prompted a worldwide control initiative including a pilot study in a few
countries. Two hyperendemic areas were chosen: Huacullani, Northern Altiplano, Bolivia, representing the Altiplanic
transmission pattern with high prevalences and intensities; Cajamarca valley, Peru, representing the valley pattern with high
prevalences but low intensities. Coprological sample collection, transport and study procedures were analyzed to improve
individual diagnosis and subsequent treatments and surveillance activities. Therefore, a coproantigen-detection technique
(MM3-COPRO ELISA) was evaluated, using classical techniques for egg detection for comparison.
Methodology and Findings: A total of 436 and 362 stool samples from schoolchildren of Huacullani and Cajamarca,
respectively, were used. Positive samples from Huacullani were 24.77% using the MM3-COPRO technique, and 21.56% using
Kato-Katz. Positive samples from Cajamarca were 11.05% using MM3-COPRO, and 5.24% using rapid sedimentation and
Kato-Katz. In Huacullani, using Kato-Katz as gold standard, sensitivity and specificity were 94.68% and 98.48%, respectively,
and using Kato-Katz and COPRO-ELISA test together, they were 95.68% and 100%. In Cajamarca, using rapid sedimentation
and Kato-Katz together, results were 94.73% and 93.58%, and using rapid sedimentation, Kato-Katz and copro-ELISA
together, they were 97.56% and 100%, respectively. There was no correlation between coproantigen detection by optical
density (OD) and infection intensity by eggs per gram of feces (epg) in Cajamarca low burden cases (,400 epg), nor in
Huacullani high burden cases ($400 epg), although there was in Huacullani low burden cases (,400 epg). Six cases of egg
emission appeared negative by MM3-COPRO, including one with a high egg count (1248 epg).
Conclusions: The coproantigen-detection test allows for high sensitivity and specificity, fast large mass screening capacity,
detection in the chronic phase, early detection of treatment failure or reinfection in post-treated subjects, and usefulness in
surveillance programs. However, this technique falls short when evaluating the fluke burden on its own.
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Introduction
Fascioliasis is an important human and animal disease caused
by the trematode species Fasciola hepatica and F. gigantica. At
present, fascioliasis is emerging or re-emerging in numerous
regions of Latin-America, Africa, Europe and Asia, both in
humans and animals, a phenomenon which has partly been
related to climate change [1]. Major human health problems are
encountered in Andean countries (Bolivia, Peru, Chile and
Ecuador), the Caribbean (Cuba), northern Africa (Egypt), western
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Europe (Portugal, France and Spain) and the Caspian area (Iran
and neighbouring countries) [1]. Emergence, long-term pathoge-
nicity [2–4] and immunological interactions [5,6] prompted the
WHO to include this disease among the so-called neglected
tropical diseases (NTDs), which are chronic, debilitating, poverty-
promoting and among the most common causes of illness in
developing countries. Their control and elimination is now
recognized as a priority to achieve the United Nations Millennium
Development Goals and targets for sustainable poverty reduction
[7,8].
Among Andean countries, the highest human fascioliasis
prevalences and intensities are encountered in the Northern
Altiplano of both Bolivia [9,10] and Peru [11], as well as in the
Cajamarca valley (Peru) [12], where F. hepatica is the only fasciolid
species present [13] and children and females are the subjects most
affected [1]. Within the human fascioliasis high altitude transmis-
sion pattern related to F. hepatica transmitted by lymnaeid vectors
of the Galba/Fossaria group in Andean countries, two different
subpatterns have been distinguished according to physiographic
and seasonal characteristics [1,13]: a) the Altiplanic pattern, with
endemicity distributed throughout an area of homogeneous
altitude and transmission throughout the whole year caused by
high evapotranspiration rates leading lymnaeid vectors to
concentrate in permanent water bodies, e.g. the Northern Bolivian
Altiplano [14]; b) the valley pattern, with endemicity distributed
throughout an area of heterogeneous altitude and seasonal
transmission related to climate, e.g. the Cajamarca valley in Peru
[12,15,16].
In recent years, the availability of a very effective drug against
fascioliasis, namely triclabendazole [17], prompted the WHO to
launch a worldwide initiative against human fascioliasis [18,19].
This initiative includes interventions in human fascioliasis endemic
areas presenting different epidemiological situations and transmis-
sion patterns [1]. Bolivia and Peru are two of the countries selected
for priority intervention due to the very large public health
problem posed by this disease. Different pilot schemes were
designed to assess the best control strategies according to the
different epidemiological situations and transmission patterns. The
Northern Bolivian Altiplano was chosen as an example of the
Altiplanic pattern, while the Cajamarca valley was chosen as an
example of the valley pattern.
An alternative to coprological egg detection is the use of
immunodiagnostic tests based on the detection of anti-Fasciola
antibodies and/or coproantigens released by the parasite. In the
last decades, several ELISA methods based on the use of
polyclonal and monoclonal antibodies have been reported to be
useful for detection of F. hepatica and F. gigantica in the feces of
sheep and cattle [20–23] and also rat feces [24]. Nevertheless,
surveys on human fascioliasis have usually been made through
various coprological techniques verifying the presence of eggs in
stools [25] and antibody detection tests to confirm the diagnosis of
human fascioliasis [26]. Among these techniques, classical
coprological egg detection methods are the most frequently used
[27]. However, so far, the use of coproantigen detection was
applied to diagnose F. hepatica infection in patients in Cuba only
[28,29].
Enzyme-linked immunosorbent assay (ELISA) methods devel-
oped for determination of Fasciola coproantigens in stool samples
from animals and humans provide an alternative to coprological
examination [30,31]. One of these methods is the MM3 capture
ELISA (MM3-COPRO) test for fascioliasis diagnosis detection of
fecal excretory-secretory antigens (ESAs) using a monoclonal
antibody (mAb), whose usefulness for detection of F. hepatica and F.
gigantica coproantigens in experimental and natural Fasciola
infections of sheep and cattle has already been demonstrated
[22,32]. This test proved to be highly sensitive (confirmed by
necropsy) and specific (no cross reaction was observed with
antigens from other helminths), and allowed for the detection of
Fasciola infections 1–5 weeks before patency in cattle. Furthermore,
other researchers recently tested a commercial version of the test,
and its appropriateness for the detection of F. hepatica infections in
cattle was confirmed under field conditions [33]. The suitability of
the MM3-COPRO method for detection of Fasciola coproantigens
in both fresh and preserved stools from hospital patients has been
demonstrated [34], but its applicability for detection of F. hepatica
infections in humans under field conditions has not been proved.
An efficient coproantigen test for human fascioliasis diagnosis
represents a valuable tool to facilitate population screening and
post-treatment surveillance in control campaigns, above all in
communities where people are reluctant to furnish blood samples
due to ethnic/religious aspects. The aim of the present study is to
evaluate the coproantigen technique MM3-COPRO ELISA
under field conditions for human fascioliasis diagnosis in human
hyperendemic areas of Andean countries, using classical
coprological techniques for egg detection for comparison
purposes (rapid sedimentation and Kato-Katz). Thus, two
endemic areas were chosen: Huacullani (Bolivia) representing
the Altiplanic pattern with high prevalences and intensities, and
the rural areas of Cajamarca (Peru), representing the valley
pattern with high prevalences but with low intensities. Results of
the pilot intervention implemented in Huacullani to assess the
feasibility of a strategy of large-scale administration of tricla-




In Bolivia, the study was approved by the Comisio´n de Etica de
la Investigacio´n of the Comite´ Nacional de Bioe´tica. In Peru, it
was approved by the Comite´ Institucional de Etica of the
Author Summary
A coproantigen-detection technique (MM3-COPRO ELISA)
was evaluated in 436 and 362 schoolchildren of Huacullani,
Bolivia, and Cajamarca valley, Peru, respectively. Classical
techniques for egg detection were used for comparison. In
Huacullani, using Kato-Katz as gold standard, sensitivity
and specificity were 94.68% and 98.48%, respectively, and
using Kato-Katz and COPRO-ELISA test together, they were
95.68% and 100%, respectively. In Cajamarca, using rapid
sedimentation and Kato-Katz together, these results were
94.73% and 93.58%, respectively, and using rapid sedi-
mentation, Kato-Katz and copro-ELISA together, results
were 97.56% and 100%, respectively. There was no
correlation between coproantigen detection by optical
density (OD) and infection intensity by eggs per gram of
feces (epg) in Cajamarca low burden cases (,400 epg), nor
in Huacullani high burden cases ($400 epg), although
there was in Huacullani low burden cases (,400 epg). Six
cases of egg emission appeared negative by MM3-COPRO,
including one with a high egg count (1248 epg). The
coproantigen-detection test allows for high sensitivity and
specificity, fast large mass screening capacity, detection in
the chronic phase, early detection of treatment failure or
reinfection in post-treated subjects, and usefulness for
surveillance programs. However, this technique falls short
when evaluating the fluke burden on its own.
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Universidad Peruana Cayetano Heredia and the Comite´ de E´tica
of the Instituto Nacional de Salud.
All subjects involved provided written informed consent.
Samples from children were obtained after consent from the
children’s parents, following the principles expressed in the
Declaration of Helsinki. Consent was also obtained from the local
authorities of the communities and heads and teachers of the
school.
In Huacullani, activities were performed in collaboration with
the Servicio Departamental de Salud La Paz and the Unidad de
Epidemiologı´a of the Bolivian Ministry of Health and Sports
(MSyD). In Cajamarca, the study was done in cooperation with
the Direccio´n Regional de Salud of Cajamarca, and the Estrategia
Nacional de Zoonosis, Direccio´n General de Salud de las
Personas, Ministerio de Salud (MINSA), Lima.
Stool samples and coprological techniques
Coprological studies were carried out in the locality of
Huacullani, which belongs to the municipality of Tiwanaku, third
section of the province of Ingavi of the Departamento de La Paz,
Bolivia. This locality is situated 85 km from the capital La Paz, at
the western end of the so-called Tambillo-Aygachi corridor of the
Northern Bolivian Altiplano. Huacullani has 2525 inhabitants,
according to the last 2005 census of the Bolivian Instituto Nacional
de Estadı´stica. Stool collection was performed in the school of the
locality and samples were obtained from a total of 436 children.
Previous surveys in that locality showed very high prevalence rates
of 38.2% in the year 1992, 31.2% in 1993, and 34.8% in 1996 in
children, and 18.4% in 1996 and 11.8% in 1997 in total
community surveys (children plus adults) [10].
Stool samples were also obtained in the Departmento de
Cajamarca, Peru, which covers an area of around 35,400 km2 in
the northern Andean part of Peru and is inhabited by 1,416,000
people. This Department comprises 13 provinces and the province
of Cajamarca in turn includes 12 districts [12]. A total of 362 fecal
samples were obtained from children of the schools of Escuela de
Varones del Distrito (Jesus district), Santa Rosa de Chaquil (La
Encan˜ada district), and Andres Avelino Caceres (Ban˜os del Inca
district). Previous surveys showed very high prevalences in that
endemic area, with a mean of 24.4% and the maximum
prevalence of 47.7% in Santa Rosa de Chaquil, the hitherto
highest local prevalence detected in Peru [12].
Classical coprological techniques for egg detection were used for
qualitative (rapid sedimentation and Kato-Katz) and quantitative
(Kato-Katz) diagnosis. The combined use of highly specific
techniques has been reported as a means of compensating the
low sensitivity of the Kato-Katz technique [36]. Thus, identifica-
tion of true positive and true negative cases was carried out by
using two criteria: i) finding of F. hepatica eggs in feces; ii) egg
finding plus COPRO ELISA test results. Applying the Kato-Katz
technique, eggs were detected in fresh stools after analysis of three
Kato-Katz slides (Helm-Test, AK test, AK Industria e Come´rcio
Ltda, Belo Horizonte, Brasil) per sample, depending on the
concentration of Fasciola eggs following WHO recommendations,
using a template delivering about 41.7 mg of feces [37]. The
average egg output was calculated as eggs per grams of feces (epg).
Parasitological analysis was done microscopically by a trained
parasitologist. Intensity of infection, measured as eggs per gram
(epg), was used as an indicator of F. hepatica burden in infected
subjects. Kato-Katz was used in both study areas and rapid
sedimentation was an additional test done in Cajamarca. In the
case of the Huacullani samples, a single Kato-Katz slide was used
for each sample. In the case of the Cajamarca samples, the rapid
sedimentation procedure was applied and those fecal samples
positive for the MM3-COPRO ELISA were also quantitatively
analyzed by three Kato-Katz slides.
Fecal sample procedures and analyses
Children were not included in the study if they presented any
chronic or acute hepatic disease, pregnancy, breast-feeding, any
acute infection within a week of enrolment, or receiving treatment
for any other disease or condition. In Huacullani, at the time of the
baseline survey (April 2008), the school population consisted of
459 children aged 5 to 14 years, who were all considered eligible
for an interventional treatment study. A total of 447 children
returned the plastic container. From these, 437 fecal samples from
an equivalent number of children were examined (four children
returned an empty plastic container, and six other children
provided insufficient stool quantities to apply both Kato-Katz slide
and COPRO ELISA). Thus, fecal samples were obtained from
437 children (220 males and 217 females) of 5–16 years of age
(mean 6 SD = 8.862.3). A clean, plastic, wide-mouthed, num-
bered container with a snap-on lid was given to every participant.
All subjects were then asked to try to fill the container with their
own feces and to return it immediately. One stool sample per
subject was collected and personal data (name, sex, and age) were
noted on delivery of the container. Samples were transported to
the parasitological laboratory of the Faculty of Pharmacy,
Universidad Mayor de San Andre´s (UMSA), La Paz, within 1–
3 h after collection. One aliquot was used to carry out the MM3-
COPRO ELISA and another was preserved at 4uC to make the
Kato-Katz slides. All Kato-Katz slides were made at the
Laboratory of Parasitology of the Faculty of Medicine, UMSA,
and were initially examined within 1 h of preparation to avoid
overclarification of some helminth eggs.
In Cajamarca, at the time of the baseline survey (December
2007), the target population was 616 school children (age range 6–
15 years old), with a coverage of 4.25% of the school children
population and 0.86% of the overall population from the three
aforementioned districts. Thus, in the present study, fecal samples
were obtained from 362 children (264 males and 98 females), 7–15
years of age (mean 6 S.D. = 9.962.2), by similar procedures.
Samples were transported to Cajamarca city within 1–3 h after
collection and stored at 4uC until being sent to the Laboratory of
Parasitology at the Instituto de Medicina Tropical Alexander von
Humboldt, Lima, where coproparasitological analyses were
carried out. Both ELISA and Kato-Katz slides were applied to
two aliquots of the material preserved at 4uC. A third aliquot was
preserved in 10% formalin solution (1:3) for subsequent egg
detection by means of the rapid sedimentation technique [38].
To assure quality standards and possible handling differences,
procedures in the two laboratories were implemented by the same
personnel of the Valencia team in addition to the respective local
personnel of each laboratory. In Cajamarca, stool samples were
distributed into two groups according to the 400-epg threshold
used for identifying high intensity infections [18]: a high burden
group ($400 epg) and a low burden group (,400 epg). However,
in Huacullani, as precautionary measure, a lower threshold (300
epg) was requested to be applied by Bolivian health responsibles to
distinguish between samples whose respective infected children
were in need to be hospitalized for prevention follow up of
potential post-treatment colics, and samples whose respective
infected children were not hospitalized and were treated on an
out-patient basis [35].
Statistical analyses
Statistical analyses were done using PASW 17 software. For the
evaluation of categorical variables, the chi-square test or Fisher’s
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exact test was used. Bivariant correlations (Pearson’s correlation)
were calculated to assess the relationship between optical density
(OD) and epg of F. hepatica. A P value below 0.05 was considered
significant.
Theoretical positive predictive values (PPV) and negative
predictive values (NPV) were calculated from sensitivity and
specificity values obtained using only classical coprological tests for
the identification of F. hepatica eggs in feces as ‘‘gold standard’’.
The following formulas were used for their calculation:
PPV~(sensitivity|prevalence)=(sensitivity|prevalence)z
1{specificityð Þ| 1{prevalenceð Þð Þ
NPV~ specificity| 1 prevalenceð Þð Þ=
1{sensitivityð Þ|prevalenceð Þz specificityð Þ| 1{prevalenceð Þð Þð Þ
MM3-COPRO ELISA detection of Fasciola hepatica
coproantigens in fecal samples
The MM3-COPRO ELISA kits were prepared and tests
performed as previously described [22,32,34]. Kits were provided
by Dr. F.M. Ubeira (University of Santiago de Compostela,
Spain). Briefly, polystyrene microtiter 168 F strip plates (Greiner
Bio-One GmbH, Frickenhausen, Germany) were coated overnight
with 100 mL/well of a solution containing 10 mg/mL of rabbit
anti-Fasciola polyclonal IgG antibody in phosphate buffered saline
(PBS) (wells from odd-numbered rows), or with 100 mL/well of a
solution containing 10 mg/mL of IgG polyclonal antibodies from
non-immunized rabbits (wells from even-numbered rows). Un-
coated sites were blocked with 1.5% of sodium caseinate in PBS
for 1 h at RT, and each fecal supernatant (100 mL) was then
added in quadruplicate (2 odd-numbered wells plus 2 even-
numbered wells), and incubated overnight at 4uC. After washing 6
times with PBS containing 0.2% Tween-20 (PBS-T), 100 mL of a
solution containing 0.3 mg of biotinylated MM3 antibodies in PBS-
T plus 1% bovine serum albumin (PBS-T-BSA) was added to each
well and incubated for 1 hr at 37uC. After washing as above,
bound MM3 antibody was detected by incubation, first with
peroxidase-conjugated neutravidin (Pierce, Rockford, Illinois;
dilution 1:2000 in PBS-T-BSA) for 1 hr at 37uC, and then with
the substrate (buffered H2O2 and o–phenylenediamine [OPD],
Sigma-Aldrich, Madrid, Spain). After incubation for 20 min at
RT, the reaction was stopped by addition of 3N H2SO4. Finally,
OD was measured at 492 nm. The OD value for each sample was
calculated as OD1–OD2, where OD1 is the mean for the 2 even-
numbered wells (coated with anti-Fasciola polyclonal antibodies),
and OD2 is the mean for the 2 odd-numbered wells (coated with
irrelevant polyclonal antibodies). The OD value for each sample
was calculated by subtracting the OD of the blank well from the
OD of the test well using the cut-off point 0.097 [34].
Results
Diagnostic parameters of the MM3-COPRO ELISA were
estimated by (i) only choosing coprology as the ‘‘gold standard’’ assay
to detect F. hepatica infection in humans, and also by (ii) considering
results of both coprology and COPRO ELISA together. Positive cases
of the MM3-COPRO ELISA and egg detection techniques of F.
hepatica infection and performance characteristics of the MM3-
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Studies in Huacullani, Bolivia
Huacullani positive cases were globally 24.77% using MM3-
COPRO ELISA and 21.56% applying an egg detection technique
(Kato-Katz). No significant differences were encountered between
either % (P = 0.093).
In this Bolivian locality, using Kato-Katz as gold standard,
sensitivity and specificity were 94.68% and 98.48%, respectively,
and using Kato-Katz and COPRO-ELISA test together as gold
standard, sensitivity and specificity were 95.68% and 100%,
respectively.
Of 436 samples assayed, 94 showed the presence of eggs
through the Kato-Katz technique (21.56%). MM3-COPRO
ELISA was positive in 108 samples (24.77%), which included
samples with Fasciola eggs (89) and without Fasciola eggs (19), i.e.
82.40% of the children who were positive for the MM3-COPRO
ELISA were also positive through the Kato-Katz procedure. It
should be emphasized that there were five children shedding eggs
with emissions of 48, 72, 96, 120 and 1248 epg, whose MM3-
COPRO ELISA results were negative (1.14%). The stool sample
showing 1248 epg was repeatedly re-analyzed and a negative result
was always obtained with the MM3-COPRO ELISA test.
The geometric mean egg content in F. hepatica positive samples
was 142.17 epg, and the arithmetic mean was 334.98 (with SD of
692.56), with a range of 24 to 8088 epg (Table 1). In these
samples from Huacullani, epg data were distributed into two
groups: a high burden group ($400 epg) and a low burden group
(,400 epg) of samples.
The OD values obtained for individual F. hepatica positive and
negative fecal samples from Huacullani are shown in Figure 1.
Positive samples with F. hepatica eggs showed OD values above the
cut-off value except in five cases (determined by the Kato-Katz
technique).
In children who were positive in egg emission, the bivariant
correlation between OD and epg data from low and high burden
groups was carried out separately. A significant positive correlation
was detected only between OD and low burden (r2 = 0.20)
(Figure 2), but no significant positive correlation was detected
when considering OD and high burden (r2 = 0.01) (Figure 3).
Theoretical PPVs and NPVs vs fascioliasis prevalence are
represented in Figure 4A, showing the expected PPVs and NPVs
depending on whether the test was used in low, medium or high
prevalence scenarios in this Altiplanic highly endemic locality.
Studies in Cajamarca, Peru
Cajamarca positive cases were globally 11.05% using MM3-
COPRO ELISA and 5.60% employing egg detection techniques
(rapid sedimentation and Kato-Katz). Significant differences were
detected between both % (P = 0.007).
Differences between the two local patterns were detected, i.e.
significant differences were found when comparing MM3-
COPRO ELISA positive cases % from Huacullani and Cajamarca
(P = 0.0025), and also when comparing egg detection positive cases
% from Huacullani and Cajamarca (P = 0.001).
In Cajamarca, using rapid sedimentation and Kato-Katz
together as gold standard, sensitivity and specificity were 94.73%
and 93.58%, respectively, and using rapid sedimentation, Kato-
Katz and copro-ELISA together as gold standard, results were
97.56% and 100%, respectively.
In this Peruvian locality, of 362 samples assayed, 19 showed the
presence of eggs through the rapid sedimentation and Kato-Katz
techniques (5.24%), whereas MM3-COPRO ELISA was positive
in 40 samples, which included the samples with Fasciola eggs (18)
and without Fasciola eggs (22), i.e. 45.0% of the children who were
positive by MM3-COPRO ELISA were also positive through
coprological egg detection procedures. Interestingly, one child
shed eggs (by the rapid sedimentation technique) but was negative
by MM3-COPRO ELISA. The remaining 321 MM3-COPRO
ELISA negative samples, however, included 237 negative samples,
Figure 1. MM3-COPRO ELISA in feces from children (n=436) from Huacullani (Northern Bolivian Altiplano). Data points represent the
mean absorbance at 492 nm obtained from three replicates of each sample tested. The dotted line represents the cut-off value 0.097 units of OD at
492 nm.
doi:10.1371/journal.pntd.0001812.g001
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and 84 positive samples for parasitic infections other than Fasciola.
They involved one or more parasitic protozoans (Blastocystis
hominis, Chilomastix mensnilii, Giardia intestinalis, Entamoeba histolytica/
E. dispar/E. moshkovskii, E. coli, Endolimax nana, Iodamoeba buetschlii)
and helminth species (Strongyloides stercoralis, Ascaris lumbricoides,
Trichuris trichiura, Enterobius vermicularis and Hymenolepis nana).
The geometric mean egg content in F. hepatica positive samples
from Cajamarca was 89.80 epg, and the arithmetic mean was
116.47 (with SD of 684.80), with a range of 16 to 376 epg
(Table 1), i.e. samples were all considered as belonging to the low
burden group as their epg counts were ,400.
The OD values obtained for individual F. hepatica positive and
negative fecal samples from Cajamarca are shown in Figure 5.
Positive samples with F. hepatica eggs showed OD values above the
cut-off value except in one case (determined by the rapid
sedimentation technique).
In children who were positive in egg emission, the bivariant
correlation between OD and epg data (low burden) was carried
out. No significant positive correlation between OD and low
burden (r2 = 0.05) was detected (Figure 6).
Theoretical PPVs and NPVs vs fascioliasis prevalence are
represented in Figure 4B, showing the expected PPVs and NPVs
depending on whether the test was used in low, medium or high
prevalence scenarios in this Peruvian highly endemic locality.
Discussion
Sensitivity is defined as the proportion of people with the disease
who have a positive test for the disease. A sensitive test will rarely
miss people with the disease. Specificity is the proportion of people
without the disease who have a negative test. A specific test will
rarely misclassify people as having the disease when they do not
[39]. Knowing true positive and true negative cases is essential
when calculating sensitivity and specificity, respectively. The
identification of true positive and true negative cases was carried
out using classical coprological tests for the identification of F.
hepatica eggs in feces. Nevertheless, in the case of human
fascioliasis, the application of the rapid sedimentation or Kato-
Katz techniques may result in false negative cases. The ethiological
diagnosis based on egg detection in stools is complicated because
Figure 2. MM3-COPRO ELISA and intensity of Fasciola hepatica infection in the low burden group of Huacullani. Data points represent
the mean absorbance at 492 nm from egg positive children from Huacullani. epg represents the egg count per gram of feces. The dotted line
represents the cut-off value 0.097 units of OD at 492 nm.
doi:10.1371/journal.pntd.0001812.g002
Figure 3. MM3-COPRO ELISA and intensity of Fasciola hepatica infection in the high burden group of Huacullani. Data points represent
the mean absorbance at 492 nm from egg positive children from Huacullani. epg represents the egg count per gram of feces. The dotted line
represents the cut-off value 0.097 units of OD at 492 nm.
doi:10.1371/journal.pntd.0001812.g003
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parasite eggs are not found during the prepatent period [27,40],
when juvenile worms migrate through the intestinal wall to the
peritoneal cavity (at one week), penetrate the liver parenchyma (at
five to seven weeks), and pass into the biliary tract where they
ultimately reach maturity (at two months or more). Previous
studies have even estimated a period of at least three to four
months to be necessary for F. hepatica flukes to attain sexual
maturity in humans [27,41]. Once the worms have matured,
diagnosis still remains difficult because commonly employed
microscopic techniques for quantitative diagnosis of Fasciola eggs
are very specific but rather insensitive. In addition, in some cases
diagnosis is also difficult during the biliary stage, due to the
intermittent excretion of parasite eggs. Fecal egg counts are known
to follow inter- and intraindividual variations in fascioliasis
[42,43]. In our case, we used the Kato-Katz technique as a ‘‘gold
standard’’ because it is considered the best available for
quantitative analysis, although taking into account that it is
admittedly rather imperfect. Therefore, results from the rapid
sedimentation were also considered to improve the first gold
standard in Cajamarca, and the combination of results from both
Figure 4. Theoretical PPVs and NPV values vs fascioliasis prevalence. Curves show the expected PPVs (continuous line) and NPV (dotted
line) values in low (below 1%), medium (between 1% and 10%) or high (above 10%) prevalence scenarios (expressed in vertical lines) in Huacullani (A)
and Cajamarca (B).
doi:10.1371/journal.pntd.0001812.g004
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coprological methods and COPRO ELISA were used for both
study areas.
When liver-flukes are located in the bile ducts, excretory-
secretory (ES) products are released, being eliminated via feces.
The detection of these products by means of a sandwich-ELISA
reflects the installation of flukes in the bile ducts and the presence
of the biliary stage of the disease [30]. No statistically-significant
differences were detected between prevalence results obtained
using egg detection techniques and the MM3-COPRO ELISA in
Huacullani, where egg intensities are higher according to the
typical feature of the Altiplanic pattern. On the contrary, such
differences were detected in Cajamarca, probably as a conse-
quence of the low egg intensities characteristic of the valley
pattern, i.e. in Cajamarca low burdens are common and therefore
the higher probability of infected subjects intermittently shedding
very few eggs is higher, with the consequence that such cases go
unnoticed.
Five and one cases of egg emission were negative using the
MM3-COPRO ELISA in Huacullani and Cajamarca, respectively,
including one case of very high egg count (1248 epg) in the Bolivian
locality. Such cases pose a question mark. This result raises the
question as to whether these false negative cases may be interpreted
as being inherent to the kit design, or due to external factors not
attributable to the ELISA kit. However, considering that there is
broad experience in detecting Fasciola coproantigens in ovine and
bovine samples, and that animals with egg emission were not found
to be negative with the MM3 ELISA, it is unlikely that these false
negative results were due to kit construction. Furthermore, a recent
study has shown that the monoclonal antibody used in the MM3
assay recognizes L1 and L2 cathepsins [44], as does the ES78 in the
FasciDig test [20], and there were no observations of false negative
results with this test either. Three possible explanations include (i) an
intermittent release of the ES products from the liver to the intestine
through the bile ducts, (ii) spurious infections, and (iii) the existence
of food remains in the intestine masking or interfering with the
detection of the fluke ES antigens. The first does not seem to be the
case, as previous studies using this and other kits do not indicate the
emission of cathepsins L1 and L2 in either human or animal species
Figure 5. MM3-COPRO ELISA in feces from children (n=362) from Cajamarca valley (Peru). Data points represent the mean absorbance at
492 nm obtained from three replicates of each sample tested. The dotted line represents the cut-off value 0.097 units of OD at 492 nm.
doi:10.1371/journal.pntd.0001812.g005
Figure 6. MM3-COPRO ELISA and intensity of Fasciola hepatica infection in the low burden group of Cajamarca. Data points represent
the mean absorbance at 492 nm from egg positive children from Cajamarca. epg represents the egg count per gram of feces. The dotted line
represents the cut-off value 0.097 units of OD at 492 nm.
doi:10.1371/journal.pntd.0001812.g006
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to be intermittent (unlike with eggs). A spurious infection was
excluded after meticuluous study of the aspect of eggs in each one of
these children. A potential negative influence of high temperatures
during the transport or/and an inadequate handling of the samples
at a given moment throughout the whole procedure cannot be ruled
out, although the relatively short storage period does not suggest a
considerable denaturation of the L-cathepsins to have occurred.
In both Huacullani (representing the fascioliasis Altiplanic
pattern) and Cajamarca (representing the fascioliasis valley
pattern), cases of coproantigens present in the feces of humans
without F. hepatica eggs in stools were detected. Previous time-
course studies in animals on the detection of F. hepatica
coproantigens by ELISA indicated that coproantigens were
detectable prior to patency [45]. Furthermore, a marked increase
in the levels of these coproantigens at the beginning of fecal egg
output was observed [32]. Considering the positivity/negativity of
MM3-COPRO ELISA and the presence/absence of eggs in feces,
two situations were established in the current study: the Altiplanic
pattern with a correlation between positivity of MM3-COPRO
ELISA and the presence of eggs, and the valley pattern with a
larger number of positive cases applying MM3-COPRO ELISA
but without presence of eggs in feces.
The Altiplanic pattern, characterized by higher prevalences and
intensities, showed no statistical differences between the percent-
age of children who were positive in coproantigens and eggs in
feces. Thus, it may be concluded that the majority of children with
liver-flukes in the biliary ducts shed eggs. Nevertheless, in the
valley pattern, characterized by high prevalences but low
intensities, differences were detected between the percentage of
children who were positive to coproantigens and the reduced
number of these children that shed eggs in feces. This suggests that
children did not shed eggs or only a much reduced, undetectable
number even despite presenting parasites in their biliary canals.
In Europe, for instance, the diagnosis of human fascioliasis is
frequently established using serological tests, because the detection
of F. hepatica eggs in stools is not always possible. Thus, in an
epidemiological survey from 1970 to 1999 to record cases of
human fascioliasis detected in the Limousin region (central
France), egg detection in stools was positive in only 27.6% of a
total of 711 persons with fascioliasis [46]. Future studies are
needed in Cajamarca (and other endemic areas in valleys of the
Andean countries) to verify whether in these cases the non-
detection of eggs implies that the parasite (i) has not reached the
biliary ducts or is located in the bile-ducts but oviposition has not
yet started (suggesting a more or less recent infection) or (ii)
oviposition is taking already place but with only very low egg
numbers or with intermittent shedding (indicating that subjects
present only one or a very few flukes in the chronic stage).
Negative results by the MM3-COPRO ELISA after treatment,
which occurs approximately one to three weeks in animals, is
usually accepted when determining the efficacy of anthelminthic
treatment of biliary fascioliasis [22]. Contrarily, serological
methods have limitations when determining the efficacy of
anthelminthic treatment because the presence of antibodies
indicates previous exposure to the parasite rather than the
existence of a current infection. Additionally, after successful
anthelminthic treatment, several months have to pass for
serological antibody-detection tests to become negative. Hence,
the detection of specific antigens in feces allows for the
confirmation of a current infection, whereas antibody detection
tests need to be complemented by another technique to confirm
the results obtained in treated subjects. Future studies should be
carried out to determine the time required for negativization of
MM3-COPRO ELISA results after effective treatment in humans.
The MM3-COPRO ELISA is also a reliable method for
detecting F. gigantica coproantigens in fecal samples from
experimentally infected sheep [32]. Although most reported cases
of human fascioliasis are caused by F. hepatica, infections by F.
gigantica have also been reported [25]. The fact that the MM3-
COPRO ELISA can detect infections by both species may be of
great value to ensure diagnosis of human and animal fascioliasis in
countries where F. gigantica predominates, or where both species of
Fasciola are present [25,34].
Determining a patient’s parasitic burden is crucial given the
necessity to monitor drug treatment in order to prevent a hepatic
colic as the consequence of the massive expulsion of liver-flukes
[18], similar to other helminth diseases [47]. The Kato-Katz is
usually employed as a coprological quantitative technique.
Nevertheless, this technique has a low sensitivity, and the
elaboration of several slides from the same individual stool sample
is indispensable. The application of the Kato-Katz technique in
community surveys becomes problematic because (i) it is
pronouncedly time consuming when the number of samples is
high, (ii) microscopic egg count is also time consuming in cases of
heavy egg burdens, and (iii) it requires an additional technique to
increase the sensitivity in areas where subjects shed a very low
number of eggs in an intermittent way.
Results obtained in the samples from Huacullani showed that
the concentration of coproantigens in feces is correlated with epg
in the low burden group (,300 epg). This result agrees with a
previous study using the MM3-COPRO ELISA in cattle, which
showed that the concentration of coproantigens in feces is also
correlated with the number of flukes found in the livers of animals
collected after slaughter [22], as well as with the results of positive
correlation found with another coproantigen test in fascioliasis
infected patients in Cuba [30]. Nevertheless, our findings in the
high burden group ($300 epg) showed that the concentration of
coproantigens in feces is not correlated with epg. This result agrees
with the absence of any correlation between egg shedding in
human samples from Hospital patients, measured by the Kato-
Katz technique, and coproantigen concentration, measured by the
MM3-COPRO ELISA [34]. One possible explanation for this
discrepancy may be that the positive cases analyzed in Cuba [30]
probably corresponded to recent infections with less than a year of
age (early chronic stage), whereas our samples were from patients
with chronic infections, in which egg excretion is probably more
erratic. It must be kept in mind that fasciolid flukes may survive for
up to 13.5 years in humans, and the pattern of egg shedding is not
linear but fluctuates between maximum and minimum values [43].
By comparison, the kinetics of coproantigen release versus the
kinetics of egg shedding showed a similar pattern but with a two-
week time lag in epg [32].
In Cajamarca, chronic fascioliasis in valley samples, coproanti-
gen levels did not show a good correlation with epg. Therefore, the
use of only one coproproantigen technique appears to be
insufficient to evaluate the fluke burden.
In these hyperendemic areas, the number of subjects who
participate in surveys of this kind is very large, which implies the
problem of transporting and preserving the fecal samples, as the
coproantigen degrades at ambient temperature within a few days
and the fecal material cannot be treated with any classical fixative.
The monoclonal antibody MM3 recognizes a single conforma-
tional epitope, located in Fasciola cathepsins L1 and L2, which are
the main cysteine proteases produced by adult flukes gut [44]. The
stability of the antigen was observed during a period of 5 weeks,
except for samples preserved in CoproGuard, which were
observed for 17 weeks. Comparison of the different preservation
conditions revealed that even when maintained at 37uC, only the
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antigenicity of coproantigens in the samples diluted with
CoproGuard did not vary throughout the observation period. In
contrast, biocides such as sodium azide and thimerosal did not
preserve the antigenicity, as the start signal decreased to
approximately 30% by the end of the observation period. When
the samples were maintained at 4uC, the F. hepatica coproantigens
retained about 70% of their initial antigenicity after 5 weeks.
However, the antigens are relatively stable in some stools. This
suggests that degradation of MM3-recognized Fasciola coproanti-
gens depends on the presence of particular protease species, or
other factors, which differ for each patient [34].
Other studies have also referred to the stability of Fasciola
coproantigens. The monoclonal antibody F10 recognizes a 26–
28 kDa antigen which is a monomeric proteoglycan secreted and
excreted from the tegument and the gut of the flukes. The
antigenicity of that coproantigen was noted to be stable or even
enhanced by the action of proteolytic enzymes found in the
digestive tract and under a variety of standard laboratory storage
conditions. Storage at various temperatures resulted in some break
down of the protein. The storage of the purified protein at room
temperature overnight gave rise to several new bands ranging from
8 kDa to 20 kDa. Incubation of the purified coproantigen at 4uC
for two months resulted in a major band at 8 kDa and a minor
band at 20 kDa which decreased in size with longer incubation.
Storage of ES for more than three years resulted in a major band
at 8 kDa not seen in fresh ES. All these bands were recognized by
the monoclonal antibody. The 26–28 kDa band was always
detectable and the smaller bands are lower in intensity, suggesting
that the coproantigen is relatively stable during storage. Thus, that
degradation probably represents a loss of carbohydrate, since
antigenicity is maintained [48,49].
One possible alternative would be freezing the samples at
220uC, but this poses the additional problems of (i) difficult and
expensive transport of frozen samples to the laboratory where
determination is to take place, and (ii) the non-appropriateness of
frozen samples for the diagnosis of other parasite species present in
coinfections. Another solution is the use of Coproguard, which has
been demonstrated to be convenient for sample preservation in
this kind of surveys including the application of a coproantigen-
detection test [34].
In Huacullani and Cajamarca, the PPVs calculated for diverse
epidemiological situations are very different. PPVs in hyperen-
demic situations were very high, making this test recommendable
for such situations. Contrarily, NPVs calculated for diverse
epidemiological situations are similar.
Current efforts for the control of human fascioliasis need
diagnostic techniques which allow for high sensitivity and
specificity, large mass screening, detection in the chronic phase,
early detection of treatment failure or reinfection in post-treated
subjects, and usefulness in surveillance programs. Our results
indicate that a coproantigen-detection test such as MM3-COPRO
ELISA fulfils all these aspects. It provides a good tool to detect
biliary fascioliasis in humans under field conditions in Andean
hyperendemic countries, including a higher sensitivity than egg
detection techniques, especially in areas where burdens are usually
low, such as in areas of the valley transmission pattern. Hence, the
MM3-COPRO ELISA appears to be not only useful for individual
diagnosis in hospitals, but also in human surveys in fascioliasis
endemic areas characterized by low to high parasitic burdens.
The present MM3-COPRO ELISA validation is expected to
facilitate the improvement of human fascioliasis diagnosis in
endemic areas (a commercial version of the MM3-COPRO
ELISA is today available). The practical application of this
sensitive and convenient method for large scale surveillance in the
control programs in the Northern Bolivian Altiplano and
Cajamarca could improve screening of human fascioliasis in these
endemic areas by detecting infected humans in the biliary stage of
the disease, as a large number of samples can easily be processed.
Keeping in mind that most affected subjects are usually children,
the attainment of fecal samples is easier and faster than taking
blood samples, which is considered invasive. The former does not
pose difficulties for community elders, school head teachers and
parents who usually give their consent. Moreover, to many of these
indigenous communities, blood extraction is culturally not
acceptable.
Furthermore, our experience in Huacullani and Cajamarca
indicates that MM3-COPRO ELISA offers the easiest and fastest
way to adequately face large mass screenings, by initially applying
the coproantigen technique to all the coprological samples
obtained in the community survey and thereafter applying the
Kato-Katz technique only or first in coproantigen-positive
samples. It is recommended to treat subjects with coproantigen-
positive samples but with negative egg detection. This allows for a
quick selected treatment action, lending the positive effects of (i)
fast response in the communities surveyed that verify that infected
subjects are treated within a few days after the survey, and (ii)
reducing the probability of drug resistance appearance. The
remaining coproantigen-negative samples may finally be analyzed
for the eventual detection and subsequent selected treatment of
very few subjects shedding eggs, although this last step will
unavoidably be time-consuming.
Given the aforementioned advantages a coproantigen-detection
test offers, one wonders why there are only relatively few of such
tests for parasitic diseases affecting the digestive system available:
amebiasis [50], giardiasis [51], opisthorchiasis [52], taeniasis [53],
trichinelliasis [54], strongyloidiasis [55], hookworm infection [56].
Developing and/or improving highly specific coproantigen-detec-
tion test for diseases in which coprological diagnosis requires
specialized personnel and time-consuming microscope work would
evidently be welcome.
Acknowledgments
Studies of this article have been performed within the framework of the
Worldwide Initiative of WHO against Human Fascioliasis (WHO
Headquarters, Geneva, Switzerland). Technical support was provided by
Dra. K. Espinoza, Zoonosis Responsible Officer, Servicio Departamental
de Salud La Paz (SEDES L.P.) and Ministerio de Salud y Deportes
(MSyD), La Paz, Bolivia, and by Dra. A.M. Navarro, Coordinator,
Estrategia Nacional de Zoonosis, Direccio´n General de Salud de las
Personas, Ministerio de Salud (MINSA), Lima, Peru, and Dra. E. Vargas,
Direccio´n Regional de Salud (DIRESA), Cajamarca, Peru.
Author Contributions
Conceived and designed the experiments: MAV SM-C. Performed the
experiments: MAV MVP IP-C CA WS PH AT. Analyzed the data: MAV
RA FV JRE HT DE AFG SM-C. Contributed reagents/materials/analysis
tools: RA FV JRE PH. Wrote the paper: MAV SM-C.
References
1. Mas-Coma S, Valero MA, Bargues MD (2009a) Fasciola, lymnaeids and human
fascioliasis, with a global overview on disease transmission, epidemiology,
evolutionary genetics, molecular epidemiology and control. Adv Parasitol 69:
41–146.
Field Evaluation of Fascioliasis Coproantigen Test
PLOS Neglected Tropical Diseases | www.plosntds.org September 2012 | Volume 6 | Issue 9 | e1812208
2. Valero MA, Santana M, Morales M, Hernandez JL, Mas-Coma S (2003) Risk of
gallstone disease in advanced chronic phase of fascioliasis: an experimental study
in a rat model. J Inf Dis 188: 787–793.
3. Valero MA, Navarro M, Garcia-Bodelon MA, Marcilla A, Morales M, et al.
(2006a) High risk of bacterobilia in advanced experimental chronic fasciolosis.
Acta Trop 100: 17–23.
4. Valero MA, Girones N, Garcia-Bodelon MA, Periago MV, Chico-Calero I, et
al. (2008) Anaemia in advanced chronic fasciolosis. Acta Trop 108: 35–43.
5. Brady MT, O’Neill SM, Dalton JP, Mills KH (1999) Fasciola hepatica supresses a
protective Th1 response against Bordetella pertussis. Infect Immunity 67: 5372–
5378.
6. Girones N, Valero MA, Garcia-Bodelon MA, Chico-Calero MI, Punzon C, et
al. (2007) Immune supression in advanced chronic fascioliasis: an experimental
study in a rat model. J Inf Dis 195: 1504–1512.
7. Hotez PJ, Molyneux DH, Fenwick A, Kumaresan J, Ehrlich Sachs S, et al.
(2007) Control of neglected tropical diseases. N Engl J Med 357: 1018–1027
8. Hotez PJ, Bottazzi ME, Franco-Paredes C, Ault SK, Roses Periago M (2008)
The neglected tropical diseases of Latin America and the Caribbean: a review of
disease burden and distribution and a roadmap for control and elimination.
PLoS Negl Trop Dis 2: e300.
9. Esteban JG, Flores A, Angles R, Strauss W, Aguirre C, et al. (1997) A
population-based coprological study of human fascioliasis in a hyperendemic
area of the Bolivian Altiplano. Trop Med Int Health 2: 695–699.
10. Esteban JG, Flores A, Angles R, Mas-Coma S (1999) High endemicity of human
fascioliasis between Lake Titicaca and La Paz valley, Bolivia. Trans R Soc Trop
Med Hyg 93: 151–156.
11. Esteban JG, Gonzalez C, Bargues MD, Angles R, Sanchez C, et al. (2002) High
fascioliasis infection in children linked to a man-made irrigation zone in Peru.
Trop Med Int Health 7: 339–348.
12. Gonzalez LC, Esteban JG, Bargues MD, Valero MA, Ortiz P, et al. (2011)
Hyperendemic human fascioliasis in Andean valleys: An altitudinal transect
analysis in children of Cajamarca province, Peru. Acta Trop 120: 119–129.
13. Valero MA, Pe´rez-Crespo I, Khoubbane M, Artigas P, Panova M, et al. (2012)
Fasciola hepatica phenotypic characterization in Andean human endemic areas:
valley versus altiplanic patterns analysed in liver flukes from sheep from
Cajamarca and Mantaro, Peru. Infect Genet Evol 12: 403–410.
14. Fuentes MV, Valero MA, Bargues MD, Esteban JG, Angles R, et al. (1999)
Analysis of climatic data and forecast indices for human fascioliasis at very high
altitude. Ann Trop Med Parasitol 93: 835–850.
15. Claxton JR, Zambrano H, Ortiz P, Amoros C, Delgado E, et al. (1997) The
epidemiology of fasciolosis in the inter-Andean valley of Cajamarca, Peru.
Parasitol Int 46: 281–288.
16. Claxton JR, Sutherst J, Ortiz P, Clarkson MJ (1999) The effect of cyclic
temperatures on the growth of Fasciola hepatica and Lymnaea viatrix. Vet J 157:
166–171.
17. Savioli L, Chitsulo L, Montresor A (1999) New opportunities for the control of
fascioliasis. Bull WHO 77: 300.
18. World Health Organization (2007) Report of the WHO Informal Meeting on
use of triclabendazole in fascioliasis control. World Health Organization,
Headquarters Geneva, 17–18 October 2006: WHO/CDS/NTD/PCT/2007.1.
19. World Health Organization (2008) Fact sheet on fascioliasis. In: Action Against
Worms, World Health Organization, Headquarters Geneva (December 2007),
Newsletter 10: 1–8.
20. Dumenigo BE, Espino AM, Finlay CM (1996) Detection of Fasciola hepatica
antigen in cattle faeces by a monoclonal antibody based sandwich immunoassay.
Res Vet Sci 60: 278–279.
21. Abdel-Rahman S, O’Reilly KL, Malone JB (1998) Evaluation of a diagnostic
monoclonal antibody-based capture enzyme-linked immunosorbent assay for
detection of a 26–28 kd Fasciola hepatica coproantigen in cattle. Am J Vet Res 59:
533–537.
22. Mezo M, Gonzalez-Warleta M, Carro C, Ubeira FM (2004) An ultrasensitive
capture ELISA for detection of Fasciola hepatica coproantigens in sheep and
cattle using a new monoclonal antibody (MM3). J Parasitol 90: 845–852.
23. Estuningsih SE, Widjayanti S, Adiwinata G, Piedrafita D (2004) Detection of
coproantigens by sandwich ELISA in sheep experimentally infected with Fasciola
gigantica. Trop Biomed 21: 51–56.
24. Paz-Silva A, Pedreira J, Sa´nchez-Andrade R, Sua´rez JL, Dı´az P, et al. (2002)
Time-course analysis of coproantigens in rats infected and challenged with
Fasciola hepatica. Parasitol Res 88: 568–573.
25. Valero MA, Pe´rez-Crespo I, Periago MV, Khoubbane M, Mas-Coma S (2009a)
Fluke egg characteristics for the diagnosis of human and animal fascioliasis by
Fasciola hepatica and F. gigantica. Acta Trop 111: 150–159.
26. Hillyer GV (1999) Immunodiagnosis of human and animal fasciolosis. In: Dalton
JP, ed. Fasciolosis. Wallingford, UK: CAB International Publishing. pp. 435–
447.
27. Chen MG, Mott KE (1990) Progress in assessment of morbidity due to Fasciola
hepatica infections: a review of recent literature. Trop Dis Bull 87: R1-R38
28. Espino AM, Diaz A, Perez A, Finlay CM (1998) Dynamics of antigenemia and
coproantigens during a human Fasciola hepatica outbreak. J Cli Microbiol 36:
2723–2726.
29. Milla´n JC, Mull R, Freise S, Richter J, Triclabendazole Study Group (2000) The
efficacy and tolerability of triclabendazole in Cuban patients with latent and
chronic Fasciola hepatica infection. Am J Trop Med Hyg 63: 264–269.
30. Espino AM, Finlay CM (1994) Sandwich enzyme-linked immunosorbent assay
for detection of excretory secretory antigens in humans with fascioliasis. J Clin
Microbiol 32: 190–193.
31. Abdel-Rahman S, O’Reilly KL, Malone JB (1998) Evaluation of a diagnostic
monoclonal antibody-based capture enzyme-linked immunosorbent assay for
detection of a 26–28 kd Fasciola hepatica coproantigen in cattle. Am J Vet Res 59:
533–537.
32. Valero MA, Ubeira FM, Khoubbane M, Artigas P, Muin˜o L, et al. (2009b)
MM3-ELISA evaluation of coproantigen release and serum antibody production
in sheep experimentally infected with Fasciola hepatica and Fasciola gigantica. Vet
Parasitol 159: 77–81.
33. Charlier J, De Meulemeester L, Claerebout E, Williams D, Vercruysse J (2008)
Qualitative and quantitative evaluation of coprological and serological
techniques for the diagnosis of fascioliasis in cattle. Vet Parasitol 153: 44–51.
34. Ubeira FM, Muin˜o L, Valero MA, Periago MV, Pe´rez-Crespo I, et al. (2009)
MM3-ELISA detection of Fasciola hepatica coproantigens in preserved human
stool samples. Am J Trop Med Hyg 81: 156–162.
35. Villegas F, Angles R, Barrios G, Valero MA, Hamed K, et al. (2012)
Administration of triclabendazole is safe and effective in controlling fascioliasis in
an endemic community of the Bolivian Altiplano. PLoS PLoS Negl Trop Dis: in
press.
36. Habtamu K, Degarege A, Ye-Ebiyo Y, Erko B (2011) Comparison of the Kato-
Katz and FLOTAC techniques for the diagnosis of soil-transmitted helminth
infections. Parasitol Int 60: 398–402
37. Ash LR, Orihel TC, Savioli L (1994) Bench aids for the diagnosis of intestinal
parasites. World Health Organization, Geneva.
38. Lumbreras H, Cantella R, Burga R (1962) Acerca de un procedimiento de
sedimentacion rapida para investigar huevos de Fasciola hepatica en las heces, su
evaluacion y uso en el campo. Rev Med Peru 31: 167–174.
39. Fletcher RH, Fletcher SW (2005) Clinical Epidemiology The Essentials, Fourth
Edition. Lippincott WIlliams & Wilkins, Baltimore, MD, USA. Chapter 3.
Diagnosis. pp. 35–58.
40. Levine DM, Hillyer GV, Flores SI (1980) Comparison of counterelectrophoresis,
the enzyme-linked immunosorbent assay and kato fecal examination for the
diagnosis of fascioliasis in infected mice and rabbits. Am J Trop Med Hyg 29:
602–608.
41. Wei DX (1984) Fasciola and fascioliasis. Chin J Vet Med 9: 16–18.
42. El-Morshedy H, Shehab A, Zaki A, Farag H (2002) Intra-specimen and day-to-
day variations of Fasciola egg counts in human stools. East Mediterr Health J 8:
619–625.
43. Valero MA, Panova M, Pe´rez-Crespo I, Khoubbane M, Mas-Coma S (2011)
Correlation between egg-shedding and uterus development in Fasciola hepatica
human and animal isolates: applied implications. Vet Parasitol 183: 79–86.
44. Muin˜o L, Perteguer MJ, Ga´rate T, Martı´nez-Serna´ndez V, Beltra´n A, et al.
(2011) Molecular and immunological characterization of Fasciola antigens
recognized by the MM3 monoclonal antibody. Mol Biochem Parasitol
179:80–90.
45. Espino AM, Marcet R, Finlay CM (1997) Fasciola hepatica: detection of
antigenemia and coproantigens in experimentally infected rats. Exp Parasitol
85: 117–120.
46. Rondelaud D, Dreyfuss G, Vignoles P (2006) Clinical and biological
abnormalities in patients after fasciolosis treatment. Med Mal Infect 36: 466–
468.
47. Montresor A, Crompton DWT, Bundy DAP, Hall A, Savioli L (1998)
Guidelines for the Evaluation of Soil-Transmitted Helminthiasis and Schisto-
somiasis at Community Level. A Guide for Managers of Control Programmes.
Geneva, Switzerland: World Health Organization. WHO/CTD/SIP/98.1.
48. El-Bahy MM, Malone JB, Todd WJ, Schnorr KL (1992) Detection of stable
diagnostic antigen in the bile and feces of Fasciola hepatica infected cattle. Vet
Parasitol 45:157–167.
49. Abdel-Rahman S, O’Reily KL, Malone JB (1999) Biochemical characterization
and localization of Fasciola hepatica 26–28 kDa diagnostic coproantigen. Parasite
Immunol 21: 279–286.
50. Singh K, Vinayak VK, Bhasin DK, Ganguly NK (1999) A monoclonal
antibody-based test system for detection of Entamoeba histolytica-specific
coproantigen. Indian J Gastroenterol 18: 104–108.
51. Jelinek T, Peyerl G, Lo¨scher T, Nothdurft HD (1996) Giardiasis in travellers:
evaluation of an antigen-capture ELISA for the detection of Giardia lamblia-
antigen in stool. Z Gastroenterol 34: 237–240.
52. Sirisinha S, Chawengkirttikul R, Haswell-Elkins MR, Elkins DB, Kaewkes S, et
al. (1995) Evaluation of a monoclonal antibody-based enzyme linked
immunosorbent assay for the diagnosis of Opisthorchis viverrini infection in an
endemic area. Am J Trop Med Hyg 52: 521–524.
53. Allan JC, Craig PS (2006) Coproantigens in taeniasis and echinococcosis.
Parasitol Int 55 (Suppl): 75–80.
54. Boulos LM, Ibrahim IR, Negm AY, Aly SM (2001) Detection of coproantigen in
early trichinellosis. Parasite 8 (2 Suppl): 136–139.
55. Sykes AM, McCarthy JS (2011) A coproantigen diagnostic test for Strongyloides
infection. 5(2): e955.
56. Bungiro RD Jr, Cappello M (2005) Detection of excretory/secretory coproanti-
gens in experimental hookworm infection. Am J Trop Med Hyg 73: 915–920.
Field Evaluation of Fascioliasis Coproantigen Test
PLOS Neglected Tropical Diseases | www.plosntds.org September 2012 | Volume 6 | Issue 9 | e1812209
